data_2knm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2knm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.247 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.5 mt -130.36 131.32 23.31 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.33 126.75 17.6 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.52 2.147 . . . . 0.0 111.633 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.1 m -81.2 -48.12 12.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.079 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.43 -53.9 0.4 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.788 -1.196 . . . . 0.0 113.856 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.523 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 3.4 mp0 -67.32 147.45 52.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.314 0.578 . . . . 0.0 112.098 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -110.21 127.33 54.89 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.324 178.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.7 m -73.61 41.63 0.12 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.852 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.727 HG22 ' HD2' ' A' ' 25' ' ' LYS . 7.6 t -104.87 -49.16 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -139.09 -11.48 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.333 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.464 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 48.4 mm -116.2 125.26 28.71 Favored Pre-proline 0 CA--C 1.528 0.111 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.908 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 11' ' ' ILE . 2.8 Cg_exo -74.17 143.49 32.14 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.695 2.264 . . . . 0.0 110.859 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.0 m -69.76 95.36 0.88 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.884 0.374 . . . . 0.0 111.997 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.42 HD12 HG23 ' A' ' 14' ' ' ILE . 47.1 mm -69.18 -32.28 53.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.682 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 17.4 p -61.81 -6.7 2.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.255 -1.793 . . . . 0.0 111.608 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 23.8 m -58.81 -26.09 63.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.34 -31.26 69.02 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.73 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.8 pt -103.93 27.53 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.547 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.43 5.45 79.14 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 115.362 0.905 . . . . 0.0 115.362 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 15' ' ' SER . 92.6 m -75.34 141.43 43.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.48 1.14 . . . . 0.0 110.556 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -148.49 146.39 28.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.78 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.1 m -53.61 125.01 16.67 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 38.8 mttp -151.72 122.9 7.7 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.3 m 59.78 36.86 22.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.429 . . . . 0.0 110.245 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.727 ' HD2' HG22 ' A' ' 9' ' ' VAL . 18.3 tppt? 71.69 0.92 3.68 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.501 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -125.85 146.85 30.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 121.724 -0.61 . . . . 0.0 110.458 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 39.8 m -69.98 117.76 11.97 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.46 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 3.9 m-85 -122.91 152.68 40.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.389 0.614 . . . . 0.0 111.344 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.494 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 5.6 tmm_? . . . . . 0 C--N 1.316 -0.885 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.313 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.394 0 CA-C-O 120.475 -0.07 . . . . 0.0 113.185 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 2' ' ' ILE . 64.6 mt -103.07 126.66 31.76 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.68 123.17 12.47 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.321 2.014 . . . . 0.0 112.273 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.68 -16.83 60.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.362 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.55 -36.0 3.97 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.078 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.534 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 25.9 mt-10 -63.39 133.0 53.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.866 0.365 . . . . 0.0 110.281 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -119.77 125.17 47.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.418 0.628 . . . . 0.0 110.779 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.3 m -71.01 6.02 1.77 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.19 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.613 HG22 ' HB3' ' A' ' 25' ' ' LYS . 13.2 t -79.43 -33.51 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.318 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -118.95 -45.5 2.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.222 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -142.43 133.62 12.93 Favored Pre-proline 0 N--CA 1.464 0.26 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.299 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.94 140.89 92.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.271 1.981 . . . . 0.0 110.995 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.543 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 2.9 m -72.42 115.21 11.41 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.483 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.6 mt -67.44 -37.62 79.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.451 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 15.3 m -61.61 -8.57 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.017 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 33.1 m -59.96 -35.89 75.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.12 -24.91 67.43 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.951 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.9 pt -104.41 13.87 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.91 -24.42 5.13 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.167 -1.492 . . . . 0.0 115.604 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 16' ' ' SER . 73.4 m -63.58 137.22 58.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.415 1.107 . . . . 0.0 111.547 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -122.36 126.19 47.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.915 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.3 t -75.91 124.22 26.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.051 0.453 . . . . 0.0 110.798 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -137.88 123.03 19.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 m 59.42 34.86 22.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.184 0.516 . . . . 0.0 110.083 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.613 ' HB3' HG22 ' A' ' 9' ' ' VAL . 64.2 mttp 70.48 13.22 7.45 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.306 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 t -128.03 132.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.6 m -89.13 135.15 33.72 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.97 142.95 49.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.322 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 . . . . . 0 C--N 1.317 -0.824 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.374 0 N-CA-C 113.305 0.082 . . . . 0.0 113.305 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.407 HG23 HD12 ' A' ' 2' ' ' ILE . 71.8 mt -123.13 127.2 25.74 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.64 124.82 15.34 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.504 2.136 . . . . 0.0 113.189 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.7 m -78.22 -28.02 47.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.583 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.16 -41.22 2.25 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.297 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.79 136.33 50.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.779 0.324 . . . . 0.0 111.084 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.75 129.11 54.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 p -72.3 -18.43 61.79 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.818 HG23 ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -67.65 -44.16 86.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.326 178.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -78.35 -45.97 21.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.904 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.787 HD11 ' HD2' ' A' ' 12' ' ' PRO . 6.9 tp -170.22 135.29 1.18 Allowed Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.787 ' HD2' HD11 ' A' ' 11' ' ' ILE . 1.2 Cg_endo -47.82 134.98 22.96 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.443 2.095 . . . . 0.0 112.222 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.457 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 3.5 m -72.01 125.49 27.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.986 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.8 -38.68 83.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.453 ' HB2' HH21 ' A' ' 29' ' ' ARG . 40.3 p -62.08 -14.58 37.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.007 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 58.6 m -62.88 -34.33 77.17 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.56 -20.64 64.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.251 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.428 HD12 HG22 ' A' ' 18' ' ' ILE . 34.8 pt -112.24 20.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.34 -27.57 5.51 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 118.963 -1.589 . . . . 0.0 116.244 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 16' ' ' SER . 68.1 m -62.64 133.33 54.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.508 1.154 . . . . 0.0 112.457 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -120.9 121.68 38.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.981 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.884 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 8.0 t -68.31 131.62 45.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.056 0.455 . . . . 0.0 111.02 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -143.85 131.03 20.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.3 m 57.74 35.9 26.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.374 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.818 ' HB3' HG23 ' A' ' 9' ' ' VAL . 30.1 mtmm 82.74 -16.72 0.57 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.573 1.149 . . . . 0.0 112.927 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.9 p -116.68 135.07 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.351 0.596 . . . . 0.0 112.016 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.884 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 m -69.85 137.15 51.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.277 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -129.34 155.5 45.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.708 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 29' ' ' ARG . 13.7 ptp180 . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.952 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.276 0 N-CA-C 112.7 -0.16 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 75.8 mt -129.77 131.39 23.51 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 23.1 Cg_exo -63.19 127.45 20.19 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.474 2.116 . . . . 0.0 111.949 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.9 m -79.79 -49.76 11.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.941 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.95 -52.42 0.4 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.972 -1.108 . . . . 0.0 113.503 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.536 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 1.3 mp0 -75.19 166.94 22.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.578 0.704 . . . . 0.0 111.863 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.2 m -127.23 138.91 53.21 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -64.19 -23.76 67.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 0.0 111.606 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -71.42 -33.29 49.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.578 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.512 ' O ' HG23 ' A' ' 11' ' ' ILE . 12.4 m95 -85.86 -55.88 3.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.755 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 10' ' ' TRP . 1.5 pp -160.15 162.84 23.42 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.72 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -62.35 143.62 93.96 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.152 1.901 . . . . 0.0 111.43 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.406 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 35.8 m -65.31 107.33 1.58 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.128 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 pt -68.41 -36.48 75.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.487 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 41.5 m -59.45 -7.43 1.38 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.508 -1.678 . . . . 0.0 111.834 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 48.2 m -58.31 -32.65 68.66 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.01 -30.22 69.01 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.503 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.481 HD11 HG22 ' A' ' 18' ' ' ILE . 24.1 pt -101.53 24.47 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.17 12.11 57.85 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 115.384 0.913 . . . . 0.0 115.384 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 16' ' ' SER . 75.2 m -87.93 153.13 21.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 118.208 1.004 . . . . 0.0 110.084 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.4 t -144.87 142.87 30.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.784 0.326 . . . . 0.0 110.378 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.453 ' O ' ' HE3' ' A' ' 23' ' ' LYS . 41.9 t -66.8 131.35 45.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.771 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HE3' ' O ' ' A' ' 22' ' ' CYS . 1.2 tppp? -158.86 129.4 6.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m 59.53 33.56 22.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.1 0.476 . . . . 0.0 110.889 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt 71.59 10.49 6.45 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.635 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.544 HG21 ' CE1' ' A' ' 28' ' ' TYR . 1.3 m -136.26 152.67 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.922 0.391 . . . . 0.0 110.649 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 22.9 m -80.01 122.24 26.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.659 0.266 . . . . 0.0 111.119 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.544 ' CE1' HG21 ' A' ' 26' ' ' VAL . 3.9 m-85 -129.25 155.03 46.21 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.285 0.564 . . . . 0.0 111.148 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.417 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 45.7 ttp180 . . . . . 0 C--N 1.314 -0.949 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.839 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 112.039 -0.424 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.72 125.94 27.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.33 130.33 33.53 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.589 2.193 . . . . 0.0 112.611 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 58.9 m -98.65 15.65 24.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.333 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.93 -46.66 2.7 Favored Glycine 0 C--N 1.331 0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.677 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -64.59 160.03 20.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.177 0.513 . . . . 0.0 111.342 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.56 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -148.03 133.01 18.14 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.286 0.565 . . . . 0.0 110.947 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.5 m -75.67 25.89 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.196 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.56 ' H ' ' C ' ' A' ' 7' ' ' SER . 25.0 t -92.49 -37.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -108.86 -45.13 3.86 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.69 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -153.37 155.79 31.97 Favored Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -64.29 146.54 90.26 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.382 2.055 . . . . 0.0 110.486 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 22' ' ' CYS . 1.5 m -67.84 115.62 7.59 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.34 -33.95 63.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.5 p -62.97 -5.91 3.38 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.82 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 29.4 m -62.03 -30.48 71.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -24.58 63.91 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.128 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.3 pt -112.35 28.23 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.26 -16.0 53.7 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 116.376 1.31 . . . . 0.0 116.376 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 16' ' ' SER . 89.6 m -70.24 141.07 52.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 118.983 1.392 . . . . 0.0 111.573 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 p -142.31 124.39 15.38 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.799 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 21.5 p -73.76 130.25 39.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.952 0.882 . . . . 0.0 111.663 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.842 ' HE2' ' HB2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -132.17 133.44 44.23 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.6 m 61.79 31.28 18.43 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 33.6 mttm 73.75 -5.82 1.93 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.051 -1.431 . . . . 0.0 113.353 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.1 t -105.11 132.98 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 118.401 0.546 . . . . 0.0 109.901 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.799 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 57.6 m -75.78 125.31 28.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.842 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 9.5 m-85 -136.32 141.21 43.77 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.321 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.464 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 22.4 ttm180 . . . . . 0 C--N 1.307 -1.259 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.349 0 CA-C-O 120.378 -0.123 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 65.0 mt -94.16 124.03 57.18 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.973 0.386 . . . . 0.0 110.223 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.75 118.91 5.83 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.083 1.856 . . . . 0.0 112.514 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.6 m -75.37 -23.92 57.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.375 0.607 . . . . 0.0 109.57 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.43 -37.95 3.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.058 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 3.0 pt-20 -71.3 125.75 27.79 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.155 0.502 . . . . 0.0 111.225 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.42 132.61 38.87 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.6 p -72.59 -22.52 60.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.126 0.488 . . . . 0.0 112.211 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.99 -33.08 42.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.241 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -82.34 -52.55 6.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.741 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.6 pt -152.25 155.73 33.34 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.914 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -63.6 136.0 52.0 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.277 1.318 . . . . 0.0 110.442 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.563 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 56.2 m -73.84 114.59 12.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.053 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mm -66.29 -41.9 89.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.419 ' HA ' HG12 ' A' ' 18' ' ' ILE . 49.5 m -64.13 -7.81 10.12 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.055 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.563 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 18.8 m -64.15 -34.33 77.82 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.52 -18.55 62.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.954 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.419 HG12 ' HA ' ' A' ' 15' ' ' SER . 21.8 pt -117.93 23.99 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.81 -30.89 5.37 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 118.946 -1.597 . . . . 0.0 116.754 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 16' ' ' SER . 96.2 m -62.33 133.53 55.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.623 1.211 . . . . 0.0 112.479 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.9 t -126.89 134.29 50.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 14.1 t -75.02 135.07 41.3 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.366 0.603 . . . . 0.0 112.285 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -150.86 132.42 14.79 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.235 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 4.3 m 59.48 35.02 22.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 24' ' ' SER . 67.3 mttm 77.95 -16.97 0.61 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.892 0.877 . . . . 0.0 112.852 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -110.85 137.63 42.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-O 121.009 0.433 . . . . 0.0 111.717 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 2.1 m -77.94 136.18 37.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.162 0.506 . . . . 0.0 112.257 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -129.12 148.05 51.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.679 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.533 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 19.5 ttm180 . . . . . 0 C--N 1.314 -0.947 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.209 0 N-CA-C 112.682 -0.167 . . . . 0.0 112.682 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mm -120.66 127.12 26.42 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.15 125.47 14.14 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.39 2.06 . . . . 0.0 112.377 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.2 m -85.65 -0.56 55.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.616 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.06 -45.35 3.43 Favored Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 113.406 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.562 ' OE2' HG12 ' A' ' 14' ' ' ILE . 53.8 mt-10 -62.89 142.27 58.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.824 0.345 . . . . 0.0 111.13 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.06 138.35 49.55 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.258 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.9 m -66.25 -15.55 63.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.54 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.422 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 41.9 t -68.77 -34.76 66.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.937 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -93.24 -57.13 2.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.217 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.4 pt -160.55 160.34 25.77 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.177 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -63.12 137.93 64.34 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.658 1.572 . . . . 0.0 110.326 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.3 m -75.71 122.77 24.5 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.346 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.562 HG12 ' OE2' ' A' ' 6' ' ' GLU . 12.4 pt -65.64 -37.4 79.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 m -60.32 -11.84 7.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.839 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 59.0 m -61.84 -34.3 75.72 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.01 -24.09 66.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.974 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.462 HG23 HD11 ' A' ' 18' ' ' ILE . 24.0 pt -107.33 25.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.19 -19.98 28.94 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 116.361 1.304 . . . . 0.0 116.361 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.627 ' O ' ' HA ' ' A' ' 16' ' ' SER . 84.1 m -68.54 137.44 54.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.746 1.273 . . . . 0.0 112.004 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.6 p -137.38 138.13 39.57 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 2.1 m -64.95 121.07 13.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.655 0.74 . . . . 0.0 111.934 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -123.67 121.02 34.45 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.6 m 57.44 38.3 28.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 24' ' ' SER . 97.2 mttt 81.17 -18.34 0.5 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.988 -1.006 . . . . 0.0 113.3 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.11 133.51 52.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 117.955 0.343 . . . . 0.0 110.826 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 4.1 m -68.23 129.68 40.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.446 0.641 . . . . 0.0 112.434 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -132.82 154.54 50.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.24 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.444 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 51.7 ttp180 . . . . . 0 C--N 1.315 -0.9 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 pt -129.18 140.05 37.49 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.947 0.374 . . . . 0.0 110.184 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.91 128.42 24.22 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.383 2.056 . . . . 0.0 112.596 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 63.1 m -82.06 -48.37 11.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.618 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.25 -55.82 0.35 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.564 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.84 158.68 35.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.614 0.721 . . . . 0.0 111.248 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.428 ' C ' ' H ' ' A' ' 9' ' ' VAL . 1.1 m -128.6 137.61 51.78 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.07 3.86 2.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.098 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.548 HG23 ' HB3' ' A' ' 25' ' ' LYS . 32.1 t -85.81 -33.57 7.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.427 ' O ' HG22 ' A' ' 11' ' ' ILE . 11.8 m95 -104.12 -52.45 2.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.012 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.445 HD11 ' N ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -146.17 157.64 49.35 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-O 120.776 0.322 . . . . 0.0 111.645 -178.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.49 146.91 86.21 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.811 2.341 . . . . 0.0 111.149 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.476 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 23.8 m -64.36 103.75 0.68 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.6 mt -69.57 -36.67 72.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.553 ' HA ' HG12 ' A' ' 18' ' ' ILE . 68.8 m -63.51 0.25 0.77 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.841 -1.527 . . . . 0.0 111.923 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.577 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 65.2 m -60.36 -33.58 72.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.01 -22.18 65.91 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.425 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.553 HG12 ' HA ' ' A' ' 15' ' ' SER . 1.4 mm -94.13 9.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.612 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.38 17.09 43.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.487 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 16' ' ' SER . 93.8 m -94.13 154.91 17.35 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -144.23 149.96 37.19 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.98 126.57 30.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.206 0.526 . . . . 0.0 110.858 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -144.34 121.66 11.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 m 58.08 37.8 26.52 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.973 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.548 ' HB3' HG23 ' A' ' 9' ' ' VAL . 30.4 mmmt 68.49 13.73 9.01 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.839 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.548 HG21 ' CE1' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -133.91 143.15 39.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.9 m -78.55 121.14 24.22 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.548 ' CE1' HG21 ' A' ' 26' ' ' VAL . 3.1 m-85 -126.47 148.95 49.59 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.358 0.599 . . . . 0.0 110.707 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.616 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.2 ttm180 . . . . . 0 C--N 1.311 -1.071 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.444 0 CA-C-O 120.069 -0.295 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.94 126.58 52.95 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 117.303 0.551 . . . . 0.0 110.592 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.79 120.41 8.29 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.445 2.096 . . . . 0.0 112.582 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 61.4 m -76.23 -25.3 54.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.441 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.18 -31.01 8.27 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.7 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.524 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 32.9 mt-10 -61.53 130.72 47.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.61 0.243 . . . . 0.0 110.411 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.18 125.9 51.55 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 m -65.14 -18.19 65.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.527 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.8 t -71.23 -35.53 58.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.309 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.461 ' O ' HG23 ' A' ' 11' ' ' ILE . 19.3 m95 -89.92 -52.88 4.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.505 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 10' ' ' TRP . 1.6 pp -155.58 153.85 27.11 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.285 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.16 147.91 88.63 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.581 2.187 . . . . 0.0 111.231 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.6 m -58.27 103.94 0.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.574 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.425 ' C ' ' H ' ' A' ' 16' ' ' SER . 67.9 mt -68.77 -39.85 80.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.5 m -64.3 2.65 0.56 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 113.61 -1.632 . . . . 0.0 111.695 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 62.5 p -62.47 -32.65 73.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.67 -20.64 57.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.203 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 pt -119.62 26.53 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.13 -22.15 16.39 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 16' ' ' SER . 85.6 m -68.13 137.67 55.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.992 1.396 . . . . 0.0 111.957 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -133.77 138.4 45.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.085 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.4 t -72.23 130.69 41.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.872 0.368 . . . . 0.0 111.492 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.494 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 17.7 ttpt -153.84 127.47 8.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 16.5 m 59.14 36.01 23.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.822 0.344 . . . . 0.0 111.031 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 24' ' ' SER . 1.1 mptm? 71.54 10.54 6.5 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.532 0.733 . . . . 0.0 112.643 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.424 HG11 ' O ' ' A' ' 23' ' ' LYS . 2.1 p -140.01 139.93 36.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.147 0.499 . . . . 0.0 110.318 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 34.0 m -78.93 136.13 37.17 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.494 ' CE1' ' HE2' ' A' ' 23' ' ' LYS . 27.7 m-85 -128.45 146.04 50.92 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.339 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.593 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 26.5 ttm180 . . . . . 0 C--N 1.314 -0.962 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 29' ' ' ARG . 37.4 pt -122.95 137.13 27.65 Favored Pre-proline 0 C--N 1.333 -0.123 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.3 129.29 23.66 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.548 2.165 . . . . 0.0 113.512 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.3 m -93.87 9.6 36.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.088 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.88 -41.96 2.44 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 113.459 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -63.75 141.17 58.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 122.639 0.376 . . . . 0.0 110.588 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 132.6 53.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.5 t -70.49 -28.31 64.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.397 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.8 t -71.45 -40.36 72.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.677 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -71.44 -52.63 17.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.552 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.66 156.22 38.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -62.13 138.93 75.57 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.08 1.187 . . . . 0.0 109.15 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 66.1 m -59.47 99.56 0.06 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.4 mt -68.94 -32.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.5 p -64.12 -12.62 41.31 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.231 -1.349 . . . . 0.0 110.776 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.736 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 6.6 t -62.87 -34.79 78.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.89 -20.95 64.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.32 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.4 pt -113.19 21.53 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.0 -31.2 5.4 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.522 -1.323 . . . . 0.0 115.743 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.736 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.3 m -71.28 171.14 11.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.12 0.96 . . . . 0.0 111.232 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.3 p -166.47 145.24 5.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.203 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.3 m -53.34 129.13 30.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 110.467 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.627 ' HZ1' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -153.07 115.92 4.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.5 m 55.82 41.94 29.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.544 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 24' ' ' SER . 1.0 OUTLIER 76.1 -14.52 0.79 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.582 0.753 . . . . 0.0 112.856 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.1 t -112.55 146.81 16.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.911 0.386 . . . . 0.0 110.757 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.0 m -73.5 119.51 17.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.4 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 3.2 m-85 -123.72 144.92 49.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.498 0.666 . . . . 0.0 111.521 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.402 ' O ' HG12 ' A' ' 2' ' ' ILE . 51.5 ttm-85 . . . . . 0 C--N 1.311 -1.097 0 CA-C-N 114.535 -1.211 . . . . 0.0 107.884 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 113.831 0.292 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.423 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.5 mp -96.75 125.75 45.57 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 117.329 0.565 . . . . 0.0 110.231 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.62 123.59 14.22 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.133 1.888 . . . . 0.0 112.287 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.4 m -76.52 -37.98 55.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.305 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.09 -40.7 2.07 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.323 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.4 ' CD ' ' HG ' ' A' ' 15' ' ' SER . 1.7 mt-10 -72.65 133.01 44.44 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.245 0.545 . . . . 0.0 111.278 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -106.5 127.7 53.51 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.206 178.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 37.12 0.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.701 0.762 . . . . 0.0 110.972 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.666 HG21 ' HE3' ' A' ' 25' ' ' LYS . 21.4 t -124.37 -40.87 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' O ' HG13 ' A' ' 11' ' ' ILE . 17.1 m0 -92.8 -49.23 6.17 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.119 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 10' ' ' TRP . 56.9 mt -157.27 135.22 7.26 Favored Pre-proline 0 N--CA 1.468 0.463 0 O-C-N 123.006 0.191 . . . . 0.0 110.723 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.21 139.74 80.94 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.478 2.119 . . . . 0.0 111.763 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.438 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.7 m -73.83 117.83 16.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.279 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.13 -34.47 66.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.4 ' HG ' ' CD ' ' A' ' 6' ' ' GLU . 77.9 p -60.6 -12.65 10.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.222 -1.353 . . . . 0.0 112.0 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 19.1 m -59.63 -36.09 75.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.29 67.28 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.875 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.426 HD13 HG22 ' A' ' 18' ' ' ILE . 41.0 pt -104.91 17.22 5.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.71 -21.13 8.07 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 119.038 -1.553 . . . . 0.0 115.524 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 16' ' ' SER . 55.6 m -64.77 138.21 58.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.272 1.036 . . . . 0.0 111.76 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.3 t -123.6 134.32 53.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.651 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.5 t -75.73 116.77 16.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.022 0.439 . . . . 0.0 110.576 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -130.91 126.41 36.04 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m 58.58 36.94 25.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.198 0.523 . . . . 0.0 110.666 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.666 ' HE3' HG21 ' A' ' 9' ' ' VAL . 31.5 mmmt 70.7 11.27 7.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.962 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 p -136.78 134.73 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.174 0.511 . . . . 0.0 109.68 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.0 m -79.17 134.37 36.7 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -129.79 146.13 51.55 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.635 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 2' ' ' ILE . 9.6 ptp180 . . . . . 0 C--N 1.313 -1.011 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.568 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.196 0 N-CA-C 112.737 -0.145 . . . . 0.0 112.737 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 70.3 mt -123.81 130.48 24.42 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 27.9 Cg_exo -62.21 126.07 17.79 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.615 2.21 . . . . 0.0 111.983 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.4 m -78.36 -22.63 47.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.612 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.86 -38.54 3.06 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.608 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -69.85 137.57 51.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.982 0.42 . . . . 0.0 110.72 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 t -111.1 144.95 39.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.024 0.916 . . . . 0.0 110.426 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -73.8 -16.97 61.14 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.701 -1.591 . . . . 0.0 110.859 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.28 -38.95 23.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.99 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -77.54 -52.2 9.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.553 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.716 HD11 ' HD2' ' A' ' 12' ' ' PRO . 8.1 tp -177.72 141.82 0.46 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.716 ' HD2' HD11 ' A' ' 11' ' ' ILE . 1.2 Cg_endo -46.21 133.44 15.31 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.394 2.063 . . . . 0.0 112.075 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.2 m -71.86 122.58 21.0 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.405 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.536 HD13 ' H ' ' A' ' 14' ' ' ILE . 2.8 mp -65.8 -35.58 75.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.434 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 61.4 p -61.19 -15.59 35.76 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.829 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 74.5 m -61.32 -35.41 77.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.89 -23.1 66.1 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.432 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 pt -108.71 23.37 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.29 -23.57 7.59 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 119.119 -1.515 . . . . 0.0 115.986 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.631 ' SG ' ' HD2' ' A' ' 29' ' ' ARG . 96.5 m -65.07 134.56 54.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.533 1.167 . . . . 0.0 112.213 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.3 t -117.86 133.32 56.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.939 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 40.4 t -76.77 117.12 18.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.402 . . . . 0.0 110.616 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.78 129.17 22.49 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.5 m 60.6 31.97 20.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.121 0.486 . . . . 0.0 110.105 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 69.7 14.07 8.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.13 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.5 t -131.88 140.75 47.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.4 m -87.67 132.81 33.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.304 0.573 . . . . 0.0 112.474 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -134.54 144.87 48.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.679 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.631 ' HD2' ' SG ' ' A' ' 20' ' ' CYS . 6.1 ptm180 . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.371 0 N-CA-C 112.882 -0.087 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.46 HG21 ' HD2' ' A' ' 3' ' ' PRO . 73.4 mt -127.31 130.48 23.72 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.46 ' HD2' HG21 ' A' ' 2' ' ' ILE . 23.5 Cg_endo -62.83 123.43 12.27 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.351 2.034 . . . . 0.0 112.217 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.5 m -73.96 -32.08 63.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.358 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.54 -46.15 1.1 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.744 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 50.3 mt-10 -66.48 146.56 54.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.016 0.436 . . . . 0.0 111.256 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.91 133.13 56.4 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -66.79 -13.91 62.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.306 0.574 . . . . 0.0 111.579 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.3 -35.57 27.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.311 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.9 m95 -89.5 -44.41 10.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.629 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.443 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.6 tt -165.34 141.8 4.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.167 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.443 ' HD2' HG13 ' A' ' 11' ' ' ILE . 43.2 Cg_exo -53.72 146.91 42.54 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.183 1.922 . . . . 0.0 111.705 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 56.5 m -59.33 103.12 0.16 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.75 -32.2 48.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.503 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 15.8 p -61.97 -9.21 6.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.364 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 22.1 m -60.04 -27.09 66.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.42 -31.34 71.27 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.947 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.9 pt -99.9 14.93 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.754 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.27 -2.49 46.99 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.266 -0.969 . . . . 0.0 115.457 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 16' ' ' SER . 64.2 m -72.45 140.2 48.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 118.613 1.206 . . . . 0.0 110.319 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -127.5 142.0 51.51 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 23' ' ' LYS . 50.3 t -70.32 114.38 8.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.02 0.438 . . . . 0.0 110.787 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' A' ' 22' ' ' CYS . 29.0 mmmt -129.08 122.77 30.65 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.0 m 56.85 39.36 29.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.964 0.411 . . . . 0.0 111.409 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' SER . 33.9 mmtp 71.19 11.13 6.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.521 HG23 ' CE1' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -135.69 138.56 47.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.03 0.443 . . . . 0.0 110.406 178.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 18.3 m -71.41 125.33 26.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.587 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.521 ' CE1' HG23 ' A' ' 26' ' ' VAL . 4.6 m-85 -128.22 154.22 46.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.388 0.613 . . . . 0.0 111.23 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 . . . . . 0 C--N 1.318 -0.795 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.67 178.991 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.244 0 N-CA-C 112.65 -0.18 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.8 mm -129.09 130.43 23.41 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.63 131.08 40.33 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.715 2.277 . . . . 0.0 112.494 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.621 ' SG ' ' HG2' ' A' ' 29' ' ' ARG . 61.4 m -76.87 -40.93 45.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.164 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.65 -46.19 1.05 Allowed Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.346 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.729 ' HG3' ' SG ' ' A' ' 27' ' ' CYS . 14.3 pt-20 -83.02 159.43 22.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.199 0.523 . . . . 0.0 110.709 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 9' ' ' VAL . 1.6 m -134.18 142.29 47.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.489 0.661 . . . . 0.0 110.672 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -74.53 13.89 0.55 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.458 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.649 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 44.2 t -78.7 -35.14 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -120.36 -38.25 2.93 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.587 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 26.6 pt -139.26 151.14 66.69 Favored Pre-proline 0 N--CA 1.463 0.215 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -72.23 142.35 37.48 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.602 2.201 . . . . 0.0 110.329 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 24.7 m -58.84 99.43 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.6 tp -67.55 -35.37 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.49 ' C ' ' HB2' ' A' ' 20' ' ' CYS . 49.7 m -61.6 -3.31 1.0 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.937 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 54.5 m -59.0 -29.86 67.56 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.11 -29.25 68.48 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.491 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.0 pt -103.46 22.71 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.73 -3.87 56.18 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.149 -1.024 . . . . 0.0 115.224 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 16' ' ' SER . 45.9 m -71.47 146.17 48.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.297 1.049 . . . . 0.0 110.683 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.0 t -134.81 132.59 38.85 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.113 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.425 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 45.4 t -78.36 138.08 38.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.722 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.607 ' O ' HG12 ' A' ' 26' ' ' VAL . 2.5 ptpt -165.97 134.79 3.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.3 m 59.08 29.43 18.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.399 0.619 . . . . 0.0 109.815 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.649 ' HE3' ' HA ' ' A' ' 9' ' ' VAL . 30.6 mtpp 63.13 26.06 15.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.175 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.607 HG12 ' O ' ' A' ' 23' ' ' LYS . 13.8 p -137.31 143.28 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.729 ' SG ' ' HG3' ' A' ' 6' ' ' GLU . 35.2 m -88.16 124.03 33.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -131.73 152.67 50.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.269 0.557 . . . . 0.0 110.881 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.621 ' HG2' ' SG ' ' A' ' 4' ' ' CYS . 9.5 ptt85 . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.027 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 112.294 -0.322 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -112.21 115.49 50.0 Favored Pre-proline 0 N--CA 1.461 0.106 0 CA-C-N 117.03 0.415 . . . . 0.0 110.193 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.51 126.61 14.38 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.496 2.131 . . . . 0.0 113.286 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -80.06 -35.57 36.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.139 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.99 -40.19 1.71 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.376 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.539 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 16.2 mt-10 -62.43 152.54 34.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.681 0.277 . . . . 0.0 110.664 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -130.6 129.89 43.31 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.321 0.581 . . . . 0.0 110.862 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.1 m -75.69 36.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.998 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 7' ' ' SER . 17.0 t -112.64 -27.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.1 m-90 -130.88 -35.5 1.42 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.18 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.0 pt -140.11 145.25 41.13 Favored Pre-proline 0 N--CA 1.463 0.224 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.21 154.08 70.45 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.438 2.092 . . . . 0.0 111.525 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 30.3 m -71.88 101.23 2.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.292 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.5 mm -65.99 -36.37 77.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.3 m -62.5 -0.36 0.59 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.135 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 32.4 m -62.96 -30.69 71.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.45 -25.45 66.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.976 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.0 pt -109.3 3.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.16 -26.01 5.36 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.4 -1.381 . . . . 0.0 116.244 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 16' ' ' SER . 1.5 m -67.61 139.85 56.86 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.868 1.334 . . . . 0.0 112.503 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.4 p -142.46 158.6 43.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.048 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m -58.8 117.15 4.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 0.0 112.061 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.437 ' HG3' ' HB2' ' A' ' 28' ' ' TYR . 74.9 mmtt -134.62 111.33 9.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.8 m 57.17 40.5 28.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.125 0.488 . . . . 0.0 109.992 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 24' ' ' SER . 30.9 mmtp 76.22 -12.36 1.03 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.132 -0.94 . . . . 0.0 113.028 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.412 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 19.6 t -109.36 143.46 19.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 117.893 0.315 . . . . 0.0 110.156 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 62.6 m -74.29 115.38 13.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.914 0.387 . . . . 0.0 111.806 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.437 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 3.9 m-85 -125.41 142.47 51.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.478 0.656 . . . . 0.0 110.583 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.591 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 69.2 ttt-85 . . . . . 0 C--N 1.309 -1.167 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.0 mt -128.9 128.27 23.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.62 122.61 11.94 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.483 2.122 . . . . 0.0 112.725 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.1 m -78.26 -32.41 49.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.975 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.7 -36.51 3.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.026 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.509 ' OE1' ' HA ' ' A' ' 13' ' ' CYS . 34.0 mt-10 -69.06 124.68 24.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.948 0.404 . . . . 0.0 110.682 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.58 136.19 33.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.71 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 m -69.02 -27.37 65.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.524 0.678 . . . . 0.0 111.301 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 25' ' ' LYS . 47.5 t -72.46 -31.57 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.106 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.631 ' O ' HG22 ' A' ' 11' ' ' ILE . 13.0 m0 -79.12 -59.95 2.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.718 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 10' ' ' TRP . 4.2 pt -162.75 163.96 17.1 Favored Pre-proline 0 N--CA 1.469 0.501 0 O-C-N 123.243 0.339 . . . . 0.0 110.505 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -64.35 136.5 51.36 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.803 1.669 . . . . 0.0 109.985 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.509 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 3.4 m -77.29 116.72 18.14 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.706 -177.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.597 ' H ' HD11 ' A' ' 14' ' ' ILE . 3.6 mp -64.41 -36.87 78.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -60.37 -6.07 1.4 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.236 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 38.4 p -59.35 -34.99 73.04 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.74 -27.1 68.48 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.115 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 pt -99.35 12.7 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.34 -11.97 19.26 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 119.663 -1.256 . . . . 0.0 114.967 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 16' ' ' SER . 80.7 m -69.28 136.28 51.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.225 1.012 . . . . 0.0 110.921 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -130.54 136.77 49.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 42.5 t -60.6 129.49 41.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.289 0.566 . . . . 0.0 112.048 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 25' ' ' LYS . 70.0 mmtt -121.83 -155.95 0.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -45.5 79.25 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 23' ' ' LYS . 11.8 mptt 61.84 6.89 1.78 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.222 1.009 . . . . 0.0 111.913 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.46 HG21 ' C ' ' A' ' 25' ' ' LYS . 59.0 t -146.59 139.03 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 122.289 -0.257 . . . . 0.0 111.561 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.6 m -75.63 135.69 40.48 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -129.17 142.15 50.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.488 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.494 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.7 ttt180 . . . . . 0 C--N 1.31 -1.111 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.512 0 N-CA-C 113.712 0.245 . . . . 0.0 113.712 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.7 mt -95.99 127.0 42.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 117.042 0.421 . . . . 0.0 110.717 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.51 124.63 15.49 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 122.308 2.005 . . . . 0.0 112.316 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.4 m -83.65 10.08 10.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.961 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.48 -39.25 1.91 Allowed Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.525 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.424 ' CD ' ' HA ' ' A' ' 13' ' ' CYS . 42.7 tt0 -63.37 139.98 58.83 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.88 136.47 54.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.038 0.447 . . . . 0.0 110.676 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -69.02 -17.96 63.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.821 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' A' ' 25' ' ' LYS . 40.4 t -66.24 -39.14 83.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.99 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -87.72 -55.67 3.68 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.76 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.2 mt -151.24 136.41 10.42 Favored Pre-proline 0 N--CA 1.462 0.15 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.712 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -49.8 141.36 28.27 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.314 2.01 . . . . 0.0 111.312 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.424 ' HA ' ' CD ' ' A' ' 6' ' ' GLU . 35.6 m -52.95 98.06 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.445 HD11 HG21 ' A' ' 14' ' ' ILE . 65.3 mt -69.85 -32.45 51.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 175.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.464 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.5 m -61.71 -2.93 0.92 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 113.31 -1.768 . . . . 0.0 111.537 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.717 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 68.7 m -57.99 -35.5 71.3 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.42 69.27 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.321 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 15' ' ' SER . 7.7 mm -81.33 -19.13 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.476 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.95 1.62 12.95 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.185 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.717 ' O ' ' HA ' ' A' ' 16' ' ' SER . 75.5 m -79.75 138.52 37.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.359 . . . . 0.0 110.077 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 p -121.61 143.22 49.43 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.215 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.4 t -76.66 120.54 21.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.133 0.492 . . . . 0.0 111.222 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 16.3 ttpt -134.83 125.58 27.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 p 51.64 39.94 26.2 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.082 0.468 . . . . 0.0 111.318 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' HB3' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 69.21 16.52 8.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.681 179.474 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.418 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 44.2 t -131.71 140.34 48.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.8 m -82.1 128.51 34.2 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.555 ' CE1' ' HE2' ' A' ' 23' ' ' LYS . 56.5 m-85 -131.88 144.38 50.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.096 0.474 . . . . 0.0 110.89 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.538 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 59.6 ttt-85 . . . . . 0 C--N 1.315 -0.923 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.206 0 N-CA-C 112.82 -0.112 . . . . 0.0 112.82 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.0 mt -125.63 129.26 24.43 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.14 124.94 14.79 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.386 2.058 . . . . 0.0 111.786 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m -77.15 -32.62 56.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.847 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.6 -44.51 1.22 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.601 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.448 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 53.8 mt-10 -66.93 146.89 53.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.949 0.404 . . . . 0.0 110.875 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.87 137.49 52.75 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.6 m -64.1 -25.63 68.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.426 0.632 . . . . 0.0 111.243 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.4 t -70.38 -33.15 52.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.275 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.573 ' O ' HG21 ' A' ' 11' ' ' ILE . 39.9 m0 -81.67 -59.74 2.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.938 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 10' ' ' TRP . 11.3 pt -156.85 161.71 29.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.897 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -62.76 144.42 93.76 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 121.965 1.777 . . . . 0.0 110.533 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.4 m -61.58 101.29 0.18 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.2 mt -69.82 -32.89 53.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.605 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 23.4 p -61.97 -8.38 5.12 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.34 -1.755 . . . . 0.0 111.456 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 16.8 m -60.43 -28.32 68.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.66 -28.34 68.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.07 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.9 pt -105.28 21.72 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.98 -4.62 56.04 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.235 -0.984 . . . . 0.0 115.413 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.65 ' O ' ' HA ' ' A' ' 16' ' ' SER . 92.7 m -74.45 143.6 44.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.427 1.114 . . . . 0.0 110.351 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -132.01 138.9 48.42 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.176 -0.327 . . . . 0.0 110.985 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.1 t -74.51 128.14 34.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.872 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -166.29 138.26 3.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.414 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.4 m 60.98 30.36 19.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 110.229 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 71.13 7.57 6.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.668 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.609 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 25.4 t -133.88 150.8 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.444 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.492 ' N ' HG13 ' A' ' 26' ' ' VAL . 33.3 m -84.42 121.04 27.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.609 ' CE1' ' HB ' ' A' ' 26' ' ' VAL . 87.3 m-85 -123.36 148.47 46.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.939 0.399 . . . . 0.0 111.082 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 54.9 ttp85 . . . . . 0 C--N 1.318 -0.797 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.147 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.3 mt -126.32 128.47 24.4 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -60.16 131.98 41.86 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.461 2.107 . . . . 0.0 112.823 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.2 m -96.62 17.51 16.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.535 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.33 37.89 93.79 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.885 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.42 ' OE1' ' HA ' ' A' ' 13' ' ' CYS . 42.5 tt0 -149.01 153.46 37.93 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -139.06 139.15 37.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.367 0.603 . . . . 0.0 111.152 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -10.22 59.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.597 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.797 HG22 ' HE3' ' A' ' 25' ' ' LYS . 25.2 t -71.77 -38.23 65.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.446 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -89.93 -43.82 10.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.996 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.574 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.5 tt -166.53 141.95 3.72 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.263 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HD2' HG13 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -47.09 138.9 15.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.609 2.206 . . . . 0.0 111.709 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.42 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 59.7 m -56.73 98.47 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -177.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.9 mm -69.01 -30.7 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.477 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 71.3 p -59.85 -12.45 7.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.801 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.685 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 30.0 m -57.49 -33.98 68.59 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.33 -28.16 66.56 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.732 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.1 pt -104.76 27.56 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.66 1.58 63.72 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.685 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.1 m -86.53 162.58 17.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 118.197 0.998 . . . . 0.0 110.405 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 t -150.02 148.37 28.96 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.6 t -70.62 114.39 8.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.111 0.481 . . . . 0.0 110.731 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -125.84 115.41 19.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m 58.56 38.67 25.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.131 0.491 . . . . 0.0 110.671 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.797 ' HE3' HG22 ' A' ' 9' ' ' VAL . 30.5 mtpp 71.12 7.21 6.1 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.222 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.8 t -123.7 138.32 53.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 m -75.74 118.67 18.81 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -132.61 145.14 50.85 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.417 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 . . . . . 0 C--N 1.311 -1.073 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.71 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 111.704 -0.559 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 2' ' ' ILE . 48.5 mm -120.67 126.37 26.74 Favored Pre-proline 0 C--N 1.331 -0.196 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 33.0 Cg_exo -59.24 122.64 11.89 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.528 2.152 . . . . 0.0 112.795 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 56.0 m -88.11 -32.51 18.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.448 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.56 -37.96 2.88 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.779 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.44 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 27.5 mt-10 -59.65 144.83 46.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.9 0.381 . . . . 0.0 110.635 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.42 126.22 43.47 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.1 -7.63 24.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.437 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.3 t -77.59 -31.72 17.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.971 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -104.09 -53.57 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.896 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 12' ' ' PRO . 20.6 mm -147.85 136.37 11.34 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.227 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.414 ' N ' HG23 ' A' ' 11' ' ' ILE . 35.2 Cg_exo -56.8 146.67 76.92 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.488 2.125 . . . . 0.0 111.745 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.585 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.6 m -61.35 102.12 0.21 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.211 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.453 ' C ' ' H ' ' A' ' 16' ' ' SER . 48.8 mm -68.7 -38.13 78.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.451 ' HA ' HG12 ' A' ' 18' ' ' ILE . 18.0 m -63.84 4.42 0.29 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.846 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.743 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 73.2 m -61.12 -35.44 77.06 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.43 -21.24 66.59 Favored 'General case' 0 CA--C 1.526 0.036 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.455 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 15' ' ' SER . 8.7 mm -89.2 -17.59 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.013 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.78 -13.88 5.54 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.653 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.743 ' O ' ' HA ' ' A' ' 16' ' ' SER . 82.5 m -68.72 151.57 46.49 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.7 m -150.73 141.56 22.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.4 t -65.26 124.08 21.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.279 0.562 . . . . 0.0 111.152 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.677 ' HD3' ' HB2' ' A' ' 28' ' ' TYR . 27.9 mtpp -141.18 116.2 9.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.0 m 57.79 40.06 26.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 24' ' ' SER . 33.0 mmtp 72.58 0.56 3.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.928 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.569 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 23.8 t -119.47 140.33 43.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 39.2 m -85.73 122.79 30.33 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.086 0.469 . . . . 0.0 112.055 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.677 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 64.8 m-85 -128.0 135.65 50.19 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.088 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 5.9 tmm_? . . . . . 0 C--N 1.314 -0.959 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.247 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.5 mt -130.36 131.32 23.31 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.33 126.75 17.6 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.52 2.147 . . . . 0.0 111.633 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.1 m -81.2 -48.12 12.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.079 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.43 -53.9 0.4 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.788 -1.196 . . . . 0.0 113.856 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.523 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 3.4 mp0 -67.32 147.45 52.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.314 0.578 . . . . 0.0 112.098 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -110.21 127.33 54.89 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.324 178.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.7 m -73.61 41.63 0.12 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.852 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.727 HG22 ' HD2' ' A' ' 25' ' ' LYS . 7.6 t -104.87 -49.16 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -139.09 -11.48 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.333 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.464 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 48.4 mm -116.2 125.26 28.71 Favored Pre-proline 0 CA--C 1.528 0.111 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.908 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 11' ' ' ILE . 2.8 Cg_exo -74.17 143.49 32.14 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.695 2.264 . . . . 0.0 110.859 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.0 m -69.76 95.36 0.88 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.884 0.374 . . . . 0.0 111.997 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.42 HD12 HG23 ' A' ' 14' ' ' ILE . 47.1 mm -69.18 -32.28 53.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.682 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 17.4 p -61.81 -6.7 2.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.255 -1.793 . . . . 0.0 111.608 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 23.8 m -58.81 -26.09 63.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.34 -31.26 69.02 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.73 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.8 pt -103.93 27.53 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.547 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.43 5.45 79.14 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 115.362 0.905 . . . . 0.0 115.362 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 15' ' ' SER . 92.6 m -75.34 141.43 43.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.48 1.14 . . . . 0.0 110.556 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -148.49 146.39 28.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.78 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.1 m -53.61 125.01 16.67 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 38.8 mttp -151.72 122.9 7.7 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.3 m 59.78 36.86 22.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.429 . . . . 0.0 110.245 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.727 ' HD2' HG22 ' A' ' 9' ' ' VAL . 18.3 tppt? 71.69 0.92 3.68 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.501 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -125.85 146.85 30.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 121.724 -0.61 . . . . 0.0 110.458 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 39.8 m -69.98 117.76 11.97 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.46 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 3.9 m-85 -122.91 152.68 40.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.389 0.614 . . . . 0.0 111.344 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.494 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 5.6 tmm_? -146.25 125.5 13.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.313 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.463 ' HB2' ' HD2' ' A' ' 29' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 121.306 0.574 . . . . 0.0 110.02 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.394 0 CA-C-O 120.475 -0.07 . . . . 0.0 113.185 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 2' ' ' ILE . 64.6 mt -103.07 126.66 31.76 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.68 123.17 12.47 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.321 2.014 . . . . 0.0 112.273 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.68 -16.83 60.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.362 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.55 -36.0 3.97 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.078 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.534 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 25.9 mt-10 -63.39 133.0 53.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.866 0.365 . . . . 0.0 110.281 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -119.77 125.17 47.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.418 0.628 . . . . 0.0 110.779 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.3 m -71.01 6.02 1.77 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.19 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.613 HG22 ' HB3' ' A' ' 25' ' ' LYS . 13.2 t -79.43 -33.51 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.318 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -118.95 -45.5 2.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.222 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -142.43 133.62 12.93 Favored Pre-proline 0 N--CA 1.464 0.26 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.299 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.94 140.89 92.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.271 1.981 . . . . 0.0 110.995 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.543 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 2.9 m -72.42 115.21 11.41 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.483 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.6 mt -67.44 -37.62 79.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.451 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 15.3 m -61.61 -8.57 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.017 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 33.1 m -59.96 -35.89 75.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.12 -24.91 67.43 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.951 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.9 pt -104.41 13.87 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.91 -24.42 5.13 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.167 -1.492 . . . . 0.0 115.604 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 16' ' ' SER . 73.4 m -63.58 137.22 58.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.415 1.107 . . . . 0.0 111.547 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -122.36 126.19 47.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.915 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.3 t -75.91 124.22 26.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.051 0.453 . . . . 0.0 110.798 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -137.88 123.03 19.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 m 59.42 34.86 22.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.184 0.516 . . . . 0.0 110.083 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.613 ' HB3' HG22 ' A' ' 9' ' ' VAL . 64.2 mttp 70.48 13.22 7.45 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.306 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 t -128.03 132.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.6 m -89.13 135.15 33.72 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.97 142.95 49.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.322 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.5 ttt-85 -128.52 117.46 21.34 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 m120 . . . . . 0 C--N 1.327 -0.386 0 O-C-N 123.445 0.466 . . . . 0.0 110.412 -178.515 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.374 0 N-CA-C 113.305 0.082 . . . . 0.0 113.305 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.407 HG23 HD12 ' A' ' 2' ' ' ILE . 71.8 mt -123.13 127.2 25.74 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.64 124.82 15.34 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.504 2.136 . . . . 0.0 113.189 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.7 m -78.22 -28.02 47.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.583 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.16 -41.22 2.25 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.297 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.79 136.33 50.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.779 0.324 . . . . 0.0 111.084 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.75 129.11 54.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 p -72.3 -18.43 61.79 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.818 HG23 ' HB3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -67.65 -44.16 86.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.326 178.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -78.35 -45.97 21.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.904 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.787 HD11 ' HD2' ' A' ' 12' ' ' PRO . 6.9 tp -170.22 135.29 1.18 Allowed Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.787 ' HD2' HD11 ' A' ' 11' ' ' ILE . 1.2 Cg_endo -47.82 134.98 22.96 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.443 2.095 . . . . 0.0 112.222 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.457 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 3.5 m -72.01 125.49 27.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.986 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.8 -38.68 83.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.453 ' HB2' HH21 ' A' ' 29' ' ' ARG . 40.3 p -62.08 -14.58 37.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.007 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 58.6 m -62.88 -34.33 77.17 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.56 -20.64 64.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.251 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.428 HD12 HG22 ' A' ' 18' ' ' ILE . 34.8 pt -112.24 20.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.34 -27.57 5.51 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 118.963 -1.589 . . . . 0.0 116.244 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 16' ' ' SER . 68.1 m -62.64 133.33 54.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.508 1.154 . . . . 0.0 112.457 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -120.9 121.68 38.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.981 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.884 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 8.0 t -68.31 131.62 45.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.056 0.455 . . . . 0.0 111.02 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -143.85 131.03 20.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.3 m 57.74 35.9 26.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.374 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.818 ' HB3' HG23 ' A' ' 9' ' ' VAL . 30.1 mtmm 82.74 -16.72 0.57 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.573 1.149 . . . . 0.0 112.927 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.9 p -116.68 135.07 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.351 0.596 . . . . 0.0 112.016 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.884 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 m -69.85 137.15 51.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.277 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -129.34 155.5 45.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.708 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 29' ' ' ARG . 13.7 ptp180 -138.68 116.7 11.69 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.952 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.5 t30 . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.305 0.574 . . . . 0.0 110.94 -179.235 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.276 0 N-CA-C 112.7 -0.16 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 75.8 mt -129.77 131.39 23.51 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 23.1 Cg_exo -63.19 127.45 20.19 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.474 2.116 . . . . 0.0 111.949 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.9 m -79.79 -49.76 11.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.941 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.95 -52.42 0.4 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.972 -1.108 . . . . 0.0 113.503 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.536 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 1.3 mp0 -75.19 166.94 22.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.578 0.704 . . . . 0.0 111.863 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.2 m -127.23 138.91 53.21 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -64.19 -23.76 67.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 0.0 111.606 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -71.42 -33.29 49.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.578 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.512 ' O ' HG23 ' A' ' 11' ' ' ILE . 12.4 m95 -85.86 -55.88 3.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.755 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 10' ' ' TRP . 1.5 pp -160.15 162.84 23.42 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.72 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -62.35 143.62 93.96 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.152 1.901 . . . . 0.0 111.43 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.406 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 35.8 m -65.31 107.33 1.58 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.128 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 pt -68.41 -36.48 75.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.487 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 41.5 m -59.45 -7.43 1.38 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.508 -1.678 . . . . 0.0 111.834 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 48.2 m -58.31 -32.65 68.66 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.01 -30.22 69.01 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.503 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.481 HD11 HG22 ' A' ' 18' ' ' ILE . 24.1 pt -101.53 24.47 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.17 12.11 57.85 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 115.384 0.913 . . . . 0.0 115.384 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 16' ' ' SER . 75.2 m -87.93 153.13 21.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 118.208 1.004 . . . . 0.0 110.084 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.4 t -144.87 142.87 30.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.784 0.326 . . . . 0.0 110.378 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.453 ' O ' ' HE3' ' A' ' 23' ' ' LYS . 41.9 t -66.8 131.35 45.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.771 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' HE3' ' O ' ' A' ' 22' ' ' CYS . 1.2 tppp? -158.86 129.4 6.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m 59.53 33.56 22.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.1 0.476 . . . . 0.0 110.889 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt 71.59 10.49 6.45 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.635 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.544 HG21 ' CE1' ' A' ' 28' ' ' TYR . 1.3 m -136.26 152.67 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.922 0.391 . . . . 0.0 110.649 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 22.9 m -80.01 122.24 26.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.659 0.266 . . . . 0.0 111.119 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.544 ' CE1' HG21 ' A' ' 26' ' ' VAL . 3.9 m-85 -129.25 155.03 46.21 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.285 0.564 . . . . 0.0 111.148 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.417 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 45.7 ttp180 -146.97 122.42 10.36 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.839 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.9 t30 . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.463 0.649 . . . . 0.0 110.433 -179.004 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 112.039 -0.424 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.72 125.94 27.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.33 130.33 33.53 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.589 2.193 . . . . 0.0 112.611 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 58.9 m -98.65 15.65 24.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.333 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.93 -46.66 2.7 Favored Glycine 0 C--N 1.331 0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.677 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -64.59 160.03 20.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.177 0.513 . . . . 0.0 111.342 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.56 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -148.03 133.01 18.14 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.286 0.565 . . . . 0.0 110.947 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.5 m -75.67 25.89 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.196 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.56 ' H ' ' C ' ' A' ' 7' ' ' SER . 25.0 t -92.49 -37.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -108.86 -45.13 3.86 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.69 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -153.37 155.79 31.97 Favored Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -64.29 146.54 90.26 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.382 2.055 . . . . 0.0 110.486 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 22' ' ' CYS . 1.5 m -67.84 115.62 7.59 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.34 -33.95 63.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.5 p -62.97 -5.91 3.38 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.82 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.674 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 29.4 m -62.03 -30.48 71.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -24.58 63.91 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.128 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.3 pt -112.35 28.23 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.26 -16.0 53.7 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 116.376 1.31 . . . . 0.0 116.376 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 16' ' ' SER . 89.6 m -70.24 141.07 52.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 118.983 1.392 . . . . 0.0 111.573 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 p -142.31 124.39 15.38 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.799 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 21.5 p -73.76 130.25 39.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.952 0.882 . . . . 0.0 111.663 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.842 ' HE2' ' HB2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -132.17 133.44 44.23 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.6 m 61.79 31.28 18.43 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 33.6 mttm 73.75 -5.82 1.93 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.051 -1.431 . . . . 0.0 113.353 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.1 t -105.11 132.98 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 118.401 0.546 . . . . 0.0 109.901 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.799 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 57.6 m -75.78 125.31 28.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.842 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 9.5 m-85 -136.32 141.21 43.77 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.321 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.464 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 22.4 ttm180 -98.41 98.81 9.98 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 . . . . . 0 N--CA 1.47 0.533 0 O-C-N 124.069 0.856 . . . . 0.0 109.912 -177.25 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.349 0 CA-C-O 120.378 -0.123 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 65.0 mt -94.16 124.03 57.18 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.973 0.386 . . . . 0.0 110.223 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.75 118.91 5.83 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.083 1.856 . . . . 0.0 112.514 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.6 m -75.37 -23.92 57.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.375 0.607 . . . . 0.0 109.57 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.43 -37.95 3.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.058 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 27' ' ' CYS . 3.0 pt-20 -71.3 125.75 27.79 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.155 0.502 . . . . 0.0 111.225 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.42 132.61 38.87 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.6 p -72.59 -22.52 60.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.126 0.488 . . . . 0.0 112.211 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.99 -33.08 42.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.241 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -82.34 -52.55 6.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.741 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.6 pt -152.25 155.73 33.34 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.914 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -63.6 136.0 52.0 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.277 1.318 . . . . 0.0 110.442 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.563 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 56.2 m -73.84 114.59 12.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.053 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mm -66.29 -41.9 89.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.419 ' HA ' HG12 ' A' ' 18' ' ' ILE . 49.5 m -64.13 -7.81 10.12 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.055 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.563 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 18.8 m -64.15 -34.33 77.82 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.52 -18.55 62.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.954 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.419 HG12 ' HA ' ' A' ' 15' ' ' SER . 21.8 pt -117.93 23.99 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.81 -30.89 5.37 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 118.946 -1.597 . . . . 0.0 116.754 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 16' ' ' SER . 96.2 m -62.33 133.53 55.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.623 1.211 . . . . 0.0 112.479 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.9 t -126.89 134.29 50.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 14.1 t -75.02 135.07 41.3 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.366 0.603 . . . . 0.0 112.285 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -150.86 132.42 14.79 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.235 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 4.3 m 59.48 35.02 22.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 24' ' ' SER . 67.3 mttm 77.95 -16.97 0.61 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.892 0.877 . . . . 0.0 112.852 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -110.85 137.63 42.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-O 121.009 0.433 . . . . 0.0 111.717 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.705 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 2.1 m -77.94 136.18 37.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.162 0.506 . . . . 0.0 112.257 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -129.12 148.05 51.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.679 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.533 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 19.5 ttm180 -122.63 110.44 15.53 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 C--N 1.327 -0.406 0 O-C-N 123.407 0.442 . . . . 0.0 110.449 -178.678 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.209 0 N-CA-C 112.682 -0.167 . . . . 0.0 112.682 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mm -120.66 127.12 26.42 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.15 125.47 14.14 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.39 2.06 . . . . 0.0 112.377 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.2 m -85.65 -0.56 55.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.616 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.06 -45.35 3.43 Favored Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 113.406 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.562 ' OE2' HG12 ' A' ' 14' ' ' ILE . 53.8 mt-10 -62.89 142.27 58.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.824 0.345 . . . . 0.0 111.13 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.06 138.35 49.55 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.258 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.9 m -66.25 -15.55 63.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.54 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.422 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 41.9 t -68.77 -34.76 66.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.937 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -93.24 -57.13 2.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.217 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.4 pt -160.55 160.34 25.77 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.177 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -63.12 137.93 64.34 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.658 1.572 . . . . 0.0 110.326 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.3 m -75.71 122.77 24.5 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.346 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.562 HG12 ' OE2' ' A' ' 6' ' ' GLU . 12.4 pt -65.64 -37.4 79.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 m -60.32 -11.84 7.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.839 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 59.0 m -61.84 -34.3 75.72 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.01 -24.09 66.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.974 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.462 HG23 HD11 ' A' ' 18' ' ' ILE . 24.0 pt -107.33 25.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.19 -19.98 28.94 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 116.361 1.304 . . . . 0.0 116.361 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.627 ' O ' ' HA ' ' A' ' 16' ' ' SER . 84.1 m -68.54 137.44 54.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.746 1.273 . . . . 0.0 112.004 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.6 p -137.38 138.13 39.57 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 2.1 m -64.95 121.07 13.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.655 0.74 . . . . 0.0 111.934 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -123.67 121.02 34.45 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.6 m 57.44 38.3 28.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 24' ' ' SER . 97.2 mttt 81.17 -18.34 0.5 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.988 -1.006 . . . . 0.0 113.3 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.11 133.51 52.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 117.955 0.343 . . . . 0.0 110.826 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 4.1 m -68.23 129.68 40.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.446 0.641 . . . . 0.0 112.434 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -132.82 154.54 50.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.24 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.444 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 51.7 ttp180 -146.49 122.76 10.9 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 121.448 0.642 . . . . 0.0 110.023 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 pt -129.18 140.05 37.49 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.947 0.374 . . . . 0.0 110.184 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.91 128.42 24.22 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.383 2.056 . . . . 0.0 112.596 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 63.1 m -82.06 -48.37 11.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.618 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.25 -55.82 0.35 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.564 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.84 158.68 35.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.614 0.721 . . . . 0.0 111.248 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.428 ' C ' ' H ' ' A' ' 9' ' ' VAL . 1.1 m -128.6 137.61 51.78 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.07 3.86 2.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.098 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.548 HG23 ' HB3' ' A' ' 25' ' ' LYS . 32.1 t -85.81 -33.57 7.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.427 ' O ' HG22 ' A' ' 11' ' ' ILE . 11.8 m95 -104.12 -52.45 2.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.012 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.445 HD11 ' N ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -146.17 157.64 49.35 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-O 120.776 0.322 . . . . 0.0 111.645 -178.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.49 146.91 86.21 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.811 2.341 . . . . 0.0 111.149 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.476 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 23.8 m -64.36 103.75 0.68 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.6 mt -69.57 -36.67 72.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.553 ' HA ' HG12 ' A' ' 18' ' ' ILE . 68.8 m -63.51 0.25 0.77 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.841 -1.527 . . . . 0.0 111.923 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.577 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 65.2 m -60.36 -33.58 72.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.01 -22.18 65.91 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.425 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.553 HG12 ' HA ' ' A' ' 15' ' ' SER . 1.4 mm -94.13 9.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.612 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.38 17.09 43.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.487 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 16' ' ' SER . 93.8 m -94.13 154.91 17.35 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -144.23 149.96 37.19 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.98 126.57 30.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.206 0.526 . . . . 0.0 110.858 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -144.34 121.66 11.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 m 58.08 37.8 26.52 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.973 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.548 ' HB3' HG23 ' A' ' 9' ' ' VAL . 30.4 mmmt 68.49 13.73 9.01 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.839 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.548 HG21 ' CE1' ' A' ' 28' ' ' TYR . 0.7 OUTLIER -133.91 143.15 39.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.9 m -78.55 121.14 24.22 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.548 ' CE1' HG21 ' A' ' 26' ' ' VAL . 3.1 m-85 -126.47 148.95 49.59 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.358 0.599 . . . . 0.0 110.707 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.616 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.2 ttm180 -112.04 108.72 18.12 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 . . . . . 0 N--CA 1.471 0.607 0 O-C-N 124.014 0.821 . . . . 0.0 110.79 -177.867 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.444 0 CA-C-O 120.069 -0.295 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.94 126.58 52.95 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 117.303 0.551 . . . . 0.0 110.592 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.79 120.41 8.29 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.445 2.096 . . . . 0.0 112.582 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 61.4 m -76.23 -25.3 54.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.441 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.18 -31.01 8.27 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.7 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.524 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 32.9 mt-10 -61.53 130.72 47.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.61 0.243 . . . . 0.0 110.411 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.18 125.9 51.55 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 m -65.14 -18.19 65.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.527 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.8 t -71.23 -35.53 58.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.309 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.461 ' O ' HG23 ' A' ' 11' ' ' ILE . 19.3 m95 -89.92 -52.88 4.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.505 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 10' ' ' TRP . 1.6 pp -155.58 153.85 27.11 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.285 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.16 147.91 88.63 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.581 2.187 . . . . 0.0 111.231 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.6 m -58.27 103.94 0.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.574 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.425 ' C ' ' H ' ' A' ' 16' ' ' SER . 67.9 mt -68.77 -39.85 80.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.5 m -64.3 2.65 0.56 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 113.61 -1.632 . . . . 0.0 111.695 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 62.5 p -62.47 -32.65 73.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.67 -20.64 57.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.203 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 pt -119.62 26.53 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.13 -22.15 16.39 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 16' ' ' SER . 85.6 m -68.13 137.67 55.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.992 1.396 . . . . 0.0 111.957 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -133.77 138.4 45.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.085 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.4 t -72.23 130.69 41.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.872 0.368 . . . . 0.0 111.492 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.494 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 17.7 ttpt -153.84 127.47 8.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 16.5 m 59.14 36.01 23.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.822 0.344 . . . . 0.0 111.031 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 24' ' ' SER . 1.1 mptm? 71.54 10.54 6.5 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.532 0.733 . . . . 0.0 112.643 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.424 HG11 ' O ' ' A' ' 23' ' ' LYS . 2.1 p -140.01 139.93 36.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.147 0.499 . . . . 0.0 110.318 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 34.0 m -78.93 136.13 37.17 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.494 ' CE1' ' HE2' ' A' ' 23' ' ' LYS . 27.7 m-85 -128.45 146.04 50.92 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.339 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.593 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 26.5 ttm180 -118.83 107.18 13.3 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 121.427 0.632 . . . . 0.0 109.829 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 29' ' ' ARG . 37.4 pt -122.95 137.13 27.65 Favored Pre-proline 0 C--N 1.333 -0.123 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.3 129.29 23.66 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.548 2.165 . . . . 0.0 113.512 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.3 m -93.87 9.6 36.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.088 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.88 -41.96 2.44 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 113.459 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -63.75 141.17 58.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 122.639 0.376 . . . . 0.0 110.588 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 132.6 53.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.5 t -70.49 -28.31 64.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.397 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.8 t -71.45 -40.36 72.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.677 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -71.44 -52.63 17.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.552 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.66 156.22 38.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -62.13 138.93 75.57 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.08 1.187 . . . . 0.0 109.15 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 66.1 m -59.47 99.56 0.06 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.4 mt -68.94 -32.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.5 p -64.12 -12.62 41.31 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.231 -1.349 . . . . 0.0 110.776 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.736 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 6.6 t -62.87 -34.79 78.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.89 -20.95 64.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.32 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.4 pt -113.19 21.53 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.0 -31.2 5.4 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.522 -1.323 . . . . 0.0 115.743 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.736 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.3 m -71.28 171.14 11.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.12 0.96 . . . . 0.0 111.232 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.3 p -166.47 145.24 5.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.203 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.3 m -53.34 129.13 30.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 110.467 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.627 ' HZ1' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -153.07 115.92 4.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.5 m 55.82 41.94 29.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.544 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 24' ' ' SER . 1.0 OUTLIER 76.1 -14.52 0.79 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.582 0.753 . . . . 0.0 112.856 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.1 t -112.55 146.81 16.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.911 0.386 . . . . 0.0 110.757 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.0 m -73.5 119.51 17.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.4 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 3.2 m-85 -123.72 144.92 49.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.498 0.666 . . . . 0.0 111.521 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.402 ' O ' HG12 ' A' ' 2' ' ' ILE . 51.5 ttm-85 -102.58 101.87 12.06 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.535 -1.211 . . . . 0.0 107.884 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.8 m120 . . . . . 0 N--CA 1.473 0.718 0 O-C-N 123.864 0.728 . . . . 0.0 110.951 -178.266 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 113.831 0.292 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.423 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.5 mp -96.75 125.75 45.57 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 117.329 0.565 . . . . 0.0 110.231 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.62 123.59 14.22 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.133 1.888 . . . . 0.0 112.287 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.4 m -76.52 -37.98 55.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.305 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.09 -40.7 2.07 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.323 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.4 ' CD ' ' HG ' ' A' ' 15' ' ' SER . 1.7 mt-10 -72.65 133.01 44.44 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.245 0.545 . . . . 0.0 111.278 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -106.5 127.7 53.51 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.206 178.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 37.12 0.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.701 0.762 . . . . 0.0 110.972 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.666 HG21 ' HE3' ' A' ' 25' ' ' LYS . 21.4 t -124.37 -40.87 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' O ' HG13 ' A' ' 11' ' ' ILE . 17.1 m0 -92.8 -49.23 6.17 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.119 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 10' ' ' TRP . 56.9 mt -157.27 135.22 7.26 Favored Pre-proline 0 N--CA 1.468 0.463 0 O-C-N 123.006 0.191 . . . . 0.0 110.723 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.21 139.74 80.94 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.478 2.119 . . . . 0.0 111.763 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.438 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.7 m -73.83 117.83 16.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.279 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.13 -34.47 66.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.4 ' HG ' ' CD ' ' A' ' 6' ' ' GLU . 77.9 p -60.6 -12.65 10.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.222 -1.353 . . . . 0.0 112.0 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 19.1 m -59.63 -36.09 75.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.29 67.28 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.875 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.426 HD13 HG22 ' A' ' 18' ' ' ILE . 41.0 pt -104.91 17.22 5.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.71 -21.13 8.07 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 119.038 -1.553 . . . . 0.0 115.524 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 16' ' ' SER . 55.6 m -64.77 138.21 58.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.272 1.036 . . . . 0.0 111.76 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.3 t -123.6 134.32 53.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.651 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.5 t -75.73 116.77 16.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.022 0.439 . . . . 0.0 110.576 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -130.91 126.41 36.04 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m 58.58 36.94 25.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.198 0.523 . . . . 0.0 110.666 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.666 ' HE3' HG21 ' A' ' 9' ' ' VAL . 31.5 mmmt 70.7 11.27 7.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.962 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 p -136.78 134.73 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.174 0.511 . . . . 0.0 109.68 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.0 m -79.17 134.37 36.7 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -129.79 146.13 51.55 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.635 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 2' ' ' ILE . 9.6 ptp180 -114.04 99.44 7.65 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.568 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.6 t30 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.696 -178.634 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.196 0 N-CA-C 112.737 -0.145 . . . . 0.0 112.737 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 70.3 mt -123.81 130.48 24.42 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 27.9 Cg_exo -62.21 126.07 17.79 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.615 2.21 . . . . 0.0 111.983 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.4 m -78.36 -22.63 47.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.612 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.86 -38.54 3.06 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.608 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -69.85 137.57 51.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.982 0.42 . . . . 0.0 110.72 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 t -111.1 144.95 39.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.024 0.916 . . . . 0.0 110.426 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -73.8 -16.97 61.14 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.701 -1.591 . . . . 0.0 110.859 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.28 -38.95 23.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.99 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -77.54 -52.2 9.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.553 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.716 HD11 ' HD2' ' A' ' 12' ' ' PRO . 8.1 tp -177.72 141.82 0.46 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.716 ' HD2' HD11 ' A' ' 11' ' ' ILE . 1.2 Cg_endo -46.21 133.44 15.31 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.394 2.063 . . . . 0.0 112.075 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.2 m -71.86 122.58 21.0 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.405 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.536 HD13 ' H ' ' A' ' 14' ' ' ILE . 2.8 mp -65.8 -35.58 75.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.434 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 61.4 p -61.19 -15.59 35.76 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.829 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . 74.5 m -61.32 -35.41 77.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.89 -23.1 66.1 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.432 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 pt -108.71 23.37 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.29 -23.57 7.59 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 119.119 -1.515 . . . . 0.0 115.986 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.631 ' SG ' ' HD2' ' A' ' 29' ' ' ARG . 96.5 m -65.07 134.56 54.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.533 1.167 . . . . 0.0 112.213 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.3 t -117.86 133.32 56.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.939 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 40.4 t -76.77 117.12 18.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.402 . . . . 0.0 110.616 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.78 129.17 22.49 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.5 m 60.6 31.97 20.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.121 0.486 . . . . 0.0 110.105 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 69.7 14.07 8.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.13 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.5 t -131.88 140.75 47.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.4 m -87.67 132.81 33.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.304 0.573 . . . . 0.0 112.474 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -134.54 144.87 48.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.679 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.631 ' HD2' ' SG ' ' A' ' 20' ' ' CYS . 6.1 ptm180 -139.29 130.17 26.26 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 m120 . . . . . 0 N--CA 1.469 0.503 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.976 -179.109 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.371 0 N-CA-C 112.882 -0.087 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.46 HG21 ' HD2' ' A' ' 3' ' ' PRO . 73.4 mt -127.31 130.48 23.72 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.46 ' HD2' HG21 ' A' ' 2' ' ' ILE . 23.5 Cg_endo -62.83 123.43 12.27 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.351 2.034 . . . . 0.0 112.217 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.5 m -73.96 -32.08 63.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.358 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.54 -46.15 1.1 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.744 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 50.3 mt-10 -66.48 146.56 54.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.016 0.436 . . . . 0.0 111.256 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.91 133.13 56.4 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -66.79 -13.91 62.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.306 0.574 . . . . 0.0 111.579 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.3 -35.57 27.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.311 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.9 m95 -89.5 -44.41 10.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.629 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.443 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.6 tt -165.34 141.8 4.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.167 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.443 ' HD2' HG13 ' A' ' 11' ' ' ILE . 43.2 Cg_exo -53.72 146.91 42.54 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.183 1.922 . . . . 0.0 111.705 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 56.5 m -59.33 103.12 0.16 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.75 -32.2 48.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.503 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 15.8 p -61.97 -9.21 6.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.364 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 22.1 m -60.04 -27.09 66.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.42 -31.34 71.27 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.947 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.9 pt -99.9 14.93 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.754 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.27 -2.49 46.99 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.266 -0.969 . . . . 0.0 115.457 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 16' ' ' SER . 64.2 m -72.45 140.2 48.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 118.613 1.206 . . . . 0.0 110.319 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -127.5 142.0 51.51 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 23' ' ' LYS . 50.3 t -70.32 114.38 8.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.02 0.438 . . . . 0.0 110.787 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' A' ' 22' ' ' CYS . 29.0 mmmt -129.08 122.77 30.65 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.0 m 56.85 39.36 29.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.964 0.411 . . . . 0.0 111.409 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' SER . 33.9 mmtp 71.19 11.13 6.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.521 HG23 ' CE1' ' A' ' 28' ' ' TYR . 0.9 OUTLIER -135.69 138.56 47.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.03 0.443 . . . . 0.0 110.406 178.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 18.3 m -71.41 125.33 26.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.587 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.521 ' CE1' HG23 ' A' ' 26' ' ' VAL . 4.6 m-85 -128.22 154.22 46.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.388 0.613 . . . . 0.0 111.23 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -144.2 120.35 10.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.67 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.0 t30 . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 121.356 0.598 . . . . 0.0 110.539 -179.101 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.244 0 N-CA-C 112.65 -0.18 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.8 mm -129.09 130.43 23.41 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.63 131.08 40.33 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.715 2.277 . . . . 0.0 112.494 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.621 ' SG ' ' HG2' ' A' ' 29' ' ' ARG . 61.4 m -76.87 -40.93 45.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.164 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.65 -46.19 1.05 Allowed Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.346 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.729 ' HG3' ' SG ' ' A' ' 27' ' ' CYS . 14.3 pt-20 -83.02 159.43 22.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.199 0.523 . . . . 0.0 110.709 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.49 ' C ' ' H ' ' A' ' 9' ' ' VAL . 1.6 m -134.18 142.29 47.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.489 0.661 . . . . 0.0 110.672 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -74.53 13.89 0.55 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.458 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.649 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 44.2 t -78.7 -35.14 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -120.36 -38.25 2.93 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.587 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 26.6 pt -139.26 151.14 66.69 Favored Pre-proline 0 N--CA 1.463 0.215 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -72.23 142.35 37.48 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.602 2.201 . . . . 0.0 110.329 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 24.7 m -58.84 99.43 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.6 tp -67.55 -35.37 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.49 ' C ' ' HB2' ' A' ' 20' ' ' CYS . 49.7 m -61.6 -3.31 1.0 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.937 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 54.5 m -59.0 -29.86 67.56 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.11 -29.25 68.48 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.491 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.0 pt -103.46 22.71 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.73 -3.87 56.18 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.149 -1.024 . . . . 0.0 115.224 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 16' ' ' SER . 45.9 m -71.47 146.17 48.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.297 1.049 . . . . 0.0 110.683 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.0 t -134.81 132.59 38.85 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.113 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.425 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 45.4 t -78.36 138.08 38.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.722 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.607 ' O ' HG12 ' A' ' 26' ' ' VAL . 2.5 ptpt -165.97 134.79 3.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.3 m 59.08 29.43 18.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.399 0.619 . . . . 0.0 109.815 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.649 ' HE3' ' HA ' ' A' ' 9' ' ' VAL . 30.6 mtpp 63.13 26.06 15.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.175 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.607 HG12 ' O ' ' A' ' 23' ' ' LYS . 13.8 p -137.31 143.28 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.729 ' SG ' ' HG3' ' A' ' 6' ' ' GLU . 35.2 m -88.16 124.03 33.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -131.73 152.67 50.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.269 0.557 . . . . 0.0 110.881 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.621 ' HG2' ' SG ' ' A' ' 4' ' ' CYS . 9.5 ptt85 -142.07 123.36 14.76 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.027 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 . . . . . 0 N--CA 1.467 0.378 0 O-C-N 123.353 0.408 . . . . 0.0 110.786 -179.313 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 112.294 -0.322 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -112.21 115.49 50.0 Favored Pre-proline 0 N--CA 1.461 0.106 0 CA-C-N 117.03 0.415 . . . . 0.0 110.193 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.51 126.61 14.38 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.496 2.131 . . . . 0.0 113.286 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -80.06 -35.57 36.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.139 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.99 -40.19 1.71 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.376 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.539 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 16.2 mt-10 -62.43 152.54 34.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.681 0.277 . . . . 0.0 110.664 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.475 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -130.6 129.89 43.31 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.321 0.581 . . . . 0.0 110.862 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.1 m -75.69 36.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.998 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.475 ' H ' ' C ' ' A' ' 7' ' ' SER . 17.0 t -112.64 -27.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.1 m-90 -130.88 -35.5 1.42 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.18 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.0 pt -140.11 145.25 41.13 Favored Pre-proline 0 N--CA 1.463 0.224 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.21 154.08 70.45 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.438 2.092 . . . . 0.0 111.525 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 30.3 m -71.88 101.23 2.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.292 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.5 mm -65.99 -36.37 77.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.3 m -62.5 -0.36 0.59 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.135 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 32.4 m -62.96 -30.69 71.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.45 -25.45 66.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.976 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.0 pt -109.3 3.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.16 -26.01 5.36 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.4 -1.381 . . . . 0.0 116.244 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.662 ' O ' ' HA ' ' A' ' 16' ' ' SER . 1.5 m -67.61 139.85 56.86 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.868 1.334 . . . . 0.0 112.503 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.4 p -142.46 158.6 43.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.048 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m -58.8 117.15 4.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 0.0 112.061 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.437 ' HG3' ' HB2' ' A' ' 28' ' ' TYR . 74.9 mmtt -134.62 111.33 9.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.8 m 57.17 40.5 28.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.125 0.488 . . . . 0.0 109.992 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 24' ' ' SER . 30.9 mmtp 76.22 -12.36 1.03 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.132 -0.94 . . . . 0.0 113.028 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.412 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 19.6 t -109.36 143.46 19.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 117.893 0.315 . . . . 0.0 110.156 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 62.6 m -74.29 115.38 13.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.914 0.387 . . . . 0.0 111.806 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.437 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 3.9 m-85 -125.41 142.47 51.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.478 0.656 . . . . 0.0 110.583 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.591 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 69.2 ttt-85 -98.6 86.97 3.69 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 . . . . . 0 N--CA 1.468 0.47 0 O-C-N 124.084 0.865 . . . . 0.0 109.687 -177.202 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.0 mt -128.9 128.27 23.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.62 122.61 11.94 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.483 2.122 . . . . 0.0 112.725 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.1 m -78.26 -32.41 49.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.975 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.7 -36.51 3.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.026 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.509 ' OE1' ' HA ' ' A' ' 13' ' ' CYS . 34.0 mt-10 -69.06 124.68 24.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.948 0.404 . . . . 0.0 110.682 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.58 136.19 33.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.71 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 m -69.02 -27.37 65.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.524 0.678 . . . . 0.0 111.301 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 25' ' ' LYS . 47.5 t -72.46 -31.57 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.106 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.631 ' O ' HG22 ' A' ' 11' ' ' ILE . 13.0 m0 -79.12 -59.95 2.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.718 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.631 HG22 ' O ' ' A' ' 10' ' ' TRP . 4.2 pt -162.75 163.96 17.1 Favored Pre-proline 0 N--CA 1.469 0.501 0 O-C-N 123.243 0.339 . . . . 0.0 110.505 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -64.35 136.5 51.36 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.803 1.669 . . . . 0.0 109.985 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.509 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 3.4 m -77.29 116.72 18.14 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.706 -177.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.597 ' H ' HD11 ' A' ' 14' ' ' ILE . 3.6 mp -64.41 -36.87 78.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -60.37 -6.07 1.4 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.236 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 38.4 p -59.35 -34.99 73.04 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.74 -27.1 68.48 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.115 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 pt -99.35 12.7 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.34 -11.97 19.26 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 119.663 -1.256 . . . . 0.0 114.967 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 16' ' ' SER . 80.7 m -69.28 136.28 51.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.225 1.012 . . . . 0.0 110.921 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -130.54 136.77 49.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 42.5 t -60.6 129.49 41.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.289 0.566 . . . . 0.0 112.048 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 25' ' ' LYS . 70.0 mmtt -121.83 -155.95 0.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -45.5 79.25 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 23' ' ' LYS . 11.8 mptt 61.84 6.89 1.78 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.222 1.009 . . . . 0.0 111.913 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.46 HG21 ' C ' ' A' ' 25' ' ' LYS . 59.0 t -146.59 139.03 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 122.289 -0.257 . . . . 0.0 111.561 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.6 m -75.63 135.69 40.48 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -129.17 142.15 50.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.488 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.494 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.7 ttt180 -98.78 106.39 18.64 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.0 t30 . . . . . 0 N--CA 1.473 0.703 0 O-C-N 123.996 0.81 . . . . 0.0 110.878 -178.206 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.512 0 N-CA-C 113.712 0.245 . . . . 0.0 113.712 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.7 mt -95.99 127.0 42.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 117.042 0.421 . . . . 0.0 110.717 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.51 124.63 15.49 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 122.308 2.005 . . . . 0.0 112.316 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.4 m -83.65 10.08 10.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.961 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.48 -39.25 1.91 Allowed Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.525 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.424 ' CD ' ' HA ' ' A' ' 13' ' ' CYS . 42.7 tt0 -63.37 139.98 58.83 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.88 136.47 54.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.038 0.447 . . . . 0.0 110.676 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -69.02 -17.96 63.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.821 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' A' ' 25' ' ' LYS . 40.4 t -66.24 -39.14 83.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.99 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -87.72 -55.67 3.68 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.76 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.2 mt -151.24 136.41 10.42 Favored Pre-proline 0 N--CA 1.462 0.15 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.712 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -49.8 141.36 28.27 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.314 2.01 . . . . 0.0 111.312 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.424 ' HA ' ' CD ' ' A' ' 6' ' ' GLU . 35.6 m -52.95 98.06 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.445 HD11 HG21 ' A' ' 14' ' ' ILE . 65.3 mt -69.85 -32.45 51.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 175.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.464 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.5 m -61.71 -2.93 0.92 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 113.31 -1.768 . . . . 0.0 111.537 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.717 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 68.7 m -57.99 -35.5 71.3 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.42 69.27 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.321 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.464 HG12 ' HA ' ' A' ' 15' ' ' SER . 7.7 mm -81.33 -19.13 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.476 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.95 1.62 12.95 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.185 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.717 ' O ' ' HA ' ' A' ' 16' ' ' SER . 75.5 m -79.75 138.52 37.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.359 . . . . 0.0 110.077 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 p -121.61 143.22 49.43 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.215 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.4 t -76.66 120.54 21.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.133 0.492 . . . . 0.0 111.222 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 16.3 ttpt -134.83 125.58 27.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 p 51.64 39.94 26.2 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.082 0.468 . . . . 0.0 111.318 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' HB3' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 69.21 16.52 8.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.681 179.474 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.418 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 44.2 t -131.71 140.34 48.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.8 m -82.1 128.51 34.2 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.555 ' CE1' ' HE2' ' A' ' 23' ' ' LYS . 56.5 m-85 -131.88 144.38 50.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.096 0.474 . . . . 0.0 110.89 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.538 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 59.6 ttt-85 -126.16 113.83 17.55 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.5 t30 . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 121.581 0.705 . . . . 0.0 109.49 -178.092 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.206 0 N-CA-C 112.82 -0.112 . . . . 0.0 112.82 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.0 mt -125.63 129.26 24.43 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.14 124.94 14.79 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.386 2.058 . . . . 0.0 111.786 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m -77.15 -32.62 56.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.847 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.6 -44.51 1.22 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.601 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.448 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 53.8 mt-10 -66.93 146.89 53.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.949 0.404 . . . . 0.0 110.875 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.87 137.49 52.75 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.6 m -64.1 -25.63 68.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.426 0.632 . . . . 0.0 111.243 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.4 t -70.38 -33.15 52.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.275 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.573 ' O ' HG21 ' A' ' 11' ' ' ILE . 39.9 m0 -81.67 -59.74 2.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.938 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 10' ' ' TRP . 11.3 pt -156.85 161.71 29.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.897 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -62.76 144.42 93.76 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 121.965 1.777 . . . . 0.0 110.533 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.4 m -61.58 101.29 0.18 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.2 mt -69.82 -32.89 53.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.605 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 23.4 p -61.97 -8.38 5.12 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.34 -1.755 . . . . 0.0 111.456 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 16.8 m -60.43 -28.32 68.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.66 -28.34 68.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.07 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.9 pt -105.28 21.72 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.98 -4.62 56.04 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.235 -0.984 . . . . 0.0 115.413 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.65 ' O ' ' HA ' ' A' ' 16' ' ' SER . 92.7 m -74.45 143.6 44.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.427 1.114 . . . . 0.0 110.351 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -132.01 138.9 48.42 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.176 -0.327 . . . . 0.0 110.985 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.1 t -74.51 128.14 34.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.872 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -166.29 138.26 3.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.414 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.4 m 60.98 30.36 19.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 110.229 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 71.13 7.57 6.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.668 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.609 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 25.4 t -133.88 150.8 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.444 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.492 ' N ' HG13 ' A' ' 26' ' ' VAL . 33.3 m -84.42 121.04 27.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.609 ' CE1' ' HB ' ' A' ' 26' ' ' VAL . 87.3 m-85 -123.36 148.47 46.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.939 0.399 . . . . 0.0 111.082 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 54.9 ttp85 -140.87 121.68 14.42 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.147 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 . . . . . 0 N--CA 1.469 0.506 0 O-C-N 123.547 0.529 . . . . 0.0 110.746 -178.77 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.3 mt -126.32 128.47 24.4 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -60.16 131.98 41.86 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.461 2.107 . . . . 0.0 112.823 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.2 m -96.62 17.51 16.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.535 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.33 37.89 93.79 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.885 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.42 ' OE1' ' HA ' ' A' ' 13' ' ' CYS . 42.5 tt0 -149.01 153.46 37.93 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -139.06 139.15 37.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.367 0.603 . . . . 0.0 111.152 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -10.22 59.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.597 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.797 HG22 ' HE3' ' A' ' 25' ' ' LYS . 25.2 t -71.77 -38.23 65.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.446 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -89.93 -43.82 10.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.996 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.574 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.5 tt -166.53 141.95 3.72 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.263 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.574 ' HD2' HG13 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -47.09 138.9 15.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.609 2.206 . . . . 0.0 111.709 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.42 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 59.7 m -56.73 98.47 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -177.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.9 mm -69.01 -30.7 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.477 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 71.3 p -59.85 -12.45 7.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.801 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.685 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 30.0 m -57.49 -33.98 68.59 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.33 -28.16 66.56 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.732 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.1 pt -104.76 27.56 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.66 1.58 63.72 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.685 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.1 m -86.53 162.58 17.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 118.197 0.998 . . . . 0.0 110.405 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 t -150.02 148.37 28.96 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.6 t -70.62 114.39 8.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.111 0.481 . . . . 0.0 110.731 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -125.84 115.41 19.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m 58.56 38.67 25.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.131 0.491 . . . . 0.0 110.671 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.797 ' HE3' HG22 ' A' ' 9' ' ' VAL . 30.5 mtpp 71.12 7.21 6.1 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.222 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.8 t -123.7 138.32 53.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 m -75.74 118.67 18.81 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -132.61 145.14 50.85 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.417 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -104.12 105.59 15.81 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.683 0 O-C-N 123.776 0.673 . . . . 0.0 110.441 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 111.704 -0.559 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 2' ' ' ILE . 48.5 mm -120.67 126.37 26.74 Favored Pre-proline 0 C--N 1.331 -0.196 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 33.0 Cg_exo -59.24 122.64 11.89 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.528 2.152 . . . . 0.0 112.795 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 56.0 m -88.11 -32.51 18.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.448 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.56 -37.96 2.88 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.779 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.44 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 27.5 mt-10 -59.65 144.83 46.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.9 0.381 . . . . 0.0 110.635 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.42 126.22 43.47 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.1 -7.63 24.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.437 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.3 t -77.59 -31.72 17.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.971 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -104.09 -53.57 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.896 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 12' ' ' PRO . 20.6 mm -147.85 136.37 11.34 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.227 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.414 ' N ' HG23 ' A' ' 11' ' ' ILE . 35.2 Cg_exo -56.8 146.67 76.92 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.488 2.125 . . . . 0.0 111.745 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.585 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.6 m -61.35 102.12 0.21 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.211 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.453 ' C ' ' H ' ' A' ' 16' ' ' SER . 48.8 mm -68.7 -38.13 78.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.451 ' HA ' HG12 ' A' ' 18' ' ' ILE . 18.0 m -63.84 4.42 0.29 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.846 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.743 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 73.2 m -61.12 -35.44 77.06 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.43 -21.24 66.59 Favored 'General case' 0 CA--C 1.526 0.036 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.455 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 15' ' ' SER . 8.7 mm -89.2 -17.59 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.013 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.78 -13.88 5.54 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.653 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.743 ' O ' ' HA ' ' A' ' 16' ' ' SER . 82.5 m -68.72 151.57 46.49 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.7 m -150.73 141.56 22.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.4 t -65.26 124.08 21.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.279 0.562 . . . . 0.0 111.152 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.677 ' HD3' ' HB2' ' A' ' 28' ' ' TYR . 27.9 mtpp -141.18 116.2 9.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.0 m 57.79 40.06 26.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 24' ' ' SER . 33.0 mmtp 72.58 0.56 3.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.928 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.569 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 23.8 t -119.47 140.33 43.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 39.2 m -85.73 122.79 30.33 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.086 0.469 . . . . 0.0 112.055 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.677 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 64.8 m-85 -128.0 135.65 50.19 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.088 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 5.9 tmm_? -84.6 96.72 9.27 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.47 0.566 0 O-C-N 124.041 0.838 . . . . 0.0 110.039 -177.917 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.247 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.5 mt -130.36 131.32 23.31 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.33 126.75 17.6 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.52 2.147 . . . . 0.0 111.633 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.1 m -81.2 -48.12 12.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.079 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.43 -53.9 0.4 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.788 -1.196 . . . . 0.0 113.856 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.538 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 3.4 mp0 -67.32 147.45 52.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.314 0.578 . . . . 0.0 112.098 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -110.21 127.33 54.89 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.324 178.685 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.7 m -73.61 41.63 0.12 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.852 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.639 HG22 ' HD2' ' A' ' 25' ' ' LYS . 7.6 t -104.87 -49.16 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.536 ' HD1' HG12 ' A' ' 9' ' ' VAL . 27.3 m95 -139.09 -11.48 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.333 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.48 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 48.4 mm -116.2 125.26 28.71 Favored Pre-proline 0 CA--C 1.528 0.111 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.908 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 11' ' ' ILE . 2.8 Cg_exo -74.17 143.49 32.14 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.695 2.264 . . . . 0.0 110.859 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.0 m -69.76 95.36 0.88 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.884 0.374 . . . . 0.0 111.997 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.18 -32.28 53.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.682 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 17.4 p -61.81 -6.7 2.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.255 -1.793 . . . . 0.0 111.608 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 23.8 m -58.81 -26.09 63.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.34 -31.26 69.02 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.73 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.8 pt -103.93 27.53 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.547 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.43 5.45 79.14 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 115.362 0.905 . . . . 0.0 115.362 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 15' ' ' SER . 92.6 m -75.34 141.43 43.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.48 1.14 . . . . 0.0 110.556 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -148.49 146.39 28.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.78 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.1 m -53.61 125.01 16.67 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 38.8 mttp -151.72 122.9 7.7 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 20.3 m 59.78 36.86 22.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.429 . . . . 0.0 110.245 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.639 ' HD2' HG22 ' A' ' 9' ' ' VAL . 18.3 tppt? 71.69 0.92 3.68 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.501 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -125.85 146.85 30.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 121.724 -0.61 . . . . 0.0 110.458 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 39.8 m -69.98 117.76 11.97 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.485 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 3.9 m-85 -122.91 152.68 40.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.389 0.614 . . . . 0.0 111.344 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.51 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 5.6 tmm_? . . . . . 0 C--N 1.316 -0.885 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.313 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.394 0 CA-C-O 120.475 -0.07 . . . . 0.0 113.185 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.6 mt -103.07 126.66 31.76 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.68 123.17 12.47 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.321 2.014 . . . . 0.0 112.273 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.68 -16.83 60.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.362 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.55 -36.0 3.97 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.078 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.546 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 25.9 mt-10 -63.39 133.0 53.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.866 0.365 . . . . 0.0 110.281 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.77 125.17 47.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.418 0.628 . . . . 0.0 110.779 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.3 m -71.01 6.02 1.77 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.19 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 25' ' ' LYS . 13.2 t -79.43 -33.51 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.318 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -118.95 -45.5 2.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.222 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -142.43 133.62 12.93 Favored Pre-proline 0 N--CA 1.464 0.26 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.299 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.94 140.89 92.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.271 1.981 . . . . 0.0 110.995 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.552 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 2.9 m -72.42 115.21 11.41 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.483 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.6 mt -67.44 -37.62 79.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.441 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 15.3 m -61.61 -8.57 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.017 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.552 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 33.1 m -59.96 -35.89 75.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.12 -24.91 67.43 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.951 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.9 pt -104.41 13.87 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.91 -24.42 5.13 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.167 -1.492 . . . . 0.0 115.604 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 16' ' ' SER . 73.4 m -63.58 137.22 58.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.415 1.107 . . . . 0.0 111.547 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -122.36 126.19 47.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.915 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.3 t -75.91 124.22 26.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.051 0.453 . . . . 0.0 110.798 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -137.88 123.03 19.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 m 59.42 34.86 22.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.184 0.516 . . . . 0.0 110.083 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.497 ' HB3' HG22 ' A' ' 9' ' ' VAL . 64.2 mttp 70.48 13.22 7.45 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.306 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 t -128.03 132.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.6 m -89.13 135.15 33.72 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.97 142.95 49.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.322 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.405 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 58.5 ttt-85 . . . . . 0 C--N 1.317 -0.824 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.374 0 N-CA-C 113.305 0.082 . . . . 0.0 113.305 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.8 mt -123.13 127.2 25.74 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.64 124.82 15.34 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.504 2.136 . . . . 0.0 113.189 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.7 m -78.22 -28.02 47.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.583 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.16 -41.22 2.25 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.297 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.79 136.33 50.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.779 0.324 . . . . 0.0 111.084 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.75 129.11 54.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 p -72.3 -18.43 61.79 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.603 HG23 ' HD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -67.65 -44.16 86.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.326 178.732 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.603 ' HD1' HG23 ' A' ' 9' ' ' VAL . 18.7 m95 -78.35 -45.97 21.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.904 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.703 HD12 ' HD2' ' A' ' 12' ' ' PRO . 6.9 tp -170.22 135.29 1.18 Allowed Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.703 ' HD2' HD12 ' A' ' 11' ' ' ILE . 1.2 Cg_endo -47.82 134.98 22.96 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.443 2.095 . . . . 0.0 112.222 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 3.5 m -72.01 125.49 27.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.986 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.8 -38.68 83.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.481 ' HB2' HH21 ' A' ' 29' ' ' ARG . 40.3 p -62.08 -14.58 37.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.007 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 58.6 m -62.88 -34.33 77.17 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.56 -20.64 64.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.251 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 pt -112.24 20.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.34 -27.57 5.51 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 118.963 -1.589 . . . . 0.0 116.244 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 16' ' ' SER . 68.1 m -62.64 133.33 54.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.508 1.154 . . . . 0.0 112.457 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -120.9 121.68 38.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.981 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.885 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 8.0 t -68.31 131.62 45.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.056 0.455 . . . . 0.0 111.02 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -143.85 131.03 20.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.3 m 57.74 35.9 26.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.374 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 82.74 -16.72 0.57 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.573 1.149 . . . . 0.0 112.927 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.9 p -116.68 135.07 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.351 0.596 . . . . 0.0 112.016 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.885 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 m -69.85 137.15 51.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.277 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -129.34 155.5 45.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.708 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 29' ' ' ARG . 13.7 ptp180 . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.952 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.276 0 N-CA-C 112.7 -0.16 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 75.8 mt -129.77 131.39 23.51 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 23.1 Cg_exo -63.19 127.45 20.19 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.474 2.116 . . . . 0.0 111.949 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.9 m -79.79 -49.76 11.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.941 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.95 -52.42 0.4 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.972 -1.108 . . . . 0.0 113.503 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.543 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 1.3 mp0 -75.19 166.94 22.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.578 0.704 . . . . 0.0 111.863 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.2 m -127.23 138.91 53.21 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -64.19 -23.76 67.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 0.0 111.606 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.428 HG23 ' HB3' ' A' ' 25' ' ' LYS . 41.0 t -71.42 -33.29 49.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.578 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -85.86 -55.88 3.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.755 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pp -160.15 162.84 23.42 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.72 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -62.35 143.62 93.96 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.152 1.901 . . . . 0.0 111.43 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.427 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 35.8 m -65.31 107.33 1.58 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.128 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 pt -68.41 -36.48 75.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.512 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 41.5 m -59.45 -7.43 1.38 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.508 -1.678 . . . . 0.0 111.834 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 48.2 m -58.31 -32.65 68.66 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.01 -30.22 69.01 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.503 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.1 pt -101.53 24.47 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.17 12.11 57.85 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 115.384 0.913 . . . . 0.0 115.384 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 16' ' ' SER . 75.2 m -87.93 153.13 21.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 118.208 1.004 . . . . 0.0 110.084 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.4 t -144.87 142.87 30.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.784 0.326 . . . . 0.0 110.378 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 23' ' ' LYS . 41.9 t -66.8 131.35 45.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.771 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 22' ' ' CYS . 1.2 tppp? -158.86 129.4 6.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m 59.53 33.56 22.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.1 0.476 . . . . 0.0 110.889 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.428 ' HB3' HG23 ' A' ' 9' ' ' VAL . 49.0 mtmt 71.59 10.49 6.45 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.635 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 1.3 m -136.26 152.67 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.922 0.391 . . . . 0.0 110.649 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 22.9 m -80.01 122.24 26.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.659 0.266 . . . . 0.0 111.119 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -129.25 155.03 46.21 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.285 0.564 . . . . 0.0 111.148 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.434 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 45.7 ttp180 . . . . . 0 C--N 1.314 -0.949 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.839 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 112.039 -0.424 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.72 125.94 27.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.33 130.33 33.53 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.589 2.193 . . . . 0.0 112.611 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 58.9 m -98.65 15.65 24.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.333 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.93 -46.66 2.7 Favored Glycine 0 C--N 1.331 0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.677 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -64.59 160.03 20.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.177 0.513 . . . . 0.0 111.342 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -148.03 133.01 18.14 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.286 0.565 . . . . 0.0 110.947 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.5 m -75.67 25.89 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.196 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.692 HG22 ' HB3' ' A' ' 25' ' ' LYS . 25.0 t -92.49 -37.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -108.86 -45.13 3.86 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.69 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -153.37 155.79 31.97 Favored Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -64.29 146.54 90.26 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.382 2.055 . . . . 0.0 110.486 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.502 ' SG ' ' HB3' ' A' ' 22' ' ' CYS . 1.5 m -67.84 115.62 7.59 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.34 -33.95 63.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.5 p -62.97 -5.91 3.38 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.82 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.697 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 29.4 m -62.03 -30.48 71.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -24.58 63.91 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.128 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.3 pt -112.35 28.23 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.26 -16.0 53.7 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 116.376 1.31 . . . . 0.0 116.376 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.697 ' O ' ' HA ' ' A' ' 16' ' ' SER . 89.6 m -70.24 141.07 52.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 118.983 1.392 . . . . 0.0 111.573 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 p -142.31 124.39 15.38 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.825 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 21.5 p -73.76 130.25 39.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.952 0.882 . . . . 0.0 111.663 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.879 ' HE2' ' HB2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -132.17 133.44 44.23 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.632 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.6 m 61.79 31.28 18.43 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.692 ' HB3' HG22 ' A' ' 9' ' ' VAL . 33.6 mttm 73.75 -5.82 1.93 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.051 -1.431 . . . . 0.0 113.353 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.1 t -105.11 132.98 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 118.401 0.546 . . . . 0.0 109.901 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.825 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 57.6 m -75.78 125.31 28.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.879 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 9.5 m-85 -136.32 141.21 43.77 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.321 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.479 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 22.4 ttm180 . . . . . 0 C--N 1.307 -1.259 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.349 0 CA-C-O 120.378 -0.123 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 65.0 mt -94.16 124.03 57.18 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.973 0.386 . . . . 0.0 110.223 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.75 118.91 5.83 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.083 1.856 . . . . 0.0 112.514 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 21.6 m -75.37 -23.92 57.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.375 0.607 . . . . 0.0 109.57 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.43 -37.95 3.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.058 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.488 ' HG2' ' H ' ' A' ' 6' ' ' GLU . 3.0 pt-20 -71.3 125.75 27.79 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.155 0.502 . . . . 0.0 111.225 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.42 132.61 38.87 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.6 p -72.59 -22.52 60.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.126 0.488 . . . . 0.0 112.211 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.99 -33.08 42.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.241 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -82.34 -52.55 6.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.741 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.6 pt -152.25 155.73 33.34 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.914 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -63.6 136.0 52.0 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.277 1.318 . . . . 0.0 110.442 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.577 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 56.2 m -73.84 114.59 12.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.053 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mm -66.29 -41.9 89.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.427 ' HA ' HG12 ' A' ' 18' ' ' ILE . 49.5 m -64.13 -7.81 10.12 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.055 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.577 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 18.8 m -64.15 -34.33 77.82 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.52 -18.55 62.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.954 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' A' ' 15' ' ' SER . 21.8 pt -117.93 23.99 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.81 -30.89 5.37 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 118.946 -1.597 . . . . 0.0 116.754 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 16' ' ' SER . 96.2 m -62.33 133.53 55.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.623 1.211 . . . . 0.0 112.479 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.9 t -126.89 134.29 50.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 14.1 t -75.02 135.07 41.3 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.366 0.603 . . . . 0.0 112.285 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -150.86 132.42 14.79 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.235 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 4.3 m 59.48 35.02 22.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' SER . 67.3 mttm 77.95 -16.97 0.61 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.892 0.877 . . . . 0.0 112.852 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -110.85 137.63 42.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-O 121.009 0.433 . . . . 0.0 111.717 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 2.1 m -77.94 136.18 37.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.162 0.506 . . . . 0.0 112.257 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -129.12 148.05 51.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.679 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.543 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 19.5 ttm180 . . . . . 0 C--N 1.314 -0.947 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.209 0 N-CA-C 112.682 -0.167 . . . . 0.0 112.682 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mm -120.66 127.12 26.42 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.15 125.47 14.14 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.39 2.06 . . . . 0.0 112.377 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.2 m -85.65 -0.56 55.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.616 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.06 -45.35 3.43 Favored Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 113.406 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.58 ' OE2' HG12 ' A' ' 14' ' ' ILE . 53.8 mt-10 -62.89 142.27 58.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.824 0.345 . . . . 0.0 111.13 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.06 138.35 49.55 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.258 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.9 m -66.25 -15.55 63.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.54 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.43 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 41.9 t -68.77 -34.76 66.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.937 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.402 ' O ' HG23 ' A' ' 11' ' ' ILE . 27.2 m95 -93.24 -57.13 2.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.217 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 10' ' ' TRP . 5.4 pt -160.55 160.34 25.77 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.177 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -63.12 137.93 64.34 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.658 1.572 . . . . 0.0 110.326 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.3 m -75.71 122.77 24.5 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.346 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.58 HG12 ' OE2' ' A' ' 6' ' ' GLU . 12.4 pt -65.64 -37.4 79.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 m -60.32 -11.84 7.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.839 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 59.0 m -61.84 -34.3 75.72 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.01 -24.09 66.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.974 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.0 pt -107.33 25.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.19 -19.98 28.94 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 116.361 1.304 . . . . 0.0 116.361 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 16' ' ' SER . 84.1 m -68.54 137.44 54.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.746 1.273 . . . . 0.0 112.004 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.6 p -137.38 138.13 39.57 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 2.1 m -64.95 121.07 13.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.655 0.74 . . . . 0.0 111.934 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -123.67 121.02 34.45 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.6 m 57.44 38.3 28.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 24' ' ' SER . 97.2 mttt 81.17 -18.34 0.5 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.988 -1.006 . . . . 0.0 113.3 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.11 133.51 52.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 117.955 0.343 . . . . 0.0 110.826 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 4.1 m -68.23 129.68 40.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.446 0.641 . . . . 0.0 112.434 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -132.82 154.54 50.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.24 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.452 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 51.7 ttp180 . . . . . 0 C--N 1.315 -0.9 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 pt -129.18 140.05 37.49 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.947 0.374 . . . . 0.0 110.184 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.91 128.42 24.22 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.383 2.056 . . . . 0.0 112.596 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 63.1 m -82.06 -48.37 11.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.618 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.25 -55.82 0.35 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.564 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.84 158.68 35.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.614 0.721 . . . . 0.0 111.248 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m -128.6 137.61 51.78 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.07 3.86 2.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.098 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.1 t -85.81 -33.57 7.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -104.12 -52.45 2.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.012 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.42 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -146.17 157.64 49.35 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-O 120.776 0.322 . . . . 0.0 111.645 -178.218 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.49 146.91 86.21 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.811 2.341 . . . . 0.0 111.149 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.497 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 23.8 m -64.36 103.75 0.68 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.6 mt -69.57 -36.67 72.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.591 ' HA ' HG12 ' A' ' 18' ' ' ILE . 68.8 m -63.51 0.25 0.77 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.841 -1.527 . . . . 0.0 111.923 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 65.2 m -60.36 -33.58 72.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.01 -22.18 65.91 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.425 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.591 HG12 ' HA ' ' A' ' 15' ' ' SER . 1.4 mm -94.13 9.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.612 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.38 17.09 43.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.487 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 16' ' ' SER . 93.8 m -94.13 154.91 17.35 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -144.23 149.96 37.19 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.98 126.57 30.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.206 0.526 . . . . 0.0 110.858 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -144.34 121.66 11.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 m 58.08 37.8 26.52 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.973 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 68.49 13.73 9.01 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.839 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.91 143.15 39.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.9 m -78.55 121.14 24.22 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -126.47 148.95 49.59 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.358 0.599 . . . . 0.0 110.707 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.629 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.2 ttm180 . . . . . 0 C--N 1.311 -1.071 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.444 0 CA-C-O 120.069 -0.295 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.94 126.58 52.95 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 117.303 0.551 . . . . 0.0 110.592 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.79 120.41 8.29 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.445 2.096 . . . . 0.0 112.582 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 61.4 m -76.23 -25.3 54.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.441 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.18 -31.01 8.27 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.7 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.545 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 32.9 mt-10 -61.53 130.72 47.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.61 0.243 . . . . 0.0 110.411 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.18 125.9 51.55 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 m -65.14 -18.19 65.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.527 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.8 t -71.23 -35.53 58.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.309 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.3 m95 -89.92 -52.88 4.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.505 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -155.58 153.85 27.11 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.285 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.16 147.91 88.63 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.581 2.187 . . . . 0.0 111.231 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.6 m -58.27 103.94 0.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.574 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.77 -39.85 80.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.5 m -64.3 2.65 0.56 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 113.61 -1.632 . . . . 0.0 111.695 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.671 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 62.5 p -62.47 -32.65 73.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.67 -20.64 57.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.203 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 pt -119.62 26.53 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.13 -22.15 16.39 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 16' ' ' SER . 85.6 m -68.13 137.67 55.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.992 1.396 . . . . 0.0 111.957 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -133.77 138.4 45.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.085 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.4 t -72.23 130.69 41.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.872 0.368 . . . . 0.0 111.492 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.505 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 17.7 ttpt -153.84 127.47 8.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 16.5 m 59.14 36.01 23.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.822 0.344 . . . . 0.0 111.031 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 24' ' ' SER . 1.1 mptm? 71.54 10.54 6.5 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.532 0.733 . . . . 0.0 112.643 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.783 HG13 ' HE1' ' A' ' 28' ' ' TYR . 2.1 p -140.01 139.93 36.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.147 0.499 . . . . 0.0 110.318 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 34.0 m -78.93 136.13 37.17 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.783 ' HE1' HG13 ' A' ' 26' ' ' VAL . 27.7 m-85 -128.45 146.04 50.92 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.339 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.609 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 26.5 ttm180 . . . . . 0 C--N 1.314 -0.962 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 29' ' ' ARG . 37.4 pt -122.95 137.13 27.65 Favored Pre-proline 0 C--N 1.333 -0.123 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.3 129.29 23.66 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.548 2.165 . . . . 0.0 113.512 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.3 m -93.87 9.6 36.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.088 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.88 -41.96 2.44 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 113.459 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -63.75 141.17 58.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 122.639 0.376 . . . . 0.0 110.588 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 132.6 53.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.5 t -70.49 -28.31 64.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.397 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.8 t -71.45 -40.36 72.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.677 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -71.44 -52.63 17.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.552 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -149.66 156.22 38.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -62.13 138.93 75.57 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.08 1.187 . . . . 0.0 109.15 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 16' ' ' SER . 66.1 m -59.47 99.56 0.06 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.4 mt -68.94 -32.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.5 p -64.12 -12.62 41.31 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.231 -1.349 . . . . 0.0 110.776 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.764 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 6.6 t -62.87 -34.79 78.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.89 -20.95 64.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.32 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.4 pt -113.19 21.53 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.0 -31.2 5.4 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.522 -1.323 . . . . 0.0 115.743 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.764 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.3 m -71.28 171.14 11.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.12 0.96 . . . . 0.0 111.232 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.3 p -166.47 145.24 5.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.203 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.3 m -53.34 129.13 30.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 110.467 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.619 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -153.07 115.92 4.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.046 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.5 m 55.82 41.94 29.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.544 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 24' ' ' SER . 1.0 OUTLIER 76.1 -14.52 0.79 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.582 0.753 . . . . 0.0 112.856 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.411 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.1 t -112.55 146.81 16.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.911 0.386 . . . . 0.0 110.757 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.0 m -73.5 119.51 17.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.411 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 3.2 m-85 -123.72 144.92 49.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.498 0.666 . . . . 0.0 111.521 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.426 ' O ' HG12 ' A' ' 2' ' ' ILE . 51.5 ttm-85 . . . . . 0 C--N 1.311 -1.097 0 CA-C-N 114.535 -1.211 . . . . 0.0 107.884 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 113.831 0.292 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.5 mp -96.75 125.75 45.57 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 117.329 0.565 . . . . 0.0 110.231 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.62 123.59 14.22 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.133 1.888 . . . . 0.0 112.287 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.4 m -76.52 -37.98 55.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.305 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.09 -40.7 2.07 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.323 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.65 133.01 44.44 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.245 0.545 . . . . 0.0 111.278 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -106.5 127.7 53.51 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.206 178.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 37.12 0.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.701 0.762 . . . . 0.0 110.972 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.754 HG22 ' HE3' ' A' ' 25' ' ' LYS . 21.4 t -124.37 -40.87 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.445 ' O ' HG13 ' A' ' 11' ' ' ILE . 17.1 m0 -92.8 -49.23 6.17 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.119 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 10' ' ' TRP . 56.9 mt -157.27 135.22 7.26 Favored Pre-proline 0 N--CA 1.468 0.463 0 O-C-N 123.006 0.191 . . . . 0.0 110.723 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.21 139.74 80.94 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.478 2.119 . . . . 0.0 111.763 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.442 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.7 m -73.83 117.83 16.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.279 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.13 -34.47 66.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.404 ' HA ' HG12 ' A' ' 18' ' ' ILE . 77.9 p -60.6 -12.65 10.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.222 -1.353 . . . . 0.0 112.0 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 19.1 m -59.63 -36.09 75.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.29 67.28 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.875 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 15' ' ' SER . 41.0 pt -104.91 17.22 5.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.71 -21.13 8.07 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 119.038 -1.553 . . . . 0.0 115.524 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 16' ' ' SER . 55.6 m -64.77 138.21 58.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.272 1.036 . . . . 0.0 111.76 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.3 t -123.6 134.32 53.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.651 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.5 t -75.73 116.77 16.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.022 0.439 . . . . 0.0 110.576 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -130.91 126.41 36.04 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m 58.58 36.94 25.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.198 0.523 . . . . 0.0 110.666 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.754 ' HE3' HG22 ' A' ' 9' ' ' VAL . 31.5 mmmt 70.7 11.27 7.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.962 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 p -136.78 134.73 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.174 0.511 . . . . 0.0 109.68 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.0 m -79.17 134.37 36.7 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -129.79 146.13 51.55 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.635 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 2' ' ' ILE . 9.6 ptp180 . . . . . 0 C--N 1.313 -1.011 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.568 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.196 0 N-CA-C 112.737 -0.145 . . . . 0.0 112.737 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 70.3 mt -123.81 130.48 24.42 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 27.9 Cg_exo -62.21 126.07 17.79 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.615 2.21 . . . . 0.0 111.983 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.4 m -78.36 -22.63 47.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.612 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.86 -38.54 3.06 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.608 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -69.85 137.57 51.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.982 0.42 . . . . 0.0 110.72 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 t -111.1 144.95 39.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.024 0.916 . . . . 0.0 110.426 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -73.8 -16.97 61.14 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.701 -1.591 . . . . 0.0 110.859 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 25' ' ' LYS . 46.0 t -78.28 -38.95 23.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.99 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -77.54 -52.2 9.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.553 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.569 HD12 ' HD2' ' A' ' 12' ' ' PRO . 8.1 tp -177.72 141.82 0.46 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.569 ' HD2' HD12 ' A' ' 11' ' ' ILE . 1.2 Cg_endo -46.21 133.44 15.31 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.394 2.063 . . . . 0.0 112.075 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.2 m -71.86 122.58 21.0 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.405 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.8 mp -65.8 -35.58 75.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.423 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 61.4 p -61.19 -15.59 35.76 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.829 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 74.5 m -61.32 -35.41 77.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.89 -23.1 66.1 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.432 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 pt -108.71 23.37 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.29 -23.57 7.59 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 119.119 -1.515 . . . . 0.0 115.986 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.628 ' SG ' ' HD2' ' A' ' 29' ' ' ARG . 96.5 m -65.07 134.56 54.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.533 1.167 . . . . 0.0 112.213 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.3 t -117.86 133.32 56.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.939 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 40.4 t -76.77 117.12 18.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.402 . . . . 0.0 110.616 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.78 129.17 22.49 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.5 m 60.6 31.97 20.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.121 0.486 . . . . 0.0 110.105 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.495 ' HB3' HG23 ' A' ' 9' ' ' VAL . 64.8 mttp 69.7 14.07 8.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.13 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.405 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 30.5 t -131.88 140.75 47.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.4 m -87.67 132.81 33.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.304 0.573 . . . . 0.0 112.474 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.405 ' CE1' ' HB ' ' A' ' 26' ' ' VAL . 72.5 m-85 -134.54 144.87 48.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.679 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.628 ' HD2' ' SG ' ' A' ' 20' ' ' CYS . 6.1 ptm180 . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.371 0 N-CA-C 112.882 -0.087 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.4 mt -127.31 130.48 23.72 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.83 123.43 12.27 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.351 2.034 . . . . 0.0 112.217 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.5 m -73.96 -32.08 63.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.358 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.54 -46.15 1.1 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.744 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.516 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 50.3 mt-10 -66.48 146.56 54.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.016 0.436 . . . . 0.0 111.256 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.91 133.13 56.4 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -66.79 -13.91 62.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.306 0.574 . . . . 0.0 111.579 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.3 -35.57 27.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.311 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.9 m95 -89.5 -44.41 10.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.629 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.481 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.6 tt -165.34 141.8 4.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.167 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.481 ' HD2' HG13 ' A' ' 11' ' ' ILE . 43.2 Cg_exo -53.72 146.91 42.54 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.183 1.922 . . . . 0.0 111.705 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 56.5 m -59.33 103.12 0.16 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.75 -32.2 48.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.504 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 15.8 p -61.97 -9.21 6.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.364 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 22.1 m -60.04 -27.09 66.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.42 -31.34 71.27 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.947 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.9 pt -99.9 14.93 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.754 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.27 -2.49 46.99 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.266 -0.969 . . . . 0.0 115.457 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 16' ' ' SER . 64.2 m -72.45 140.2 48.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 118.613 1.206 . . . . 0.0 110.319 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -127.5 142.0 51.51 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 23' ' ' LYS . 50.3 t -70.32 114.38 8.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.02 0.438 . . . . 0.0 110.787 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' A' ' 22' ' ' CYS . 29.0 mmmt -129.08 122.77 30.65 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.0 m 56.85 39.36 29.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.964 0.411 . . . . 0.0 111.409 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 71.19 11.13 6.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.69 138.56 47.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.03 0.443 . . . . 0.0 110.406 178.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 18.3 m -71.41 125.33 26.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.587 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -128.22 154.22 46.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.388 0.613 . . . . 0.0 111.23 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 . . . . . 0 C--N 1.318 -0.795 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.67 178.991 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.244 0 N-CA-C 112.65 -0.18 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.8 mm -129.09 130.43 23.41 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.63 131.08 40.33 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.715 2.277 . . . . 0.0 112.494 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.617 ' SG ' ' HG2' ' A' ' 29' ' ' ARG . 61.4 m -76.87 -40.93 45.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.164 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.65 -46.19 1.05 Allowed Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.346 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.736 ' HG3' ' SG ' ' A' ' 27' ' ' CYS . 14.3 pt-20 -83.02 159.43 22.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.199 0.523 . . . . 0.0 110.709 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 9' ' ' VAL . 1.6 m -134.18 142.29 47.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.489 0.661 . . . . 0.0 110.672 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -74.53 13.89 0.55 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.458 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.688 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 44.2 t -78.7 -35.14 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -120.36 -38.25 2.93 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.587 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 26.6 pt -139.26 151.14 66.69 Favored Pre-proline 0 N--CA 1.463 0.215 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -72.23 142.35 37.48 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.602 2.201 . . . . 0.0 110.329 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.499 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 24.7 m -58.84 99.43 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 14' ' ' ILE . 8.6 tp -67.55 -35.37 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.498 ' C ' ' HB2' ' A' ' 20' ' ' CYS . 49.7 m -61.6 -3.31 1.0 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.937 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 54.5 m -59.0 -29.86 67.56 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.11 -29.25 68.48 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.491 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.0 pt -103.46 22.71 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.73 -3.87 56.18 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.149 -1.024 . . . . 0.0 115.224 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 16' ' ' SER . 45.9 m -71.47 146.17 48.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.297 1.049 . . . . 0.0 110.683 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.0 t -134.81 132.59 38.85 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.113 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 45.4 t -78.36 138.08 38.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.722 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.447 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 2.5 ptpt -165.97 134.79 3.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.3 m 59.08 29.43 18.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.399 0.619 . . . . 0.0 109.815 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.688 ' HE3' ' HA ' ' A' ' 9' ' ' VAL . 30.6 mtpp 63.13 26.06 15.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.175 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.8 p -137.31 143.28 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.736 ' SG ' ' HG3' ' A' ' 6' ' ' GLU . 35.2 m -88.16 124.03 33.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -131.73 152.67 50.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.269 0.557 . . . . 0.0 110.881 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.617 ' HG2' ' SG ' ' A' ' 4' ' ' CYS . 9.5 ptt85 . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.027 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 112.294 -0.322 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -112.21 115.49 50.0 Favored Pre-proline 0 N--CA 1.461 0.106 0 CA-C-N 117.03 0.415 . . . . 0.0 110.193 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.51 126.61 14.38 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.496 2.131 . . . . 0.0 113.286 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -80.06 -35.57 36.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.139 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.99 -40.19 1.71 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.376 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.556 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 16.2 mt-10 -62.43 152.54 34.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.681 0.277 . . . . 0.0 110.664 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -130.6 129.89 43.31 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.321 0.581 . . . . 0.0 110.862 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.1 m -75.69 36.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.998 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.454 ' H ' ' C ' ' A' ' 7' ' ' SER . 17.0 t -112.64 -27.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.1 m-90 -130.88 -35.5 1.42 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.18 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.0 pt -140.11 145.25 41.13 Favored Pre-proline 0 N--CA 1.463 0.224 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.21 154.08 70.45 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.438 2.092 . . . . 0.0 111.525 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.408 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 30.3 m -71.88 101.23 2.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.292 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.5 mm -65.99 -36.37 77.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.3 m -62.5 -0.36 0.59 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.135 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.689 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 32.4 m -62.96 -30.69 71.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.45 -25.45 66.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.976 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.0 pt -109.3 3.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.16 -26.01 5.36 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.4 -1.381 . . . . 0.0 116.244 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.689 ' O ' ' HA ' ' A' ' 16' ' ' SER . 1.5 m -67.61 139.85 56.86 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.868 1.334 . . . . 0.0 112.503 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.4 p -142.46 158.6 43.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.048 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m -58.8 117.15 4.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 0.0 112.061 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.468 ' HG3' ' HB2' ' A' ' 28' ' ' TYR . 74.9 mmtt -134.62 111.33 9.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.8 m 57.17 40.5 28.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.125 0.488 . . . . 0.0 109.992 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 24' ' ' SER . 30.9 mmtp 76.22 -12.36 1.03 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.132 -0.94 . . . . 0.0 113.028 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 19.6 t -109.36 143.46 19.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 117.893 0.315 . . . . 0.0 110.156 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 62.6 m -74.29 115.38 13.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.914 0.387 . . . . 0.0 111.806 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.468 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 3.9 m-85 -125.41 142.47 51.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.478 0.656 . . . . 0.0 110.583 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.604 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 69.2 ttt-85 . . . . . 0 C--N 1.309 -1.167 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.0 mt -128.9 128.27 23.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.62 122.61 11.94 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.483 2.122 . . . . 0.0 112.725 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.1 m -78.26 -32.41 49.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.975 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.7 -36.51 3.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.026 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.525 ' OE1' ' HA ' ' A' ' 13' ' ' CYS . 34.0 mt-10 -69.06 124.68 24.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.948 0.404 . . . . 0.0 110.682 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.58 136.19 33.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.71 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 m -69.02 -27.37 65.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.524 0.678 . . . . 0.0 111.301 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.46 -31.57 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.106 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.454 ' O ' HG23 ' A' ' 11' ' ' ILE . 13.0 m0 -79.12 -59.95 2.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.718 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 10' ' ' TRP . 4.2 pt -162.75 163.96 17.1 Favored Pre-proline 0 N--CA 1.469 0.501 0 O-C-N 123.243 0.339 . . . . 0.0 110.505 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -64.35 136.5 51.36 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.803 1.669 . . . . 0.0 109.985 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.525 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 3.4 m -77.29 116.72 18.14 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.706 -177.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 14' ' ' ILE . 3.6 mp -64.41 -36.87 78.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -60.37 -6.07 1.4 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.236 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 38.4 p -59.35 -34.99 73.04 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.74 -27.1 68.48 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.115 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 pt -99.35 12.7 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.34 -11.97 19.26 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 119.663 -1.256 . . . . 0.0 114.967 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 16' ' ' SER . 80.7 m -69.28 136.28 51.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.225 1.012 . . . . 0.0 110.921 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -130.54 136.77 49.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 42.5 t -60.6 129.49 41.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.289 0.566 . . . . 0.0 112.048 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 25' ' ' LYS . 70.0 mmtt -121.83 -155.95 0.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -45.5 79.25 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 23' ' ' LYS . 11.8 mptt 61.84 6.89 1.78 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.222 1.009 . . . . 0.0 111.913 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -146.59 139.03 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 122.289 -0.257 . . . . 0.0 111.561 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.6 m -75.63 135.69 40.48 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -129.17 142.15 50.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.488 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.503 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.7 ttt180 . . . . . 0 C--N 1.31 -1.111 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.512 0 N-CA-C 113.712 0.245 . . . . 0.0 113.712 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.7 mt -95.99 127.0 42.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 117.042 0.421 . . . . 0.0 110.717 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.51 124.63 15.49 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 122.308 2.005 . . . . 0.0 112.316 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.4 m -83.65 10.08 10.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.961 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.48 -39.25 1.91 Allowed Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.525 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.43 ' CD ' ' HA ' ' A' ' 13' ' ' CYS . 42.7 tt0 -63.37 139.98 58.83 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.88 136.47 54.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.038 0.447 . . . . 0.0 110.676 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -69.02 -17.96 63.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.821 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.411 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 40.4 t -66.24 -39.14 83.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.99 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -87.72 -55.67 3.68 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.76 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.2 mt -151.24 136.41 10.42 Favored Pre-proline 0 N--CA 1.462 0.15 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.712 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -49.8 141.36 28.27 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.314 2.01 . . . . 0.0 111.312 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' CD ' ' A' ' 6' ' ' GLU . 35.6 m -52.95 98.06 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.3 mt -69.85 -32.45 51.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.5 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.5 m -61.71 -2.93 0.92 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 113.31 -1.768 . . . . 0.0 111.537 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.74 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 68.7 m -57.99 -35.5 71.3 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.42 69.27 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.321 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.5 HG12 ' HA ' ' A' ' 15' ' ' SER . 7.7 mm -81.33 -19.13 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.476 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.95 1.62 12.95 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.185 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.74 ' O ' ' HA ' ' A' ' 16' ' ' SER . 75.5 m -79.75 138.52 37.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.359 . . . . 0.0 110.077 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 p -121.61 143.22 49.43 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.215 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.4 t -76.66 120.54 21.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.133 0.492 . . . . 0.0 111.222 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.558 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 16.3 ttpt -134.83 125.58 27.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 p 51.64 39.94 26.2 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.082 0.468 . . . . 0.0 111.318 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 69.21 16.52 8.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.681 179.474 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.429 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 44.2 t -131.71 140.34 48.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.8 m -82.1 128.51 34.2 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.558 ' CE1' ' HE2' ' A' ' 23' ' ' LYS . 56.5 m-85 -131.88 144.38 50.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.096 0.474 . . . . 0.0 110.89 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.548 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 59.6 ttt-85 . . . . . 0 C--N 1.315 -0.923 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.206 0 N-CA-C 112.82 -0.112 . . . . 0.0 112.82 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.0 mt -125.63 129.26 24.43 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.14 124.94 14.79 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.386 2.058 . . . . 0.0 111.786 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m -77.15 -32.62 56.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.847 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.6 -44.51 1.22 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.601 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.468 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 53.8 mt-10 -66.93 146.89 53.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.949 0.404 . . . . 0.0 110.875 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.87 137.49 52.75 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.6 m -64.1 -25.63 68.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.426 0.632 . . . . 0.0 111.243 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.4 t -70.38 -33.15 52.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.275 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -81.67 -59.74 2.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.938 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 pt -156.85 161.71 29.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.897 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -62.76 144.42 93.76 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 121.965 1.777 . . . . 0.0 110.533 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 44.4 m -61.58 101.29 0.18 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.2 mt -69.82 -32.89 53.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.606 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 23.4 p -61.97 -8.38 5.12 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.34 -1.755 . . . . 0.0 111.456 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 16.8 m -60.43 -28.32 68.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.66 -28.34 68.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.07 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.9 pt -105.28 21.72 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.98 -4.62 56.04 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.235 -0.984 . . . . 0.0 115.413 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 16' ' ' SER . 92.7 m -74.45 143.6 44.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.427 1.114 . . . . 0.0 110.351 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -132.01 138.9 48.42 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.176 -0.327 . . . . 0.0 110.985 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.402 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 19.1 t -74.51 128.14 34.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.872 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -166.29 138.26 3.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.414 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.4 m 60.98 30.36 19.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 110.229 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 71.13 7.57 6.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.668 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.621 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 25.4 t -133.88 150.8 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.444 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 33.3 m -84.42 121.04 27.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.621 ' CE1' ' HB ' ' A' ' 26' ' ' VAL . 87.3 m-85 -123.36 148.47 46.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.939 0.399 . . . . 0.0 111.082 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 54.9 ttp85 . . . . . 0 C--N 1.318 -0.797 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.147 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.3 mt -126.32 128.47 24.4 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -60.16 131.98 41.86 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.461 2.107 . . . . 0.0 112.823 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.2 m -96.62 17.51 16.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.535 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.33 37.89 93.79 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.885 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.41 ' OE1' ' HA ' ' A' ' 13' ' ' CYS . 42.5 tt0 -149.01 153.46 37.93 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -139.06 139.15 37.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.367 0.603 . . . . 0.0 111.152 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -10.22 59.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.597 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.838 HG22 ' HE3' ' A' ' 25' ' ' LYS . 25.2 t -71.77 -38.23 65.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.446 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -89.93 -43.82 10.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.996 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.591 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.5 tt -166.53 141.95 3.72 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.263 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.591 ' HD2' HG13 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -47.09 138.9 15.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.609 2.206 . . . . 0.0 111.709 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.41 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 59.7 m -56.73 98.47 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -177.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.9 mm -69.01 -30.7 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.475 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 71.3 p -59.85 -12.45 7.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.801 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.703 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 30.0 m -57.49 -33.98 68.59 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.33 -28.16 66.56 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.732 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.1 pt -104.76 27.56 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.66 1.58 63.72 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.703 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.1 m -86.53 162.58 17.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 118.197 0.998 . . . . 0.0 110.405 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 t -150.02 148.37 28.96 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.6 t -70.62 114.39 8.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.111 0.481 . . . . 0.0 110.731 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -125.84 115.41 19.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m 58.56 38.67 25.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.131 0.491 . . . . 0.0 110.671 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.838 ' HE3' HG22 ' A' ' 9' ' ' VAL . 30.5 mtpp 71.12 7.21 6.1 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.222 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.8 t -123.7 138.32 53.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 m -75.74 118.67 18.81 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -132.61 145.14 50.85 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.417 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 . . . . . 0 C--N 1.311 -1.073 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.71 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 111.704 -0.559 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 48.5 mm -120.67 126.37 26.74 Favored Pre-proline 0 C--N 1.331 -0.196 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 33.0 Cg_exo -59.24 122.64 11.89 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.528 2.152 . . . . 0.0 112.795 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 56.0 m -88.11 -32.51 18.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.448 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.56 -37.96 2.88 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.779 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.461 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 27.5 mt-10 -59.65 144.83 46.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.9 0.381 . . . . 0.0 110.635 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.42 126.22 43.47 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.1 -7.63 24.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.437 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.3 t -77.59 -31.72 17.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.971 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -104.09 -53.57 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.896 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.6 mm -147.85 136.37 11.34 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.227 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -56.8 146.67 76.92 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.488 2.125 . . . . 0.0 111.745 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.595 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.6 m -61.35 102.12 0.21 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.211 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mm -68.7 -38.13 78.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.493 ' HA ' HG12 ' A' ' 18' ' ' ILE . 18.0 m -63.84 4.42 0.29 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.846 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.767 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 73.2 m -61.12 -35.44 77.06 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.43 -21.24 66.59 Favored 'General case' 0 CA--C 1.526 0.036 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.455 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.493 HG12 ' HA ' ' A' ' 15' ' ' SER . 8.7 mm -89.2 -17.59 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.013 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.78 -13.88 5.54 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.653 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.767 ' O ' ' HA ' ' A' ' 16' ' ' SER . 82.5 m -68.72 151.57 46.49 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.7 m -150.73 141.56 22.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.4 t -65.26 124.08 21.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.279 0.562 . . . . 0.0 111.152 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.704 ' HD3' ' HB2' ' A' ' 28' ' ' TYR . 27.9 mtpp -141.18 116.2 9.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.0 m 57.79 40.06 26.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 24' ' ' SER . 33.0 mmtp 72.58 0.56 3.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.928 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.58 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 23.8 t -119.47 140.33 43.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 39.2 m -85.73 122.79 30.33 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.086 0.469 . . . . 0.0 112.055 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.704 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 64.8 m-85 -128.0 135.65 50.19 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.088 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.694 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 5.9 tmm_? . . . . . 0 C--N 1.314 -0.959 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.247 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.5 mt -130.36 131.32 23.31 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.33 126.75 17.6 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.52 2.147 . . . . 0.0 111.633 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.1 m -81.2 -48.12 12.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.079 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.43 -53.9 0.4 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.788 -1.196 . . . . 0.0 113.856 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.538 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 3.4 mp0 -67.32 147.45 52.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.314 0.578 . . . . 0.0 112.098 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -110.21 127.33 54.89 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.324 178.685 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.7 m -73.61 41.63 0.12 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.852 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.639 HG22 ' HD2' ' A' ' 25' ' ' LYS . 7.6 t -104.87 -49.16 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.536 ' HD1' HG12 ' A' ' 9' ' ' VAL . 27.3 m95 -139.09 -11.48 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.333 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.48 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 48.4 mm -116.2 125.26 28.71 Favored Pre-proline 0 CA--C 1.528 0.111 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.908 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 11' ' ' ILE . 2.8 Cg_exo -74.17 143.49 32.14 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.695 2.264 . . . . 0.0 110.859 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.0 m -69.76 95.36 0.88 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.884 0.374 . . . . 0.0 111.997 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.18 -32.28 53.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.682 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 17.4 p -61.81 -6.7 2.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.255 -1.793 . . . . 0.0 111.608 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 23.8 m -58.81 -26.09 63.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.34 -31.26 69.02 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.73 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.8 pt -103.93 27.53 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.547 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.43 5.45 79.14 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 115.362 0.905 . . . . 0.0 115.362 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 15' ' ' SER . 92.6 m -75.34 141.43 43.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.48 1.14 . . . . 0.0 110.556 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -148.49 146.39 28.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.78 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.1 m -53.61 125.01 16.67 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 38.8 mttp -151.72 122.9 7.7 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 20.3 m 59.78 36.86 22.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.429 . . . . 0.0 110.245 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.639 ' HD2' HG22 ' A' ' 9' ' ' VAL . 18.3 tppt? 71.69 0.92 3.68 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.501 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -125.85 146.85 30.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 121.724 -0.61 . . . . 0.0 110.458 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 39.8 m -69.98 117.76 11.97 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.485 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 3.9 m-85 -122.91 152.68 40.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.389 0.614 . . . . 0.0 111.344 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.51 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 5.6 tmm_? -146.25 125.5 13.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.313 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.501 ' HB2' ' HD2' ' A' ' 29' ' ' ARG . 32.9 t-20 . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 121.306 0.574 . . . . 0.0 110.02 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.394 0 CA-C-O 120.475 -0.07 . . . . 0.0 113.185 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.6 mt -103.07 126.66 31.76 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.68 123.17 12.47 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.321 2.014 . . . . 0.0 112.273 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.68 -16.83 60.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.362 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.55 -36.0 3.97 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.078 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.546 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 25.9 mt-10 -63.39 133.0 53.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.866 0.365 . . . . 0.0 110.281 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.77 125.17 47.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.418 0.628 . . . . 0.0 110.779 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.3 m -71.01 6.02 1.77 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.19 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 25' ' ' LYS . 13.2 t -79.43 -33.51 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.318 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -118.95 -45.5 2.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.222 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -142.43 133.62 12.93 Favored Pre-proline 0 N--CA 1.464 0.26 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.299 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.94 140.89 92.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.271 1.981 . . . . 0.0 110.995 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.552 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 2.9 m -72.42 115.21 11.41 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.483 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.6 mt -67.44 -37.62 79.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.441 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 15.3 m -61.61 -8.57 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.017 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.552 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 33.1 m -59.96 -35.89 75.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.12 -24.91 67.43 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.951 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.9 pt -104.41 13.87 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.91 -24.42 5.13 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.167 -1.492 . . . . 0.0 115.604 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 16' ' ' SER . 73.4 m -63.58 137.22 58.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.415 1.107 . . . . 0.0 111.547 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -122.36 126.19 47.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.915 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.3 t -75.91 124.22 26.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.051 0.453 . . . . 0.0 110.798 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -137.88 123.03 19.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 m 59.42 34.86 22.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.184 0.516 . . . . 0.0 110.083 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.497 ' HB3' HG22 ' A' ' 9' ' ' VAL . 64.2 mttp 70.48 13.22 7.45 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.306 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 t -128.03 132.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.6 m -89.13 135.15 33.72 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.97 142.95 49.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.322 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.405 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 58.5 ttt-85 -128.52 117.46 21.34 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 m120 . . . . . 0 C--N 1.327 -0.386 0 O-C-N 123.445 0.466 . . . . 0.0 110.412 -178.515 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.374 0 N-CA-C 113.305 0.082 . . . . 0.0 113.305 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.8 mt -123.13 127.2 25.74 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.64 124.82 15.34 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.504 2.136 . . . . 0.0 113.189 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.7 m -78.22 -28.02 47.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.583 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.16 -41.22 2.25 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.297 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.79 136.33 50.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.779 0.324 . . . . 0.0 111.084 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.75 129.11 54.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 p -72.3 -18.43 61.79 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.603 HG23 ' HD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -67.65 -44.16 86.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.326 178.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.603 ' HD1' HG23 ' A' ' 9' ' ' VAL . 18.7 m95 -78.35 -45.97 21.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.904 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.703 HD12 ' HD2' ' A' ' 12' ' ' PRO . 6.9 tp -170.22 135.29 1.18 Allowed Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.703 ' HD2' HD12 ' A' ' 11' ' ' ILE . 1.2 Cg_endo -47.82 134.98 22.96 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.443 2.095 . . . . 0.0 112.222 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 3.5 m -72.01 125.49 27.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.986 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.8 -38.68 83.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.481 ' HB2' HH21 ' A' ' 29' ' ' ARG . 40.3 p -62.08 -14.58 37.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.007 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 58.6 m -62.88 -34.33 77.17 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.56 -20.64 64.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.251 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 pt -112.24 20.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.34 -27.57 5.51 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 118.963 -1.589 . . . . 0.0 116.244 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 16' ' ' SER . 68.1 m -62.64 133.33 54.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.508 1.154 . . . . 0.0 112.457 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -120.9 121.68 38.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.981 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.885 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 8.0 t -68.31 131.62 45.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.056 0.455 . . . . 0.0 111.02 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -143.85 131.03 20.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.3 m 57.74 35.9 26.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.374 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 82.74 -16.72 0.57 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.573 1.149 . . . . 0.0 112.927 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.9 p -116.68 135.07 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.351 0.596 . . . . 0.0 112.016 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.885 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 m -69.85 137.15 51.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.277 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -129.34 155.5 45.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.708 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 29' ' ' ARG . 13.7 ptp180 -138.68 116.7 11.69 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.952 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.5 t30 . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.305 0.574 . . . . 0.0 110.94 -179.235 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.276 0 N-CA-C 112.7 -0.16 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 75.8 mt -129.77 131.39 23.51 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 23.1 Cg_exo -63.19 127.45 20.19 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.474 2.116 . . . . 0.0 111.949 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.9 m -79.79 -49.76 11.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.941 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.95 -52.42 0.4 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.972 -1.108 . . . . 0.0 113.503 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.543 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 1.3 mp0 -75.19 166.94 22.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.578 0.704 . . . . 0.0 111.863 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.2 m -127.23 138.91 53.21 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -64.19 -23.76 67.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 0.0 111.606 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.428 HG23 ' HB3' ' A' ' 25' ' ' LYS . 41.0 t -71.42 -33.29 49.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.578 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -85.86 -55.88 3.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.755 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pp -160.15 162.84 23.42 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.72 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -62.35 143.62 93.96 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.152 1.901 . . . . 0.0 111.43 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.427 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 35.8 m -65.31 107.33 1.58 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.128 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 pt -68.41 -36.48 75.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.512 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 41.5 m -59.45 -7.43 1.38 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.508 -1.678 . . . . 0.0 111.834 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 48.2 m -58.31 -32.65 68.66 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.01 -30.22 69.01 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.503 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.1 pt -101.53 24.47 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.17 12.11 57.85 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 115.384 0.913 . . . . 0.0 115.384 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 16' ' ' SER . 75.2 m -87.93 153.13 21.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 118.208 1.004 . . . . 0.0 110.084 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.4 t -144.87 142.87 30.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.784 0.326 . . . . 0.0 110.378 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 23' ' ' LYS . 41.9 t -66.8 131.35 45.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.771 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 22' ' ' CYS . 1.2 tppp? -158.86 129.4 6.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m 59.53 33.56 22.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.1 0.476 . . . . 0.0 110.889 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.428 ' HB3' HG23 ' A' ' 9' ' ' VAL . 49.0 mtmt 71.59 10.49 6.45 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.635 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 1.3 m -136.26 152.67 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.922 0.391 . . . . 0.0 110.649 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 22.9 m -80.01 122.24 26.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.659 0.266 . . . . 0.0 111.119 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -129.25 155.03 46.21 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.285 0.564 . . . . 0.0 111.148 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.434 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 45.7 ttp180 -146.97 122.42 10.36 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.839 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.9 t30 . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.463 0.649 . . . . 0.0 110.433 -179.004 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 112.039 -0.424 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.72 125.94 27.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.33 130.33 33.53 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.589 2.193 . . . . 0.0 112.611 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 58.9 m -98.65 15.65 24.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.333 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.93 -46.66 2.7 Favored Glycine 0 C--N 1.331 0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.677 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -64.59 160.03 20.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.177 0.513 . . . . 0.0 111.342 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -148.03 133.01 18.14 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.286 0.565 . . . . 0.0 110.947 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.5 m -75.67 25.89 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.196 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.692 HG22 ' HB3' ' A' ' 25' ' ' LYS . 25.0 t -92.49 -37.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -108.86 -45.13 3.86 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.69 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -153.37 155.79 31.97 Favored Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -64.29 146.54 90.26 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.382 2.055 . . . . 0.0 110.486 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.502 ' SG ' ' HB3' ' A' ' 22' ' ' CYS . 1.5 m -67.84 115.62 7.59 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.34 -33.95 63.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.5 p -62.97 -5.91 3.38 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.82 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.697 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 29.4 m -62.03 -30.48 71.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -24.58 63.91 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.128 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.3 pt -112.35 28.23 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.26 -16.0 53.7 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 116.376 1.31 . . . . 0.0 116.376 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.697 ' O ' ' HA ' ' A' ' 16' ' ' SER . 89.6 m -70.24 141.07 52.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 118.983 1.392 . . . . 0.0 111.573 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 p -142.31 124.39 15.38 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.825 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 21.5 p -73.76 130.25 39.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.952 0.882 . . . . 0.0 111.663 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.879 ' HE2' ' HB2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -132.17 133.44 44.23 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.6 m 61.79 31.28 18.43 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.692 ' HB3' HG22 ' A' ' 9' ' ' VAL . 33.6 mttm 73.75 -5.82 1.93 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.051 -1.431 . . . . 0.0 113.353 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.1 t -105.11 132.98 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 118.401 0.546 . . . . 0.0 109.901 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.825 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 57.6 m -75.78 125.31 28.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.879 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 9.5 m-85 -136.32 141.21 43.77 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.321 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.479 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 22.4 ttm180 -98.41 98.81 9.98 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 . . . . . 0 N--CA 1.47 0.533 0 O-C-N 124.069 0.856 . . . . 0.0 109.912 -177.25 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.349 0 CA-C-O 120.378 -0.123 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 65.0 mt -94.16 124.03 57.18 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.973 0.386 . . . . 0.0 110.223 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.75 118.91 5.83 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.083 1.856 . . . . 0.0 112.514 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 21.6 m -75.37 -23.92 57.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.375 0.607 . . . . 0.0 109.57 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.43 -37.95 3.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.058 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.488 ' HG2' ' H ' ' A' ' 6' ' ' GLU . 3.0 pt-20 -71.3 125.75 27.79 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.155 0.502 . . . . 0.0 111.225 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.42 132.61 38.87 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.6 p -72.59 -22.52 60.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.126 0.488 . . . . 0.0 112.211 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.99 -33.08 42.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.241 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -82.34 -52.55 6.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.741 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.6 pt -152.25 155.73 33.34 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.914 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -63.6 136.0 52.0 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.277 1.318 . . . . 0.0 110.442 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.577 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 56.2 m -73.84 114.59 12.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.053 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mm -66.29 -41.9 89.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.427 ' HA ' HG12 ' A' ' 18' ' ' ILE . 49.5 m -64.13 -7.81 10.12 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.055 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.577 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 18.8 m -64.15 -34.33 77.82 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.52 -18.55 62.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.954 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' A' ' 15' ' ' SER . 21.8 pt -117.93 23.99 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.81 -30.89 5.37 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 118.946 -1.597 . . . . 0.0 116.754 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 16' ' ' SER . 96.2 m -62.33 133.53 55.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.623 1.211 . . . . 0.0 112.479 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.9 t -126.89 134.29 50.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 14.1 t -75.02 135.07 41.3 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.366 0.603 . . . . 0.0 112.285 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -150.86 132.42 14.79 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.235 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 4.3 m 59.48 35.02 22.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' SER . 67.3 mttm 77.95 -16.97 0.61 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.892 0.877 . . . . 0.0 112.852 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -110.85 137.63 42.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-O 121.009 0.433 . . . . 0.0 111.717 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 2.1 m -77.94 136.18 37.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.162 0.506 . . . . 0.0 112.257 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -129.12 148.05 51.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.679 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.543 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 19.5 ttm180 -122.63 110.44 15.53 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 C--N 1.327 -0.406 0 O-C-N 123.407 0.442 . . . . 0.0 110.449 -178.678 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.209 0 N-CA-C 112.682 -0.167 . . . . 0.0 112.682 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mm -120.66 127.12 26.42 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.15 125.47 14.14 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.39 2.06 . . . . 0.0 112.377 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.2 m -85.65 -0.56 55.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.616 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.06 -45.35 3.43 Favored Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 113.406 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.58 ' OE2' HG12 ' A' ' 14' ' ' ILE . 53.8 mt-10 -62.89 142.27 58.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.824 0.345 . . . . 0.0 111.13 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.06 138.35 49.55 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.258 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.9 m -66.25 -15.55 63.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.54 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.43 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 41.9 t -68.77 -34.76 66.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.937 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.402 ' O ' HG23 ' A' ' 11' ' ' ILE . 27.2 m95 -93.24 -57.13 2.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.217 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 10' ' ' TRP . 5.4 pt -160.55 160.34 25.77 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.177 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -63.12 137.93 64.34 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.658 1.572 . . . . 0.0 110.326 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.3 m -75.71 122.77 24.5 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.346 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.58 HG12 ' OE2' ' A' ' 6' ' ' GLU . 12.4 pt -65.64 -37.4 79.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 m -60.32 -11.84 7.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.839 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 59.0 m -61.84 -34.3 75.72 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.01 -24.09 66.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.974 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.0 pt -107.33 25.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.19 -19.98 28.94 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 116.361 1.304 . . . . 0.0 116.361 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 16' ' ' SER . 84.1 m -68.54 137.44 54.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.746 1.273 . . . . 0.0 112.004 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.6 p -137.38 138.13 39.57 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 2.1 m -64.95 121.07 13.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.655 0.74 . . . . 0.0 111.934 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -123.67 121.02 34.45 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.6 m 57.44 38.3 28.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 24' ' ' SER . 97.2 mttt 81.17 -18.34 0.5 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.988 -1.006 . . . . 0.0 113.3 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.11 133.51 52.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 117.955 0.343 . . . . 0.0 110.826 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 4.1 m -68.23 129.68 40.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.446 0.641 . . . . 0.0 112.434 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -132.82 154.54 50.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.24 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.452 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 51.7 ttp180 -146.49 122.76 10.9 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 121.448 0.642 . . . . 0.0 110.023 -179.015 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 pt -129.18 140.05 37.49 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.947 0.374 . . . . 0.0 110.184 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.91 128.42 24.22 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.383 2.056 . . . . 0.0 112.596 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 63.1 m -82.06 -48.37 11.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.618 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.25 -55.82 0.35 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.564 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.84 158.68 35.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.614 0.721 . . . . 0.0 111.248 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m -128.6 137.61 51.78 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.07 3.86 2.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.098 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.1 t -85.81 -33.57 7.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -104.12 -52.45 2.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.012 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.42 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -146.17 157.64 49.35 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-O 120.776 0.322 . . . . 0.0 111.645 -178.218 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.49 146.91 86.21 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.811 2.341 . . . . 0.0 111.149 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.497 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 23.8 m -64.36 103.75 0.68 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.6 mt -69.57 -36.67 72.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.591 ' HA ' HG12 ' A' ' 18' ' ' ILE . 68.8 m -63.51 0.25 0.77 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.841 -1.527 . . . . 0.0 111.923 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 65.2 m -60.36 -33.58 72.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.01 -22.18 65.91 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.425 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.591 HG12 ' HA ' ' A' ' 15' ' ' SER . 1.4 mm -94.13 9.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.612 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.38 17.09 43.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.487 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 16' ' ' SER . 93.8 m -94.13 154.91 17.35 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -144.23 149.96 37.19 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.98 126.57 30.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.206 0.526 . . . . 0.0 110.858 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -144.34 121.66 11.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 m 58.08 37.8 26.52 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.973 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 68.49 13.73 9.01 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.839 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.91 143.15 39.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.9 m -78.55 121.14 24.22 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -126.47 148.95 49.59 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.358 0.599 . . . . 0.0 110.707 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.629 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.2 ttm180 -112.04 108.72 18.12 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 . . . . . 0 N--CA 1.471 0.607 0 O-C-N 124.014 0.821 . . . . 0.0 110.79 -177.867 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.444 0 CA-C-O 120.069 -0.295 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.94 126.58 52.95 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 117.303 0.551 . . . . 0.0 110.592 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.79 120.41 8.29 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.445 2.096 . . . . 0.0 112.582 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 61.4 m -76.23 -25.3 54.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.441 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.18 -31.01 8.27 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.7 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.545 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 32.9 mt-10 -61.53 130.72 47.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.61 0.243 . . . . 0.0 110.411 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.18 125.9 51.55 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 m -65.14 -18.19 65.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.527 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.8 t -71.23 -35.53 58.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.309 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.3 m95 -89.92 -52.88 4.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.505 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -155.58 153.85 27.11 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.285 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.16 147.91 88.63 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.581 2.187 . . . . 0.0 111.231 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.6 m -58.27 103.94 0.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.574 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.77 -39.85 80.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.5 m -64.3 2.65 0.56 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 113.61 -1.632 . . . . 0.0 111.695 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.671 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 62.5 p -62.47 -32.65 73.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.67 -20.64 57.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.203 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 pt -119.62 26.53 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.13 -22.15 16.39 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 16' ' ' SER . 85.6 m -68.13 137.67 55.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.992 1.396 . . . . 0.0 111.957 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -133.77 138.4 45.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.085 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.4 t -72.23 130.69 41.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.872 0.368 . . . . 0.0 111.492 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.505 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 17.7 ttpt -153.84 127.47 8.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 16.5 m 59.14 36.01 23.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.822 0.344 . . . . 0.0 111.031 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 24' ' ' SER . 1.1 mptm? 71.54 10.54 6.5 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.532 0.733 . . . . 0.0 112.643 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.783 HG13 ' HE1' ' A' ' 28' ' ' TYR . 2.1 p -140.01 139.93 36.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.147 0.499 . . . . 0.0 110.318 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 34.0 m -78.93 136.13 37.17 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.783 ' HE1' HG13 ' A' ' 26' ' ' VAL . 27.7 m-85 -128.45 146.04 50.92 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.339 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.609 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 26.5 ttm180 -118.83 107.18 13.3 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 121.427 0.632 . . . . 0.0 109.829 -178.223 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 29' ' ' ARG . 37.4 pt -122.95 137.13 27.65 Favored Pre-proline 0 C--N 1.333 -0.123 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.3 129.29 23.66 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.548 2.165 . . . . 0.0 113.512 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.3 m -93.87 9.6 36.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.088 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.88 -41.96 2.44 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 113.459 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -63.75 141.17 58.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 122.639 0.376 . . . . 0.0 110.588 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 132.6 53.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.5 t -70.49 -28.31 64.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.397 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.8 t -71.45 -40.36 72.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.677 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -71.44 -52.63 17.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.552 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -149.66 156.22 38.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -62.13 138.93 75.57 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.08 1.187 . . . . 0.0 109.15 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 16' ' ' SER . 66.1 m -59.47 99.56 0.06 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.4 mt -68.94 -32.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.5 p -64.12 -12.62 41.31 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.231 -1.349 . . . . 0.0 110.776 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.764 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 6.6 t -62.87 -34.79 78.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.89 -20.95 64.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.32 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.4 pt -113.19 21.53 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.0 -31.2 5.4 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.522 -1.323 . . . . 0.0 115.743 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.764 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.3 m -71.28 171.14 11.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.12 0.96 . . . . 0.0 111.232 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.3 p -166.47 145.24 5.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.203 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.3 m -53.34 129.13 30.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 110.467 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.619 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -153.07 115.92 4.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.046 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.5 m 55.82 41.94 29.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.544 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 24' ' ' SER . 1.0 OUTLIER 76.1 -14.52 0.79 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.582 0.753 . . . . 0.0 112.856 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.411 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.1 t -112.55 146.81 16.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.911 0.386 . . . . 0.0 110.757 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.0 m -73.5 119.51 17.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.411 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 3.2 m-85 -123.72 144.92 49.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.498 0.666 . . . . 0.0 111.521 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.426 ' O ' HG12 ' A' ' 2' ' ' ILE . 51.5 ttm-85 -102.58 101.87 12.06 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.535 -1.211 . . . . 0.0 107.884 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.8 m120 . . . . . 0 N--CA 1.473 0.718 0 O-C-N 123.864 0.728 . . . . 0.0 110.951 -178.266 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 113.831 0.292 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.5 mp -96.75 125.75 45.57 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 117.329 0.565 . . . . 0.0 110.231 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.62 123.59 14.22 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.133 1.888 . . . . 0.0 112.287 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.4 m -76.52 -37.98 55.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.305 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.09 -40.7 2.07 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.323 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.65 133.01 44.44 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.245 0.545 . . . . 0.0 111.278 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -106.5 127.7 53.51 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.206 178.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 37.12 0.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.701 0.762 . . . . 0.0 110.972 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.754 HG22 ' HE3' ' A' ' 25' ' ' LYS . 21.4 t -124.37 -40.87 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.445 ' O ' HG13 ' A' ' 11' ' ' ILE . 17.1 m0 -92.8 -49.23 6.17 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.119 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 10' ' ' TRP . 56.9 mt -157.27 135.22 7.26 Favored Pre-proline 0 N--CA 1.468 0.463 0 O-C-N 123.006 0.191 . . . . 0.0 110.723 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.21 139.74 80.94 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.478 2.119 . . . . 0.0 111.763 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.442 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.7 m -73.83 117.83 16.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.279 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.13 -34.47 66.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.404 ' HA ' HG12 ' A' ' 18' ' ' ILE . 77.9 p -60.6 -12.65 10.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.222 -1.353 . . . . 0.0 112.0 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 19.1 m -59.63 -36.09 75.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.29 67.28 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.875 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 15' ' ' SER . 41.0 pt -104.91 17.22 5.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.71 -21.13 8.07 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 119.038 -1.553 . . . . 0.0 115.524 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 16' ' ' SER . 55.6 m -64.77 138.21 58.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.272 1.036 . . . . 0.0 111.76 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.3 t -123.6 134.32 53.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.651 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.5 t -75.73 116.77 16.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.022 0.439 . . . . 0.0 110.576 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -130.91 126.41 36.04 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m 58.58 36.94 25.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.198 0.523 . . . . 0.0 110.666 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.754 ' HE3' HG22 ' A' ' 9' ' ' VAL . 31.5 mmmt 70.7 11.27 7.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.962 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 p -136.78 134.73 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.174 0.511 . . . . 0.0 109.68 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.0 m -79.17 134.37 36.7 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -129.79 146.13 51.55 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.635 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 2' ' ' ILE . 9.6 ptp180 -114.04 99.44 7.65 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.568 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.6 t30 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.696 -178.634 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.196 0 N-CA-C 112.737 -0.145 . . . . 0.0 112.737 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 70.3 mt -123.81 130.48 24.42 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 27.9 Cg_exo -62.21 126.07 17.79 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.615 2.21 . . . . 0.0 111.983 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.4 m -78.36 -22.63 47.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.612 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.86 -38.54 3.06 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.608 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -69.85 137.57 51.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.982 0.42 . . . . 0.0 110.72 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 t -111.1 144.95 39.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.024 0.916 . . . . 0.0 110.426 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -73.8 -16.97 61.14 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.701 -1.591 . . . . 0.0 110.859 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 25' ' ' LYS . 46.0 t -78.28 -38.95 23.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.99 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -77.54 -52.2 9.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.553 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.569 HD12 ' HD2' ' A' ' 12' ' ' PRO . 8.1 tp -177.72 141.82 0.46 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.569 ' HD2' HD12 ' A' ' 11' ' ' ILE . 1.2 Cg_endo -46.21 133.44 15.31 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.394 2.063 . . . . 0.0 112.075 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.2 m -71.86 122.58 21.0 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.405 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.8 mp -65.8 -35.58 75.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.423 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 61.4 p -61.19 -15.59 35.76 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.829 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 74.5 m -61.32 -35.41 77.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.89 -23.1 66.1 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.432 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 pt -108.71 23.37 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.29 -23.57 7.59 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 119.119 -1.515 . . . . 0.0 115.986 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.628 ' SG ' ' HD2' ' A' ' 29' ' ' ARG . 96.5 m -65.07 134.56 54.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.533 1.167 . . . . 0.0 112.213 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.3 t -117.86 133.32 56.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.939 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 40.4 t -76.77 117.12 18.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.402 . . . . 0.0 110.616 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.78 129.17 22.49 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.5 m 60.6 31.97 20.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.121 0.486 . . . . 0.0 110.105 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.495 ' HB3' HG23 ' A' ' 9' ' ' VAL . 64.8 mttp 69.7 14.07 8.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.13 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.405 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 30.5 t -131.88 140.75 47.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.4 m -87.67 132.81 33.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.304 0.573 . . . . 0.0 112.474 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.405 ' CE1' ' HB ' ' A' ' 26' ' ' VAL . 72.5 m-85 -134.54 144.87 48.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.679 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.628 ' HD2' ' SG ' ' A' ' 20' ' ' CYS . 6.1 ptm180 -139.29 130.17 26.26 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 m120 . . . . . 0 N--CA 1.469 0.503 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.976 -179.109 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.371 0 N-CA-C 112.882 -0.087 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.4 mt -127.31 130.48 23.72 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.83 123.43 12.27 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.351 2.034 . . . . 0.0 112.217 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.5 m -73.96 -32.08 63.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.358 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.54 -46.15 1.1 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.744 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.516 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 50.3 mt-10 -66.48 146.56 54.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.016 0.436 . . . . 0.0 111.256 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.91 133.13 56.4 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -66.79 -13.91 62.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.306 0.574 . . . . 0.0 111.579 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.3 -35.57 27.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.311 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.9 m95 -89.5 -44.41 10.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.629 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.481 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.6 tt -165.34 141.8 4.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.167 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.481 ' HD2' HG13 ' A' ' 11' ' ' ILE . 43.2 Cg_exo -53.72 146.91 42.54 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.183 1.922 . . . . 0.0 111.705 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 56.5 m -59.33 103.12 0.16 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.75 -32.2 48.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.504 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 15.8 p -61.97 -9.21 6.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.364 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 22.1 m -60.04 -27.09 66.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.42 -31.34 71.27 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.947 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.9 pt -99.9 14.93 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.754 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.27 -2.49 46.99 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.266 -0.969 . . . . 0.0 115.457 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 16' ' ' SER . 64.2 m -72.45 140.2 48.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 118.613 1.206 . . . . 0.0 110.319 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -127.5 142.0 51.51 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 23' ' ' LYS . 50.3 t -70.32 114.38 8.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.02 0.438 . . . . 0.0 110.787 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' A' ' 22' ' ' CYS . 29.0 mmmt -129.08 122.77 30.65 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.0 m 56.85 39.36 29.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.964 0.411 . . . . 0.0 111.409 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 71.19 11.13 6.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.69 138.56 47.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.03 0.443 . . . . 0.0 110.406 178.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 18.3 m -71.41 125.33 26.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.587 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -128.22 154.22 46.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.388 0.613 . . . . 0.0 111.23 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -144.2 120.35 10.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.67 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.0 t30 . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 121.356 0.598 . . . . 0.0 110.539 -179.101 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.244 0 N-CA-C 112.65 -0.18 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.8 mm -129.09 130.43 23.41 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.63 131.08 40.33 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.715 2.277 . . . . 0.0 112.494 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.617 ' SG ' ' HG2' ' A' ' 29' ' ' ARG . 61.4 m -76.87 -40.93 45.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.164 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.65 -46.19 1.05 Allowed Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.346 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.736 ' HG3' ' SG ' ' A' ' 27' ' ' CYS . 14.3 pt-20 -83.02 159.43 22.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.199 0.523 . . . . 0.0 110.709 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 9' ' ' VAL . 1.6 m -134.18 142.29 47.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.489 0.661 . . . . 0.0 110.672 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -74.53 13.89 0.55 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.458 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.688 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 44.2 t -78.7 -35.14 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -120.36 -38.25 2.93 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.587 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 26.6 pt -139.26 151.14 66.69 Favored Pre-proline 0 N--CA 1.463 0.215 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -72.23 142.35 37.48 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.602 2.201 . . . . 0.0 110.329 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.499 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 24.7 m -58.84 99.43 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 14' ' ' ILE . 8.6 tp -67.55 -35.37 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.498 ' C ' ' HB2' ' A' ' 20' ' ' CYS . 49.7 m -61.6 -3.31 1.0 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.937 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 54.5 m -59.0 -29.86 67.56 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.11 -29.25 68.48 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.491 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.0 pt -103.46 22.71 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.73 -3.87 56.18 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.149 -1.024 . . . . 0.0 115.224 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 16' ' ' SER . 45.9 m -71.47 146.17 48.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.297 1.049 . . . . 0.0 110.683 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.0 t -134.81 132.59 38.85 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.113 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 45.4 t -78.36 138.08 38.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.722 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.447 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 2.5 ptpt -165.97 134.79 3.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.3 m 59.08 29.43 18.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.399 0.619 . . . . 0.0 109.815 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.688 ' HE3' ' HA ' ' A' ' 9' ' ' VAL . 30.6 mtpp 63.13 26.06 15.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.175 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.8 p -137.31 143.28 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.736 ' SG ' ' HG3' ' A' ' 6' ' ' GLU . 35.2 m -88.16 124.03 33.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -131.73 152.67 50.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.269 0.557 . . . . 0.0 110.881 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.617 ' HG2' ' SG ' ' A' ' 4' ' ' CYS . 9.5 ptt85 -142.07 123.36 14.76 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.027 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 . . . . . 0 N--CA 1.467 0.378 0 O-C-N 123.353 0.408 . . . . 0.0 110.786 -179.313 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 112.294 -0.322 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -112.21 115.49 50.0 Favored Pre-proline 0 N--CA 1.461 0.106 0 CA-C-N 117.03 0.415 . . . . 0.0 110.193 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.51 126.61 14.38 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.496 2.131 . . . . 0.0 113.286 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -80.06 -35.57 36.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.139 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.99 -40.19 1.71 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.376 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.556 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 16.2 mt-10 -62.43 152.54 34.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.681 0.277 . . . . 0.0 110.664 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -130.6 129.89 43.31 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.321 0.581 . . . . 0.0 110.862 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.1 m -75.69 36.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.998 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.454 ' H ' ' C ' ' A' ' 7' ' ' SER . 17.0 t -112.64 -27.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.1 m-90 -130.88 -35.5 1.42 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.18 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.0 pt -140.11 145.25 41.13 Favored Pre-proline 0 N--CA 1.463 0.224 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.21 154.08 70.45 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.438 2.092 . . . . 0.0 111.525 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.408 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 30.3 m -71.88 101.23 2.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.292 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.5 mm -65.99 -36.37 77.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.3 m -62.5 -0.36 0.59 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.135 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.689 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 32.4 m -62.96 -30.69 71.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.45 -25.45 66.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.976 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.0 pt -109.3 3.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.16 -26.01 5.36 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.4 -1.381 . . . . 0.0 116.244 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.689 ' O ' ' HA ' ' A' ' 16' ' ' SER . 1.5 m -67.61 139.85 56.86 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.868 1.334 . . . . 0.0 112.503 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.4 p -142.46 158.6 43.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.048 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m -58.8 117.15 4.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 0.0 112.061 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.468 ' HG3' ' HB2' ' A' ' 28' ' ' TYR . 74.9 mmtt -134.62 111.33 9.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.8 m 57.17 40.5 28.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.125 0.488 . . . . 0.0 109.992 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 24' ' ' SER . 30.9 mmtp 76.22 -12.36 1.03 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.132 -0.94 . . . . 0.0 113.028 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 19.6 t -109.36 143.46 19.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 117.893 0.315 . . . . 0.0 110.156 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 62.6 m -74.29 115.38 13.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.914 0.387 . . . . 0.0 111.806 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.468 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 3.9 m-85 -125.41 142.47 51.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.478 0.656 . . . . 0.0 110.583 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.604 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 69.2 ttt-85 -98.6 86.97 3.69 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 . . . . . 0 N--CA 1.468 0.47 0 O-C-N 124.084 0.865 . . . . 0.0 109.687 -177.202 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.0 mt -128.9 128.27 23.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.62 122.61 11.94 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.483 2.122 . . . . 0.0 112.725 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.1 m -78.26 -32.41 49.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.975 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.7 -36.51 3.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.026 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.525 ' OE1' ' HA ' ' A' ' 13' ' ' CYS . 34.0 mt-10 -69.06 124.68 24.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.948 0.404 . . . . 0.0 110.682 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.58 136.19 33.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.71 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 m -69.02 -27.37 65.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.524 0.678 . . . . 0.0 111.301 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.46 -31.57 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.106 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.454 ' O ' HG23 ' A' ' 11' ' ' ILE . 13.0 m0 -79.12 -59.95 2.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.718 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 10' ' ' TRP . 4.2 pt -162.75 163.96 17.1 Favored Pre-proline 0 N--CA 1.469 0.501 0 O-C-N 123.243 0.339 . . . . 0.0 110.505 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -64.35 136.5 51.36 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.803 1.669 . . . . 0.0 109.985 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.525 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 3.4 m -77.29 116.72 18.14 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.706 -177.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 14' ' ' ILE . 3.6 mp -64.41 -36.87 78.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -60.37 -6.07 1.4 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.236 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 38.4 p -59.35 -34.99 73.04 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.74 -27.1 68.48 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.115 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 pt -99.35 12.7 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.34 -11.97 19.26 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 119.663 -1.256 . . . . 0.0 114.967 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 16' ' ' SER . 80.7 m -69.28 136.28 51.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.225 1.012 . . . . 0.0 110.921 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -130.54 136.77 49.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 42.5 t -60.6 129.49 41.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.289 0.566 . . . . 0.0 112.048 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 25' ' ' LYS . 70.0 mmtt -121.83 -155.95 0.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -45.5 79.25 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 23' ' ' LYS . 11.8 mptt 61.84 6.89 1.78 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.222 1.009 . . . . 0.0 111.913 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -146.59 139.03 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 122.289 -0.257 . . . . 0.0 111.561 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.6 m -75.63 135.69 40.48 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -129.17 142.15 50.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.488 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.503 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.7 ttt180 -98.78 106.39 18.64 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.0 t30 . . . . . 0 N--CA 1.473 0.703 0 O-C-N 123.996 0.81 . . . . 0.0 110.878 -178.206 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.512 0 N-CA-C 113.712 0.245 . . . . 0.0 113.712 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.7 mt -95.99 127.0 42.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 117.042 0.421 . . . . 0.0 110.717 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.51 124.63 15.49 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 122.308 2.005 . . . . 0.0 112.316 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.4 m -83.65 10.08 10.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.961 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.48 -39.25 1.91 Allowed Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.525 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.43 ' CD ' ' HA ' ' A' ' 13' ' ' CYS . 42.7 tt0 -63.37 139.98 58.83 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.88 136.47 54.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.038 0.447 . . . . 0.0 110.676 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -69.02 -17.96 63.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.821 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.411 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 40.4 t -66.24 -39.14 83.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.99 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -87.72 -55.67 3.68 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.76 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.2 mt -151.24 136.41 10.42 Favored Pre-proline 0 N--CA 1.462 0.15 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.712 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -49.8 141.36 28.27 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.314 2.01 . . . . 0.0 111.312 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' CD ' ' A' ' 6' ' ' GLU . 35.6 m -52.95 98.06 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.3 mt -69.85 -32.45 51.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.5 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.5 m -61.71 -2.93 0.92 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 113.31 -1.768 . . . . 0.0 111.537 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.74 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 68.7 m -57.99 -35.5 71.3 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.42 69.27 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.321 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.5 HG12 ' HA ' ' A' ' 15' ' ' SER . 7.7 mm -81.33 -19.13 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.476 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.95 1.62 12.95 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.185 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.74 ' O ' ' HA ' ' A' ' 16' ' ' SER . 75.5 m -79.75 138.52 37.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.359 . . . . 0.0 110.077 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 p -121.61 143.22 49.43 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.215 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.4 t -76.66 120.54 21.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.133 0.492 . . . . 0.0 111.222 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.558 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 16.3 ttpt -134.83 125.58 27.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 p 51.64 39.94 26.2 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.082 0.468 . . . . 0.0 111.318 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 69.21 16.52 8.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.681 179.474 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.429 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 44.2 t -131.71 140.34 48.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.8 m -82.1 128.51 34.2 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.558 ' CE1' ' HE2' ' A' ' 23' ' ' LYS . 56.5 m-85 -131.88 144.38 50.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.096 0.474 . . . . 0.0 110.89 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.548 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 59.6 ttt-85 -126.16 113.83 17.55 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.5 t30 . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 121.581 0.705 . . . . 0.0 109.49 -178.092 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.206 0 N-CA-C 112.82 -0.112 . . . . 0.0 112.82 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.0 mt -125.63 129.26 24.43 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.14 124.94 14.79 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.386 2.058 . . . . 0.0 111.786 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m -77.15 -32.62 56.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.847 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.6 -44.51 1.22 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.601 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.468 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 53.8 mt-10 -66.93 146.89 53.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.949 0.404 . . . . 0.0 110.875 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.87 137.49 52.75 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.6 m -64.1 -25.63 68.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.426 0.632 . . . . 0.0 111.243 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.4 t -70.38 -33.15 52.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.275 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -81.67 -59.74 2.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.938 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 pt -156.85 161.71 29.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.897 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -62.76 144.42 93.76 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 121.965 1.777 . . . . 0.0 110.533 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 44.4 m -61.58 101.29 0.18 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.2 mt -69.82 -32.89 53.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.606 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 23.4 p -61.97 -8.38 5.12 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.34 -1.755 . . . . 0.0 111.456 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 16.8 m -60.43 -28.32 68.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.66 -28.34 68.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.07 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.9 pt -105.28 21.72 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.98 -4.62 56.04 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.235 -0.984 . . . . 0.0 115.413 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 16' ' ' SER . 92.7 m -74.45 143.6 44.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.427 1.114 . . . . 0.0 110.351 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -132.01 138.9 48.42 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.176 -0.327 . . . . 0.0 110.985 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.402 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 19.1 t -74.51 128.14 34.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.872 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -166.29 138.26 3.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.414 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.4 m 60.98 30.36 19.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 110.229 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 71.13 7.57 6.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.668 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.621 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 25.4 t -133.88 150.8 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.444 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 33.3 m -84.42 121.04 27.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.621 ' CE1' ' HB ' ' A' ' 26' ' ' VAL . 87.3 m-85 -123.36 148.47 46.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.939 0.399 . . . . 0.0 111.082 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 54.9 ttp85 -140.87 121.68 14.42 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.147 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 . . . . . 0 N--CA 1.469 0.506 0 O-C-N 123.547 0.529 . . . . 0.0 110.746 -178.77 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.3 mt -126.32 128.47 24.4 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -60.16 131.98 41.86 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.461 2.107 . . . . 0.0 112.823 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.2 m -96.62 17.51 16.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.535 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.33 37.89 93.79 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.885 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' OE1' ' HA ' ' A' ' 13' ' ' CYS . 42.5 tt0 -149.01 153.46 37.93 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -139.06 139.15 37.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.367 0.603 . . . . 0.0 111.152 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -10.22 59.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.597 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.838 HG22 ' HE3' ' A' ' 25' ' ' LYS . 25.2 t -71.77 -38.23 65.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.446 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -89.93 -43.82 10.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.996 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.591 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.5 tt -166.53 141.95 3.72 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.263 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.591 ' HD2' HG13 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -47.09 138.9 15.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.609 2.206 . . . . 0.0 111.709 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.41 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 59.7 m -56.73 98.47 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -177.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.9 mm -69.01 -30.7 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.475 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 71.3 p -59.85 -12.45 7.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.801 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.703 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 30.0 m -57.49 -33.98 68.59 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.33 -28.16 66.56 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.732 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.1 pt -104.76 27.56 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.66 1.58 63.72 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.703 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.1 m -86.53 162.58 17.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 118.197 0.998 . . . . 0.0 110.405 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 t -150.02 148.37 28.96 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.6 t -70.62 114.39 8.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.111 0.481 . . . . 0.0 110.731 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -125.84 115.41 19.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m 58.56 38.67 25.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.131 0.491 . . . . 0.0 110.671 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.838 ' HE3' HG22 ' A' ' 9' ' ' VAL . 30.5 mtpp 71.12 7.21 6.1 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.222 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.8 t -123.7 138.32 53.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 m -75.74 118.67 18.81 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -132.61 145.14 50.85 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.417 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -104.12 105.59 15.81 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 . . . . . 0 N--CA 1.473 0.683 0 O-C-N 123.776 0.673 . . . . 0.0 110.441 -177.78 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 111.704 -0.559 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 48.5 mm -120.67 126.37 26.74 Favored Pre-proline 0 C--N 1.331 -0.196 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 33.0 Cg_exo -59.24 122.64 11.89 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.528 2.152 . . . . 0.0 112.795 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 56.0 m -88.11 -32.51 18.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.448 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.56 -37.96 2.88 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.779 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.461 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 27.5 mt-10 -59.65 144.83 46.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.9 0.381 . . . . 0.0 110.635 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.42 126.22 43.47 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.1 -7.63 24.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.437 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.3 t -77.59 -31.72 17.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.971 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -104.09 -53.57 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.896 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.6 mm -147.85 136.37 11.34 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.227 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -56.8 146.67 76.92 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.488 2.125 . . . . 0.0 111.745 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.595 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.6 m -61.35 102.12 0.21 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.211 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mm -68.7 -38.13 78.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.493 ' HA ' HG12 ' A' ' 18' ' ' ILE . 18.0 m -63.84 4.42 0.29 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.846 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.767 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 73.2 m -61.12 -35.44 77.06 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.43 -21.24 66.59 Favored 'General case' 0 CA--C 1.526 0.036 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.455 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.493 HG12 ' HA ' ' A' ' 15' ' ' SER . 8.7 mm -89.2 -17.59 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.013 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.78 -13.88 5.54 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.653 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.767 ' O ' ' HA ' ' A' ' 16' ' ' SER . 82.5 m -68.72 151.57 46.49 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.7 m -150.73 141.56 22.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.4 t -65.26 124.08 21.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.279 0.562 . . . . 0.0 111.152 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.704 ' HD3' ' HB2' ' A' ' 28' ' ' TYR . 27.9 mtpp -141.18 116.2 9.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.0 m 57.79 40.06 26.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 24' ' ' SER . 33.0 mmtp 72.58 0.56 3.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.928 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.58 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 23.8 t -119.47 140.33 43.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 39.2 m -85.73 122.79 30.33 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.086 0.469 . . . . 0.0 112.055 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.704 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 64.8 m-85 -128.0 135.65 50.19 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.088 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.694 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 5.9 tmm_? -84.6 96.72 9.27 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.47 0.566 0 O-C-N 124.041 0.838 . . . . 0.0 110.039 -177.917 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.247 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.5 mt -130.36 131.32 23.31 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.33 126.75 17.6 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.52 2.147 . . . . 0.0 111.633 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.1 m -81.2 -48.12 12.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.079 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.43 -53.9 0.4 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.788 -1.196 . . . . 0.0 113.856 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.538 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 3.4 mp0 -67.32 147.45 52.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.314 0.578 . . . . 0.0 112.098 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -110.21 127.33 54.89 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.324 178.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.7 m -73.61 41.63 0.12 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.852 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.639 HG22 ' HD2' ' A' ' 25' ' ' LYS . 7.6 t -104.87 -49.16 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.536 ' HD1' HG12 ' A' ' 9' ' ' VAL . 27.3 m95 -139.09 -11.48 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.333 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.48 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 48.4 mm -116.2 125.26 28.71 Favored Pre-proline 0 CA--C 1.528 0.111 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.908 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 11' ' ' ILE . 2.8 Cg_exo -74.17 143.49 32.14 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.695 2.264 . . . . 0.0 110.859 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.0 m -69.76 95.36 0.88 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.884 0.374 . . . . 0.0 111.997 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.18 -32.28 53.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.682 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 17.4 p -61.81 -6.7 2.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.255 -1.793 . . . . 0.0 111.608 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 23.8 m -58.81 -26.09 63.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.34 -31.26 69.02 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.73 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.8 pt -103.93 27.53 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.547 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.43 5.45 79.14 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 115.362 0.905 . . . . 0.0 115.362 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 15' ' ' SER . 92.6 m -75.34 141.43 43.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.48 1.14 . . . . 0.0 110.556 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -148.49 146.39 28.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.78 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.1 m -53.61 125.01 16.67 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 38.8 mttp -151.72 122.9 7.7 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 20.3 m 59.78 36.86 22.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.429 . . . . 0.0 110.245 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.639 ' HD2' HG22 ' A' ' 9' ' ' VAL . 18.3 tppt? 71.69 0.92 3.68 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.501 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -125.85 146.85 30.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 121.724 -0.61 . . . . 0.0 110.458 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 39.8 m -69.98 117.76 11.97 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.485 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 3.9 m-85 -122.91 152.68 40.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.389 0.614 . . . . 0.0 111.344 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.51 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 5.6 tmm_? . . . . . 0 C--N 1.316 -0.885 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.313 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.394 0 CA-C-O 120.475 -0.07 . . . . 0.0 113.185 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.6 mt -103.07 126.66 31.76 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.68 123.17 12.47 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.321 2.014 . . . . 0.0 112.273 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.68 -16.83 60.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.362 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.55 -36.0 3.97 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.078 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.546 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 25.9 mt-10 -63.39 133.0 53.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.866 0.365 . . . . 0.0 110.281 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.77 125.17 47.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.418 0.628 . . . . 0.0 110.779 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.3 m -71.01 6.02 1.77 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.19 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 25' ' ' LYS . 13.2 t -79.43 -33.51 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.318 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -118.95 -45.5 2.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.222 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -142.43 133.62 12.93 Favored Pre-proline 0 N--CA 1.464 0.26 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.299 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.94 140.89 92.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.271 1.981 . . . . 0.0 110.995 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.552 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 2.9 m -72.42 115.21 11.41 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.483 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.6 mt -67.44 -37.62 79.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.441 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 15.3 m -61.61 -8.57 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.017 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.552 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 33.1 m -59.96 -35.89 75.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.12 -24.91 67.43 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.951 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.9 pt -104.41 13.87 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.91 -24.42 5.13 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.167 -1.492 . . . . 0.0 115.604 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 16' ' ' SER . 73.4 m -63.58 137.22 58.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.415 1.107 . . . . 0.0 111.547 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -122.36 126.19 47.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.915 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.3 t -75.91 124.22 26.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.051 0.453 . . . . 0.0 110.798 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -137.88 123.03 19.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 m 59.42 34.86 22.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.184 0.516 . . . . 0.0 110.083 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.497 ' HB3' HG22 ' A' ' 9' ' ' VAL . 64.2 mttp 70.48 13.22 7.45 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.306 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 t -128.03 132.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.6 m -89.13 135.15 33.72 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.97 142.95 49.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.322 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.405 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 58.5 ttt-85 . . . . . 0 C--N 1.317 -0.824 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.374 0 N-CA-C 113.305 0.082 . . . . 0.0 113.305 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.8 mt -123.13 127.2 25.74 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.64 124.82 15.34 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.504 2.136 . . . . 0.0 113.189 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.7 m -78.22 -28.02 47.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.583 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.16 -41.22 2.25 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.297 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.79 136.33 50.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.779 0.324 . . . . 0.0 111.084 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.75 129.11 54.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 p -72.3 -18.43 61.79 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.603 HG23 ' HD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -67.65 -44.16 86.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.326 178.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.603 ' HD1' HG23 ' A' ' 9' ' ' VAL . 18.7 m95 -78.35 -45.97 21.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.904 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.703 HD12 ' HD2' ' A' ' 12' ' ' PRO . 6.9 tp -170.22 135.29 1.18 Allowed Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.703 ' HD2' HD12 ' A' ' 11' ' ' ILE . 1.2 Cg_endo -47.82 134.98 22.96 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.443 2.095 . . . . 0.0 112.222 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 3.5 m -72.01 125.49 27.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.986 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.8 -38.68 83.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.481 ' HB2' HH21 ' A' ' 29' ' ' ARG . 40.3 p -62.08 -14.58 37.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.007 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 58.6 m -62.88 -34.33 77.17 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.56 -20.64 64.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.251 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 pt -112.24 20.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.34 -27.57 5.51 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 118.963 -1.589 . . . . 0.0 116.244 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 16' ' ' SER . 68.1 m -62.64 133.33 54.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.508 1.154 . . . . 0.0 112.457 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -120.9 121.68 38.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.981 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.885 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 8.0 t -68.31 131.62 45.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.056 0.455 . . . . 0.0 111.02 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -143.85 131.03 20.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.3 m 57.74 35.9 26.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.374 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 82.74 -16.72 0.57 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.573 1.149 . . . . 0.0 112.927 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.9 p -116.68 135.07 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.351 0.596 . . . . 0.0 112.016 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.885 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 m -69.85 137.15 51.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.277 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -129.34 155.5 45.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.708 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 29' ' ' ARG . 13.7 ptp180 . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.952 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.276 0 N-CA-C 112.7 -0.16 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 75.8 mt -129.77 131.39 23.51 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 23.1 Cg_exo -63.19 127.45 20.19 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.474 2.116 . . . . 0.0 111.949 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.9 m -79.79 -49.76 11.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.941 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.95 -52.42 0.4 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.972 -1.108 . . . . 0.0 113.503 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.543 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 1.3 mp0 -75.19 166.94 22.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.578 0.704 . . . . 0.0 111.863 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.2 m -127.23 138.91 53.21 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -64.19 -23.76 67.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 0.0 111.606 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.428 HG23 ' HB3' ' A' ' 25' ' ' LYS . 41.0 t -71.42 -33.29 49.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.578 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -85.86 -55.88 3.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.755 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pp -160.15 162.84 23.42 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.72 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -62.35 143.62 93.96 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.152 1.901 . . . . 0.0 111.43 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.427 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 35.8 m -65.31 107.33 1.58 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.128 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 pt -68.41 -36.48 75.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.512 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 41.5 m -59.45 -7.43 1.38 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.508 -1.678 . . . . 0.0 111.834 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 48.2 m -58.31 -32.65 68.66 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.01 -30.22 69.01 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.503 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.1 pt -101.53 24.47 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.17 12.11 57.85 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 115.384 0.913 . . . . 0.0 115.384 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 16' ' ' SER . 75.2 m -87.93 153.13 21.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 118.208 1.004 . . . . 0.0 110.084 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.4 t -144.87 142.87 30.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.784 0.326 . . . . 0.0 110.378 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 23' ' ' LYS . 41.9 t -66.8 131.35 45.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.771 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 22' ' ' CYS . 1.2 tppp? -158.86 129.4 6.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m 59.53 33.56 22.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.1 0.476 . . . . 0.0 110.889 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.428 ' HB3' HG23 ' A' ' 9' ' ' VAL . 49.0 mtmt 71.59 10.49 6.45 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.635 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 1.3 m -136.26 152.67 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.922 0.391 . . . . 0.0 110.649 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 22.9 m -80.01 122.24 26.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.659 0.266 . . . . 0.0 111.119 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -129.25 155.03 46.21 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.285 0.564 . . . . 0.0 111.148 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.434 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 45.7 ttp180 . . . . . 0 C--N 1.314 -0.949 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.839 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 112.039 -0.424 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.72 125.94 27.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.33 130.33 33.53 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.589 2.193 . . . . 0.0 112.611 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 58.9 m -98.65 15.65 24.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.333 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.93 -46.66 2.7 Favored Glycine 0 C--N 1.331 0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.677 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -64.59 160.03 20.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.177 0.513 . . . . 0.0 111.342 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -148.03 133.01 18.14 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.286 0.565 . . . . 0.0 110.947 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.5 m -75.67 25.89 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.196 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.692 HG22 ' HB3' ' A' ' 25' ' ' LYS . 25.0 t -92.49 -37.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -108.86 -45.13 3.86 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.69 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -153.37 155.79 31.97 Favored Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -64.29 146.54 90.26 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.382 2.055 . . . . 0.0 110.486 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.502 ' SG ' ' HB3' ' A' ' 22' ' ' CYS . 1.5 m -67.84 115.62 7.59 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.34 -33.95 63.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.5 p -62.97 -5.91 3.38 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.82 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.697 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 29.4 m -62.03 -30.48 71.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -24.58 63.91 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.128 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.3 pt -112.35 28.23 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.26 -16.0 53.7 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 116.376 1.31 . . . . 0.0 116.376 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.697 ' O ' ' HA ' ' A' ' 16' ' ' SER . 89.6 m -70.24 141.07 52.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 118.983 1.392 . . . . 0.0 111.573 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 p -142.31 124.39 15.38 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.825 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 21.5 p -73.76 130.25 39.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.952 0.882 . . . . 0.0 111.663 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.879 ' HE2' ' HB2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -132.17 133.44 44.23 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.6 m 61.79 31.28 18.43 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.692 ' HB3' HG22 ' A' ' 9' ' ' VAL . 33.6 mttm 73.75 -5.82 1.93 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.051 -1.431 . . . . 0.0 113.353 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.1 t -105.11 132.98 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 118.401 0.546 . . . . 0.0 109.901 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.825 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 57.6 m -75.78 125.31 28.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.879 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 9.5 m-85 -136.32 141.21 43.77 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.321 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.479 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 22.4 ttm180 . . . . . 0 C--N 1.307 -1.259 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.349 0 CA-C-O 120.378 -0.123 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 65.0 mt -94.16 124.03 57.18 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.973 0.386 . . . . 0.0 110.223 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.75 118.91 5.83 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.083 1.856 . . . . 0.0 112.514 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 21.6 m -75.37 -23.92 57.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.375 0.607 . . . . 0.0 109.57 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.43 -37.95 3.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.058 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.488 ' HG2' ' H ' ' A' ' 6' ' ' GLU . 3.0 pt-20 -71.3 125.75 27.79 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.155 0.502 . . . . 0.0 111.225 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.42 132.61 38.87 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.6 p -72.59 -22.52 60.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.126 0.488 . . . . 0.0 112.211 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.99 -33.08 42.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.241 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -82.34 -52.55 6.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.741 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.6 pt -152.25 155.73 33.34 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.914 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -63.6 136.0 52.0 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.277 1.318 . . . . 0.0 110.442 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.577 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 56.2 m -73.84 114.59 12.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.053 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mm -66.29 -41.9 89.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.427 ' HA ' HG12 ' A' ' 18' ' ' ILE . 49.5 m -64.13 -7.81 10.12 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.055 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.577 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 18.8 m -64.15 -34.33 77.82 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.52 -18.55 62.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.954 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' A' ' 15' ' ' SER . 21.8 pt -117.93 23.99 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.81 -30.89 5.37 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 118.946 -1.597 . . . . 0.0 116.754 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 16' ' ' SER . 96.2 m -62.33 133.53 55.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.623 1.211 . . . . 0.0 112.479 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.9 t -126.89 134.29 50.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 14.1 t -75.02 135.07 41.3 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.366 0.603 . . . . 0.0 112.285 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -150.86 132.42 14.79 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 4.3 m 59.48 35.02 22.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' SER . 67.3 mttm 77.95 -16.97 0.61 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.892 0.877 . . . . 0.0 112.852 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -110.85 137.63 42.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-O 121.009 0.433 . . . . 0.0 111.717 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 2.1 m -77.94 136.18 37.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.162 0.506 . . . . 0.0 112.257 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -129.12 148.05 51.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.679 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.543 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 19.5 ttm180 . . . . . 0 C--N 1.314 -0.947 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.209 0 N-CA-C 112.682 -0.167 . . . . 0.0 112.682 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mm -120.66 127.12 26.42 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.15 125.47 14.14 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.39 2.06 . . . . 0.0 112.377 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.2 m -85.65 -0.56 55.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.616 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.06 -45.35 3.43 Favored Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 113.406 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.58 ' OE2' HG12 ' A' ' 14' ' ' ILE . 53.8 mt-10 -62.89 142.27 58.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.824 0.345 . . . . 0.0 111.13 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.06 138.35 49.55 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.258 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.9 m -66.25 -15.55 63.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.54 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.43 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 41.9 t -68.77 -34.76 66.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.937 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.402 ' O ' HG23 ' A' ' 11' ' ' ILE . 27.2 m95 -93.24 -57.13 2.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.217 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 10' ' ' TRP . 5.4 pt -160.55 160.34 25.77 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.177 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -63.12 137.93 64.34 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.658 1.572 . . . . 0.0 110.326 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.3 m -75.71 122.77 24.5 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.346 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.58 HG12 ' OE2' ' A' ' 6' ' ' GLU . 12.4 pt -65.64 -37.4 79.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 m -60.32 -11.84 7.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.839 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 59.0 m -61.84 -34.3 75.72 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.01 -24.09 66.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.974 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.0 pt -107.33 25.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.19 -19.98 28.94 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 116.361 1.304 . . . . 0.0 116.361 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 16' ' ' SER . 84.1 m -68.54 137.44 54.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.746 1.273 . . . . 0.0 112.004 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.6 p -137.38 138.13 39.57 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 2.1 m -64.95 121.07 13.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.655 0.74 . . . . 0.0 111.934 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -123.67 121.02 34.45 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.6 m 57.44 38.3 28.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 24' ' ' SER . 97.2 mttt 81.17 -18.34 0.5 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.988 -1.006 . . . . 0.0 113.3 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.11 133.51 52.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 117.955 0.343 . . . . 0.0 110.826 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 4.1 m -68.23 129.68 40.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.446 0.641 . . . . 0.0 112.434 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -132.82 154.54 50.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.24 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.452 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 51.7 ttp180 . . . . . 0 C--N 1.315 -0.9 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 pt -129.18 140.05 37.49 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.947 0.374 . . . . 0.0 110.184 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.91 128.42 24.22 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.383 2.056 . . . . 0.0 112.596 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 63.1 m -82.06 -48.37 11.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.618 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.25 -55.82 0.35 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.564 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.84 158.68 35.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.614 0.721 . . . . 0.0 111.248 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m -128.6 137.61 51.78 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.07 3.86 2.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.098 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.1 t -85.81 -33.57 7.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -104.12 -52.45 2.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.012 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.42 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -146.17 157.64 49.35 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-O 120.776 0.322 . . . . 0.0 111.645 -178.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.49 146.91 86.21 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.811 2.341 . . . . 0.0 111.149 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.497 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 23.8 m -64.36 103.75 0.68 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.6 mt -69.57 -36.67 72.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.591 ' HA ' HG12 ' A' ' 18' ' ' ILE . 68.8 m -63.51 0.25 0.77 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.841 -1.527 . . . . 0.0 111.923 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 65.2 m -60.36 -33.58 72.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.01 -22.18 65.91 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.425 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.591 HG12 ' HA ' ' A' ' 15' ' ' SER . 1.4 mm -94.13 9.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.612 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.38 17.09 43.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.487 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 16' ' ' SER . 93.8 m -94.13 154.91 17.35 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -144.23 149.96 37.19 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.98 126.57 30.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.206 0.526 . . . . 0.0 110.858 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -144.34 121.66 11.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 m 58.08 37.8 26.52 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.973 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 68.49 13.73 9.01 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.839 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.91 143.15 39.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.9 m -78.55 121.14 24.22 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -126.47 148.95 49.59 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.358 0.599 . . . . 0.0 110.707 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.629 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.2 ttm180 . . . . . 0 C--N 1.311 -1.071 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.444 0 CA-C-O 120.069 -0.295 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.94 126.58 52.95 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 117.303 0.551 . . . . 0.0 110.592 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.79 120.41 8.29 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.445 2.096 . . . . 0.0 112.582 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 61.4 m -76.23 -25.3 54.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.441 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.18 -31.01 8.27 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.7 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.545 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 32.9 mt-10 -61.53 130.72 47.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.61 0.243 . . . . 0.0 110.411 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.18 125.9 51.55 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 m -65.14 -18.19 65.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.527 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.8 t -71.23 -35.53 58.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.309 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.3 m95 -89.92 -52.88 4.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.505 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -155.58 153.85 27.11 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.285 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.16 147.91 88.63 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.581 2.187 . . . . 0.0 111.231 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.6 m -58.27 103.94 0.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.574 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.77 -39.85 80.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.5 m -64.3 2.65 0.56 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 113.61 -1.632 . . . . 0.0 111.695 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.671 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 62.5 p -62.47 -32.65 73.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.67 -20.64 57.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.203 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 pt -119.62 26.53 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.13 -22.15 16.39 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 16' ' ' SER . 85.6 m -68.13 137.67 55.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.992 1.396 . . . . 0.0 111.957 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -133.77 138.4 45.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.085 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.4 t -72.23 130.69 41.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.872 0.368 . . . . 0.0 111.492 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.505 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 17.7 ttpt -153.84 127.47 8.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 16.5 m 59.14 36.01 23.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.822 0.344 . . . . 0.0 111.031 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 24' ' ' SER . 1.1 mptm? 71.54 10.54 6.5 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.532 0.733 . . . . 0.0 112.643 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.783 HG13 ' HE1' ' A' ' 28' ' ' TYR . 2.1 p -140.01 139.93 36.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.147 0.499 . . . . 0.0 110.318 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 34.0 m -78.93 136.13 37.17 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.783 ' HE1' HG13 ' A' ' 26' ' ' VAL . 27.7 m-85 -128.45 146.04 50.92 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.339 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.609 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 26.5 ttm180 . . . . . 0 C--N 1.314 -0.962 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 29' ' ' ARG . 37.4 pt -122.95 137.13 27.65 Favored Pre-proline 0 C--N 1.333 -0.123 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.3 129.29 23.66 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.548 2.165 . . . . 0.0 113.512 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.3 m -93.87 9.6 36.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.088 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.88 -41.96 2.44 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 113.459 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -63.75 141.17 58.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 122.639 0.376 . . . . 0.0 110.588 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 132.6 53.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.5 t -70.49 -28.31 64.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.397 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.8 t -71.45 -40.36 72.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.677 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -71.44 -52.63 17.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.552 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -149.66 156.22 38.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -62.13 138.93 75.57 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.08 1.187 . . . . 0.0 109.15 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 16' ' ' SER . 66.1 m -59.47 99.56 0.06 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.4 mt -68.94 -32.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.5 p -64.12 -12.62 41.31 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.231 -1.349 . . . . 0.0 110.776 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.764 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 6.6 t -62.87 -34.79 78.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.89 -20.95 64.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.32 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.4 pt -113.19 21.53 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.0 -31.2 5.4 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.522 -1.323 . . . . 0.0 115.743 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.764 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.3 m -71.28 171.14 11.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.12 0.96 . . . . 0.0 111.232 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.3 p -166.47 145.24 5.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.203 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.3 m -53.34 129.13 30.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 110.467 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.619 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -153.07 115.92 4.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.5 m 55.82 41.94 29.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.544 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 24' ' ' SER . 1.0 OUTLIER 76.1 -14.52 0.79 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.582 0.753 . . . . 0.0 112.856 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.411 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.1 t -112.55 146.81 16.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.911 0.386 . . . . 0.0 110.757 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.0 m -73.5 119.51 17.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.411 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 3.2 m-85 -123.72 144.92 49.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.498 0.666 . . . . 0.0 111.521 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.426 ' O ' HG12 ' A' ' 2' ' ' ILE . 51.5 ttm-85 . . . . . 0 C--N 1.311 -1.097 0 CA-C-N 114.535 -1.211 . . . . 0.0 107.884 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 113.831 0.292 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.5 mp -96.75 125.75 45.57 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 117.329 0.565 . . . . 0.0 110.231 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.62 123.59 14.22 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.133 1.888 . . . . 0.0 112.287 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.4 m -76.52 -37.98 55.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.305 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.09 -40.7 2.07 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.323 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.65 133.01 44.44 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.245 0.545 . . . . 0.0 111.278 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -106.5 127.7 53.51 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.206 178.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 37.12 0.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.701 0.762 . . . . 0.0 110.972 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.754 HG22 ' HE3' ' A' ' 25' ' ' LYS . 21.4 t -124.37 -40.87 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.445 ' O ' HG13 ' A' ' 11' ' ' ILE . 17.1 m0 -92.8 -49.23 6.17 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.119 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 10' ' ' TRP . 56.9 mt -157.27 135.22 7.26 Favored Pre-proline 0 N--CA 1.468 0.463 0 O-C-N 123.006 0.191 . . . . 0.0 110.723 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.21 139.74 80.94 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.478 2.119 . . . . 0.0 111.763 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.442 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.7 m -73.83 117.83 16.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.279 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.13 -34.47 66.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.404 ' HA ' HG12 ' A' ' 18' ' ' ILE . 77.9 p -60.6 -12.65 10.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.222 -1.353 . . . . 0.0 112.0 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 19.1 m -59.63 -36.09 75.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.29 67.28 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.875 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 15' ' ' SER . 41.0 pt -104.91 17.22 5.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.71 -21.13 8.07 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 119.038 -1.553 . . . . 0.0 115.524 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 16' ' ' SER . 55.6 m -64.77 138.21 58.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.272 1.036 . . . . 0.0 111.76 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.3 t -123.6 134.32 53.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.651 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.5 t -75.73 116.77 16.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.022 0.439 . . . . 0.0 110.576 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -130.91 126.41 36.04 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m 58.58 36.94 25.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.198 0.523 . . . . 0.0 110.666 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.754 ' HE3' HG22 ' A' ' 9' ' ' VAL . 31.5 mmmt 70.7 11.27 7.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.962 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 p -136.78 134.73 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.174 0.511 . . . . 0.0 109.68 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.0 m -79.17 134.37 36.7 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -129.79 146.13 51.55 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.635 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 2' ' ' ILE . 9.6 ptp180 . . . . . 0 C--N 1.313 -1.011 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.568 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.196 0 N-CA-C 112.737 -0.145 . . . . 0.0 112.737 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 70.3 mt -123.81 130.48 24.42 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 27.9 Cg_exo -62.21 126.07 17.79 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.615 2.21 . . . . 0.0 111.983 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.4 m -78.36 -22.63 47.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.612 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.86 -38.54 3.06 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.608 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -69.85 137.57 51.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.982 0.42 . . . . 0.0 110.72 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 t -111.1 144.95 39.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.024 0.916 . . . . 0.0 110.426 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -73.8 -16.97 61.14 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.701 -1.591 . . . . 0.0 110.859 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 25' ' ' LYS . 46.0 t -78.28 -38.95 23.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.99 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -77.54 -52.2 9.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.553 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.569 HD12 ' HD2' ' A' ' 12' ' ' PRO . 8.1 tp -177.72 141.82 0.46 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.569 ' HD2' HD12 ' A' ' 11' ' ' ILE . 1.2 Cg_endo -46.21 133.44 15.31 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.394 2.063 . . . . 0.0 112.075 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.2 m -71.86 122.58 21.0 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.405 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.8 mp -65.8 -35.58 75.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.423 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 61.4 p -61.19 -15.59 35.76 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.829 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 74.5 m -61.32 -35.41 77.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.89 -23.1 66.1 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.432 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 pt -108.71 23.37 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.29 -23.57 7.59 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 119.119 -1.515 . . . . 0.0 115.986 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.628 ' SG ' ' HD2' ' A' ' 29' ' ' ARG . 96.5 m -65.07 134.56 54.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.533 1.167 . . . . 0.0 112.213 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.3 t -117.86 133.32 56.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.939 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 40.4 t -76.77 117.12 18.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.402 . . . . 0.0 110.616 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.78 129.17 22.49 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.5 m 60.6 31.97 20.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.121 0.486 . . . . 0.0 110.105 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.495 ' HB3' HG23 ' A' ' 9' ' ' VAL . 64.8 mttp 69.7 14.07 8.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.13 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.405 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 30.5 t -131.88 140.75 47.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.4 m -87.67 132.81 33.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.304 0.573 . . . . 0.0 112.474 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.405 ' CE1' ' HB ' ' A' ' 26' ' ' VAL . 72.5 m-85 -134.54 144.87 48.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.679 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.628 ' HD2' ' SG ' ' A' ' 20' ' ' CYS . 6.1 ptm180 . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.371 0 N-CA-C 112.882 -0.087 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.4 mt -127.31 130.48 23.72 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.83 123.43 12.27 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.351 2.034 . . . . 0.0 112.217 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.5 m -73.96 -32.08 63.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.358 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.54 -46.15 1.1 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.744 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.516 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 50.3 mt-10 -66.48 146.56 54.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.016 0.436 . . . . 0.0 111.256 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.91 133.13 56.4 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -66.79 -13.91 62.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.306 0.574 . . . . 0.0 111.579 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.3 -35.57 27.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.311 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.9 m95 -89.5 -44.41 10.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.629 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.481 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.6 tt -165.34 141.8 4.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.167 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.481 ' HD2' HG13 ' A' ' 11' ' ' ILE . 43.2 Cg_exo -53.72 146.91 42.54 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.183 1.922 . . . . 0.0 111.705 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 56.5 m -59.33 103.12 0.16 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.75 -32.2 48.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.504 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 15.8 p -61.97 -9.21 6.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.364 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 22.1 m -60.04 -27.09 66.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.42 -31.34 71.27 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.947 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.9 pt -99.9 14.93 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.754 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.27 -2.49 46.99 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.266 -0.969 . . . . 0.0 115.457 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 16' ' ' SER . 64.2 m -72.45 140.2 48.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 118.613 1.206 . . . . 0.0 110.319 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -127.5 142.0 51.51 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 23' ' ' LYS . 50.3 t -70.32 114.38 8.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.02 0.438 . . . . 0.0 110.787 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' A' ' 22' ' ' CYS . 29.0 mmmt -129.08 122.77 30.65 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.0 m 56.85 39.36 29.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.964 0.411 . . . . 0.0 111.409 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 71.19 11.13 6.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.69 138.56 47.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.03 0.443 . . . . 0.0 110.406 178.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 18.3 m -71.41 125.33 26.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.587 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -128.22 154.22 46.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.388 0.613 . . . . 0.0 111.23 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 . . . . . 0 C--N 1.318 -0.795 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.67 178.991 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.244 0 N-CA-C 112.65 -0.18 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.8 mm -129.09 130.43 23.41 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.63 131.08 40.33 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.715 2.277 . . . . 0.0 112.494 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.617 ' SG ' ' HG2' ' A' ' 29' ' ' ARG . 61.4 m -76.87 -40.93 45.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.164 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.65 -46.19 1.05 Allowed Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.346 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.736 ' HG3' ' SG ' ' A' ' 27' ' ' CYS . 14.3 pt-20 -83.02 159.43 22.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.199 0.523 . . . . 0.0 110.709 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 9' ' ' VAL . 1.6 m -134.18 142.29 47.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.489 0.661 . . . . 0.0 110.672 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -74.53 13.89 0.55 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.458 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.688 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 44.2 t -78.7 -35.14 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -120.36 -38.25 2.93 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.587 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 26.6 pt -139.26 151.14 66.69 Favored Pre-proline 0 N--CA 1.463 0.215 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -72.23 142.35 37.48 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.602 2.201 . . . . 0.0 110.329 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.499 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 24.7 m -58.84 99.43 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 14' ' ' ILE . 8.6 tp -67.55 -35.37 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.498 ' C ' ' HB2' ' A' ' 20' ' ' CYS . 49.7 m -61.6 -3.31 1.0 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.937 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 54.5 m -59.0 -29.86 67.56 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.11 -29.25 68.48 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.491 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.0 pt -103.46 22.71 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.73 -3.87 56.18 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.149 -1.024 . . . . 0.0 115.224 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 16' ' ' SER . 45.9 m -71.47 146.17 48.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.297 1.049 . . . . 0.0 110.683 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.0 t -134.81 132.59 38.85 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.113 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 45.4 t -78.36 138.08 38.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.722 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.447 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 2.5 ptpt -165.97 134.79 3.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.3 m 59.08 29.43 18.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.399 0.619 . . . . 0.0 109.815 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.688 ' HE3' ' HA ' ' A' ' 9' ' ' VAL . 30.6 mtpp 63.13 26.06 15.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.175 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.8 p -137.31 143.28 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.736 ' SG ' ' HG3' ' A' ' 6' ' ' GLU . 35.2 m -88.16 124.03 33.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -131.73 152.67 50.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.269 0.557 . . . . 0.0 110.881 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.617 ' HG2' ' SG ' ' A' ' 4' ' ' CYS . 9.5 ptt85 . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.027 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 112.294 -0.322 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -112.21 115.49 50.0 Favored Pre-proline 0 N--CA 1.461 0.106 0 CA-C-N 117.03 0.415 . . . . 0.0 110.193 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.51 126.61 14.38 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.496 2.131 . . . . 0.0 113.286 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -80.06 -35.57 36.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.139 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.99 -40.19 1.71 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.376 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.556 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 16.2 mt-10 -62.43 152.54 34.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.681 0.277 . . . . 0.0 110.664 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -130.6 129.89 43.31 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.321 0.581 . . . . 0.0 110.862 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.1 m -75.69 36.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.998 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.454 ' H ' ' C ' ' A' ' 7' ' ' SER . 17.0 t -112.64 -27.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.1 m-90 -130.88 -35.5 1.42 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.18 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.0 pt -140.11 145.25 41.13 Favored Pre-proline 0 N--CA 1.463 0.224 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.21 154.08 70.45 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.438 2.092 . . . . 0.0 111.525 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.408 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 30.3 m -71.88 101.23 2.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.292 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.5 mm -65.99 -36.37 77.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.3 m -62.5 -0.36 0.59 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.135 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.689 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 32.4 m -62.96 -30.69 71.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.45 -25.45 66.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.976 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.0 pt -109.3 3.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.16 -26.01 5.36 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.4 -1.381 . . . . 0.0 116.244 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.689 ' O ' ' HA ' ' A' ' 16' ' ' SER . 1.5 m -67.61 139.85 56.86 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.868 1.334 . . . . 0.0 112.503 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.4 p -142.46 158.6 43.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.048 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m -58.8 117.15 4.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 0.0 112.061 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.468 ' HG3' ' HB2' ' A' ' 28' ' ' TYR . 74.9 mmtt -134.62 111.33 9.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.8 m 57.17 40.5 28.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.125 0.488 . . . . 0.0 109.992 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 24' ' ' SER . 30.9 mmtp 76.22 -12.36 1.03 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.132 -0.94 . . . . 0.0 113.028 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 19.6 t -109.36 143.46 19.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 117.893 0.315 . . . . 0.0 110.156 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 62.6 m -74.29 115.38 13.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.914 0.387 . . . . 0.0 111.806 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.468 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 3.9 m-85 -125.41 142.47 51.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.478 0.656 . . . . 0.0 110.583 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.604 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 69.2 ttt-85 . . . . . 0 C--N 1.309 -1.167 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.0 mt -128.9 128.27 23.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.62 122.61 11.94 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.483 2.122 . . . . 0.0 112.725 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.1 m -78.26 -32.41 49.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.975 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.7 -36.51 3.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.026 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.525 ' OE1' ' HA ' ' A' ' 13' ' ' CYS . 34.0 mt-10 -69.06 124.68 24.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.948 0.404 . . . . 0.0 110.682 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.58 136.19 33.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.71 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 m -69.02 -27.37 65.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.524 0.678 . . . . 0.0 111.301 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.46 -31.57 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.106 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.454 ' O ' HG23 ' A' ' 11' ' ' ILE . 13.0 m0 -79.12 -59.95 2.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.718 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 10' ' ' TRP . 4.2 pt -162.75 163.96 17.1 Favored Pre-proline 0 N--CA 1.469 0.501 0 O-C-N 123.243 0.339 . . . . 0.0 110.505 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -64.35 136.5 51.36 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.803 1.669 . . . . 0.0 109.985 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.525 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 3.4 m -77.29 116.72 18.14 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.706 -177.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 14' ' ' ILE . 3.6 mp -64.41 -36.87 78.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -60.37 -6.07 1.4 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.236 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 38.4 p -59.35 -34.99 73.04 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.74 -27.1 68.48 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.115 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 pt -99.35 12.7 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.34 -11.97 19.26 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 119.663 -1.256 . . . . 0.0 114.967 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 16' ' ' SER . 80.7 m -69.28 136.28 51.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.225 1.012 . . . . 0.0 110.921 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -130.54 136.77 49.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 42.5 t -60.6 129.49 41.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.289 0.566 . . . . 0.0 112.048 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 25' ' ' LYS . 70.0 mmtt -121.83 -155.95 0.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -45.5 79.25 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 23' ' ' LYS . 11.8 mptt 61.84 6.89 1.78 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.222 1.009 . . . . 0.0 111.913 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -146.59 139.03 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 122.289 -0.257 . . . . 0.0 111.561 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.6 m -75.63 135.69 40.48 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -129.17 142.15 50.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.488 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.503 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.7 ttt180 . . . . . 0 C--N 1.31 -1.111 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.512 0 N-CA-C 113.712 0.245 . . . . 0.0 113.712 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.7 mt -95.99 127.0 42.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 117.042 0.421 . . . . 0.0 110.717 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.51 124.63 15.49 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 122.308 2.005 . . . . 0.0 112.316 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.4 m -83.65 10.08 10.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.961 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.48 -39.25 1.91 Allowed Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.525 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.43 ' CD ' ' HA ' ' A' ' 13' ' ' CYS . 42.7 tt0 -63.37 139.98 58.83 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.88 136.47 54.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.038 0.447 . . . . 0.0 110.676 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -69.02 -17.96 63.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.821 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.411 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 40.4 t -66.24 -39.14 83.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.99 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -87.72 -55.67 3.68 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.76 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.2 mt -151.24 136.41 10.42 Favored Pre-proline 0 N--CA 1.462 0.15 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.712 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -49.8 141.36 28.27 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.314 2.01 . . . . 0.0 111.312 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' CD ' ' A' ' 6' ' ' GLU . 35.6 m -52.95 98.06 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.3 mt -69.85 -32.45 51.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.5 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.5 m -61.71 -2.93 0.92 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 113.31 -1.768 . . . . 0.0 111.537 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.74 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 68.7 m -57.99 -35.5 71.3 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.42 69.27 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.321 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.5 HG12 ' HA ' ' A' ' 15' ' ' SER . 7.7 mm -81.33 -19.13 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.476 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.95 1.62 12.95 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.185 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.74 ' O ' ' HA ' ' A' ' 16' ' ' SER . 75.5 m -79.75 138.52 37.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.359 . . . . 0.0 110.077 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 p -121.61 143.22 49.43 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.215 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.4 t -76.66 120.54 21.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.133 0.492 . . . . 0.0 111.222 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.558 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 16.3 ttpt -134.83 125.58 27.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 p 51.64 39.94 26.2 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.082 0.468 . . . . 0.0 111.318 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 69.21 16.52 8.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.681 179.474 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.429 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 44.2 t -131.71 140.34 48.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.8 m -82.1 128.51 34.2 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.558 ' CE1' ' HE2' ' A' ' 23' ' ' LYS . 56.5 m-85 -131.88 144.38 50.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.096 0.474 . . . . 0.0 110.89 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.548 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 59.6 ttt-85 . . . . . 0 C--N 1.315 -0.923 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.206 0 N-CA-C 112.82 -0.112 . . . . 0.0 112.82 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.0 mt -125.63 129.26 24.43 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.14 124.94 14.79 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.386 2.058 . . . . 0.0 111.786 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m -77.15 -32.62 56.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.847 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.6 -44.51 1.22 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.601 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.468 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 53.8 mt-10 -66.93 146.89 53.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.949 0.404 . . . . 0.0 110.875 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.87 137.49 52.75 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.6 m -64.1 -25.63 68.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.426 0.632 . . . . 0.0 111.243 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.4 t -70.38 -33.15 52.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.275 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -81.67 -59.74 2.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.938 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 pt -156.85 161.71 29.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.897 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -62.76 144.42 93.76 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 121.965 1.777 . . . . 0.0 110.533 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 44.4 m -61.58 101.29 0.18 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.2 mt -69.82 -32.89 53.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.606 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 23.4 p -61.97 -8.38 5.12 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.34 -1.755 . . . . 0.0 111.456 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 16.8 m -60.43 -28.32 68.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.66 -28.34 68.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.07 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.9 pt -105.28 21.72 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.98 -4.62 56.04 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.235 -0.984 . . . . 0.0 115.413 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 16' ' ' SER . 92.7 m -74.45 143.6 44.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.427 1.114 . . . . 0.0 110.351 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -132.01 138.9 48.42 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.176 -0.327 . . . . 0.0 110.985 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.402 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 19.1 t -74.51 128.14 34.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.872 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -166.29 138.26 3.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.414 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.4 m 60.98 30.36 19.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 110.229 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 71.13 7.57 6.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.668 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.621 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 25.4 t -133.88 150.8 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.444 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 33.3 m -84.42 121.04 27.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.621 ' CE1' ' HB ' ' A' ' 26' ' ' VAL . 87.3 m-85 -123.36 148.47 46.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.939 0.399 . . . . 0.0 111.082 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 54.9 ttp85 . . . . . 0 C--N 1.318 -0.797 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.147 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.3 mt -126.32 128.47 24.4 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -60.16 131.98 41.86 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.461 2.107 . . . . 0.0 112.823 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.2 m -96.62 17.51 16.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.535 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.33 37.89 93.79 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.885 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.41 ' OE1' ' HA ' ' A' ' 13' ' ' CYS . 42.5 tt0 -149.01 153.46 37.93 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -139.06 139.15 37.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.367 0.603 . . . . 0.0 111.152 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -10.22 59.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.597 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.838 HG22 ' HE3' ' A' ' 25' ' ' LYS . 25.2 t -71.77 -38.23 65.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.446 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -89.93 -43.82 10.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.996 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.591 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.5 tt -166.53 141.95 3.72 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.263 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.591 ' HD2' HG13 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -47.09 138.9 15.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.609 2.206 . . . . 0.0 111.709 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.41 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 59.7 m -56.73 98.47 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -177.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.9 mm -69.01 -30.7 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.475 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 71.3 p -59.85 -12.45 7.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.801 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.703 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 30.0 m -57.49 -33.98 68.59 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.33 -28.16 66.56 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.732 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.1 pt -104.76 27.56 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.66 1.58 63.72 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.703 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.1 m -86.53 162.58 17.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 118.197 0.998 . . . . 0.0 110.405 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 t -150.02 148.37 28.96 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.6 t -70.62 114.39 8.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.111 0.481 . . . . 0.0 110.731 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -125.84 115.41 19.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m 58.56 38.67 25.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.131 0.491 . . . . 0.0 110.671 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.838 ' HE3' HG22 ' A' ' 9' ' ' VAL . 30.5 mtpp 71.12 7.21 6.1 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.222 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.8 t -123.7 138.32 53.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 m -75.74 118.67 18.81 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -132.61 145.14 50.85 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.417 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 . . . . . 0 C--N 1.311 -1.073 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.71 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 111.704 -0.559 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 48.5 mm -120.67 126.37 26.74 Favored Pre-proline 0 C--N 1.331 -0.196 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 33.0 Cg_exo -59.24 122.64 11.89 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.528 2.152 . . . . 0.0 112.795 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 56.0 m -88.11 -32.51 18.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.448 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.56 -37.96 2.88 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.779 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.461 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 27.5 mt-10 -59.65 144.83 46.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.9 0.381 . . . . 0.0 110.635 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.42 126.22 43.47 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.1 -7.63 24.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.437 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.3 t -77.59 -31.72 17.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.971 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -104.09 -53.57 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.896 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.6 mm -147.85 136.37 11.34 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.227 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -56.8 146.67 76.92 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.488 2.125 . . . . 0.0 111.745 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.595 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.6 m -61.35 102.12 0.21 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.211 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mm -68.7 -38.13 78.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.493 ' HA ' HG12 ' A' ' 18' ' ' ILE . 18.0 m -63.84 4.42 0.29 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.846 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.767 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 73.2 m -61.12 -35.44 77.06 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.43 -21.24 66.59 Favored 'General case' 0 CA--C 1.526 0.036 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.455 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.493 HG12 ' HA ' ' A' ' 15' ' ' SER . 8.7 mm -89.2 -17.59 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.013 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.78 -13.88 5.54 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.653 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.767 ' O ' ' HA ' ' A' ' 16' ' ' SER . 82.5 m -68.72 151.57 46.49 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.7 m -150.73 141.56 22.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.4 t -65.26 124.08 21.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.279 0.562 . . . . 0.0 111.152 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.704 ' HD3' ' HB2' ' A' ' 28' ' ' TYR . 27.9 mtpp -141.18 116.2 9.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.0 m 57.79 40.06 26.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 24' ' ' SER . 33.0 mmtp 72.58 0.56 3.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.928 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.58 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 23.8 t -119.47 140.33 43.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 39.2 m -85.73 122.79 30.33 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.086 0.469 . . . . 0.0 112.055 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.704 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 64.8 m-85 -128.0 135.65 50.19 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.088 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.694 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 5.9 tmm_? . . . . . 0 C--N 1.314 -0.959 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.247 0 N-CA-C 112.568 -0.213 . . . . 0.0 112.568 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.5 mt -130.36 131.32 23.31 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.33 126.75 17.6 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.52 2.147 . . . . 0.0 111.633 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.1 m -81.2 -48.12 12.5 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.079 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.43 -53.9 0.4 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 119.788 -1.196 . . . . 0.0 113.856 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.538 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 3.4 mp0 -67.32 147.45 52.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.314 0.578 . . . . 0.0 112.098 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -110.21 127.33 54.89 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.324 178.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.7 m -73.61 41.63 0.12 Allowed 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.852 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.639 HG22 ' HD2' ' A' ' 25' ' ' LYS . 7.6 t -104.87 -49.16 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 107.769 -1.196 . . . . 0.0 107.769 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.536 ' HD1' HG12 ' A' ' 9' ' ' VAL . 27.3 m95 -139.09 -11.48 1.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.333 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.48 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 48.4 mm -116.2 125.26 28.71 Favored Pre-proline 0 CA--C 1.528 0.111 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.908 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 11' ' ' ILE . 2.8 Cg_exo -74.17 143.49 32.14 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.695 2.264 . . . . 0.0 110.859 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.0 m -69.76 95.36 0.88 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.884 0.374 . . . . 0.0 111.997 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.18 -32.28 53.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.682 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 17.4 p -61.81 -6.7 2.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 113.255 -1.793 . . . . 0.0 111.608 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 23.8 m -58.81 -26.09 63.8 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.34 -31.26 69.02 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.73 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.8 pt -103.93 27.53 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.547 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.43 5.45 79.14 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 115.362 0.905 . . . . 0.0 115.362 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 15' ' ' SER . 92.6 m -75.34 141.43 43.34 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 118.48 1.14 . . . . 0.0 110.556 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -148.49 146.39 28.34 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.78 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.1 m -53.61 125.01 16.67 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 28' ' ' TYR . 38.8 mttp -151.72 122.9 7.7 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 25' ' ' LYS . 20.3 m 59.78 36.86 22.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.002 0.429 . . . . 0.0 110.245 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.639 ' HD2' HG22 ' A' ' 9' ' ' VAL . 18.3 tppt? 71.69 0.92 3.68 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.501 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -125.85 146.85 30.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 121.724 -0.61 . . . . 0.0 110.458 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 39.8 m -69.98 117.76 11.97 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.485 ' HB2' ' HB2' ' A' ' 23' ' ' LYS . 3.9 m-85 -122.91 152.68 40.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.389 0.614 . . . . 0.0 111.344 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.51 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 5.6 tmm_? -146.25 125.5 13.02 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.313 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.501 ' HB2' ' HD2' ' A' ' 29' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 121.306 0.574 . . . . 0.0 110.02 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.394 0 CA-C-O 120.475 -0.07 . . . . 0.0 113.185 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.6 mt -103.07 126.66 31.76 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.68 123.17 12.47 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.321 2.014 . . . . 0.0 112.273 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.68 -16.83 60.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.362 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.55 -36.0 3.97 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.078 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.546 ' OE1' ' HB3' ' A' ' 13' ' ' CYS . 25.9 mt-10 -63.39 133.0 53.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.866 0.365 . . . . 0.0 110.281 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.77 125.17 47.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.418 0.628 . . . . 0.0 110.779 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.3 m -71.01 6.02 1.77 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.19 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.497 HG22 ' HB3' ' A' ' 25' ' ' LYS . 13.2 t -79.43 -33.51 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.318 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -118.95 -45.5 2.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.222 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.4 mt -142.43 133.62 12.93 Favored Pre-proline 0 N--CA 1.464 0.26 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.299 -178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -60.94 140.89 92.68 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.271 1.981 . . . . 0.0 110.995 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.552 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 2.9 m -72.42 115.21 11.41 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.483 -178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 60.6 mt -67.44 -37.62 79.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.441 ' HB2' ' OE1' ' A' ' 6' ' ' GLU . 15.3 m -61.61 -8.57 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.017 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.552 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 33.1 m -59.96 -35.89 75.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.12 -24.91 67.43 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.951 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.9 pt -104.41 13.87 7.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.91 -24.42 5.13 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 119.167 -1.492 . . . . 0.0 115.604 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 16' ' ' SER . 73.4 m -63.58 137.22 58.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 118.415 1.107 . . . . 0.0 111.547 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -122.36 126.19 47.51 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.915 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.3 t -75.91 124.22 26.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.051 0.453 . . . . 0.0 110.798 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -137.88 123.03 19.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.7 m 59.42 34.86 22.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.184 0.516 . . . . 0.0 110.083 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.497 ' HB3' HG22 ' A' ' 9' ' ' VAL . 64.2 mttp 70.48 13.22 7.45 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.306 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 t -128.03 132.06 68.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.6 m -89.13 135.15 33.72 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.434 0.902 . . . . 0.0 113.434 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.97 142.95 49.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.322 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.405 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 58.5 ttt-85 -128.52 117.46 21.34 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 m120 . . . . . 0 C--N 1.327 -0.386 0 O-C-N 123.445 0.466 . . . . 0.0 110.412 -178.515 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.374 0 N-CA-C 113.305 0.082 . . . . 0.0 113.305 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.8 mt -123.13 127.2 25.74 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.64 124.82 15.34 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.504 2.136 . . . . 0.0 113.189 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.7 m -78.22 -28.02 47.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.583 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.16 -41.22 2.25 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.297 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.79 136.33 50.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.779 0.324 . . . . 0.0 111.084 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.75 129.11 54.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.4 p -72.3 -18.43 61.79 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.603 HG23 ' HD1' ' A' ' 10' ' ' TRP . 0.0 OUTLIER -67.65 -44.16 86.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.326 178.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.603 ' HD1' HG23 ' A' ' 9' ' ' VAL . 18.7 m95 -78.35 -45.97 21.22 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.904 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.703 HD12 ' HD2' ' A' ' 12' ' ' PRO . 6.9 tp -170.22 135.29 1.18 Allowed Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.703 ' HD2' HD12 ' A' ' 11' ' ' ILE . 1.2 Cg_endo -47.82 134.98 22.96 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.443 2.095 . . . . 0.0 112.222 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 3.5 m -72.01 125.49 27.37 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.986 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.8 -38.68 83.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.481 ' HB2' HH21 ' A' ' 29' ' ' ARG . 40.3 p -62.08 -14.58 37.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.007 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 58.6 m -62.88 -34.33 77.17 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.56 -20.64 64.88 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.251 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.8 pt -112.24 20.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.34 -27.57 5.51 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 118.963 -1.589 . . . . 0.0 116.244 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 16' ' ' SER . 68.1 m -62.64 133.33 54.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.508 1.154 . . . . 0.0 112.457 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -120.9 121.68 38.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.981 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.885 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 8.0 t -68.31 131.62 45.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.056 0.455 . . . . 0.0 111.02 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -143.85 131.03 20.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.3 m 57.74 35.9 26.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.374 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 82.74 -16.72 0.57 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.573 1.149 . . . . 0.0 112.927 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.9 p -116.68 135.07 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-O 121.351 0.596 . . . . 0.0 112.016 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.885 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 m -69.85 137.15 51.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.277 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -129.34 155.5 45.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.708 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 29' ' ' ARG . 13.7 ptp180 -138.68 116.7 11.69 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.952 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.5 t30 . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.305 0.574 . . . . 0.0 110.94 -179.235 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.276 0 N-CA-C 112.7 -0.16 . . . . 0.0 112.7 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 75.8 mt -129.77 131.39 23.51 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 23.1 Cg_exo -63.19 127.45 20.19 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.474 2.116 . . . . 0.0 111.949 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.9 m -79.79 -49.76 11.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.941 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.95 -52.42 0.4 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.972 -1.108 . . . . 0.0 113.503 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.543 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 1.3 mp0 -75.19 166.94 22.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.578 0.704 . . . . 0.0 111.863 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 1.2 m -127.23 138.91 53.21 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -64.19 -23.76 67.43 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.35 0.595 . . . . 0.0 111.606 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.428 HG23 ' HB3' ' A' ' 25' ' ' LYS . 41.0 t -71.42 -33.29 49.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.578 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -85.86 -55.88 3.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.755 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pp -160.15 162.84 23.42 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.72 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -62.35 143.62 93.96 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.152 1.901 . . . . 0.0 111.43 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.427 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 35.8 m -65.31 107.33 1.58 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.128 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.1 pt -68.41 -36.48 75.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.512 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 41.5 m -59.45 -7.43 1.38 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 113.508 -1.678 . . . . 0.0 111.834 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 48.2 m -58.31 -32.65 68.66 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.01 -30.22 69.01 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.503 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.1 pt -101.53 24.47 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.17 12.11 57.85 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 115.384 0.913 . . . . 0.0 115.384 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 16' ' ' SER . 75.2 m -87.93 153.13 21.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 118.208 1.004 . . . . 0.0 110.084 178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.4 t -144.87 142.87 30.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.784 0.326 . . . . 0.0 110.378 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 23' ' ' LYS . 41.9 t -66.8 131.35 45.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.771 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 22' ' ' CYS . 1.2 tppp? -158.86 129.4 6.0 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m 59.53 33.56 22.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.1 0.476 . . . . 0.0 110.889 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.428 ' HB3' HG23 ' A' ' 9' ' ' VAL . 49.0 mtmt 71.59 10.49 6.45 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.635 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 7' ' ' SER . 1.3 m -136.26 152.67 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.922 0.391 . . . . 0.0 110.649 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 22.9 m -80.01 122.24 26.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.659 0.266 . . . . 0.0 111.119 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -129.25 155.03 46.21 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.285 0.564 . . . . 0.0 111.148 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.434 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 45.7 ttp180 -146.97 122.42 10.36 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.839 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.9 t30 . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.463 0.649 . . . . 0.0 110.433 -179.004 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 112.039 -0.424 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 69.7 mt -118.72 125.94 27.44 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.33 130.33 33.53 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.589 2.193 . . . . 0.0 112.611 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 58.9 m -98.65 15.65 24.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.333 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.93 -46.66 2.7 Favored Glycine 0 C--N 1.331 0.268 0 CA-C-N 116.087 -0.506 . . . . 0.0 113.677 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -64.59 160.03 20.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.177 0.513 . . . . 0.0 111.342 -179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.531 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -148.03 133.01 18.14 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 121.286 0.565 . . . . 0.0 110.947 179.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.5 m -75.67 25.89 0.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.196 178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.692 HG22 ' HB3' ' A' ' 25' ' ' LYS . 25.0 t -92.49 -37.32 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -108.86 -45.13 3.86 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.0 -1.455 . . . . 0.0 110.69 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -153.37 155.79 31.97 Favored Pre-proline 0 N--CA 1.468 0.426 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -64.29 146.54 90.26 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.382 2.055 . . . . 0.0 110.486 178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.502 ' SG ' ' HB3' ' A' ' 22' ' ' CYS . 1.5 m -67.84 115.62 7.59 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.34 -33.95 63.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.5 p -62.97 -5.91 3.38 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 114.277 -1.329 . . . . 0.0 111.82 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.697 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 29.4 m -62.03 -30.48 71.0 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -24.58 63.91 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.128 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.3 pt -112.35 28.23 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.26 -16.0 53.7 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 116.376 1.31 . . . . 0.0 116.376 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.697 ' O ' ' HA ' ' A' ' 16' ' ' SER . 89.6 m -70.24 141.07 52.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 118.983 1.392 . . . . 0.0 111.573 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 p -142.31 124.39 15.38 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.825 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 21.5 p -73.76 130.25 39.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.952 0.882 . . . . 0.0 111.663 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.879 ' HE2' ' HB2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -132.17 133.44 44.23 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.6 m 61.79 31.28 18.43 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.692 ' HB3' HG22 ' A' ' 9' ' ' VAL . 33.6 mttm 73.75 -5.82 1.93 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.051 -1.431 . . . . 0.0 113.353 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.1 t -105.11 132.98 50.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 118.401 0.546 . . . . 0.0 109.901 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.825 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 57.6 m -75.78 125.31 28.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.879 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 9.5 m-85 -136.32 141.21 43.77 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.321 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.479 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 22.4 ttm180 -98.41 98.81 9.98 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 . . . . . 0 N--CA 1.47 0.533 0 O-C-N 124.069 0.856 . . . . 0.0 109.912 -177.25 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.349 0 CA-C-O 120.378 -0.123 . . . . 0.0 113.285 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 65.0 mt -94.16 124.03 57.18 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.973 0.386 . . . . 0.0 110.223 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.75 118.91 5.83 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.083 1.856 . . . . 0.0 112.514 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 21.6 m -75.37 -23.92 57.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.375 0.607 . . . . 0.0 109.57 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.43 -37.95 3.35 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.519 -0.764 . . . . 0.0 113.058 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.488 ' HG2' ' H ' ' A' ' 6' ' ' GLU . 3.0 pt-20 -71.3 125.75 27.79 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.155 0.502 . . . . 0.0 111.225 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.42 132.61 38.87 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.6 p -72.59 -22.52 60.97 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.126 0.488 . . . . 0.0 112.211 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.99 -33.08 42.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.241 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -82.34 -52.55 6.81 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.741 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.6 pt -152.25 155.73 33.34 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.914 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -63.6 136.0 52.0 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.277 1.318 . . . . 0.0 110.442 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.577 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 56.2 m -73.84 114.59 12.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.053 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mm -66.29 -41.9 89.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.427 ' HA ' HG12 ' A' ' 18' ' ' ILE . 49.5 m -64.13 -7.81 10.12 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.055 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.577 ' OG ' ' HB2' ' A' ' 13' ' ' CYS . 18.8 m -64.15 -34.33 77.82 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.52 -18.55 62.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.954 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' A' ' 15' ' ' SER . 21.8 pt -117.93 23.99 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.81 -30.89 5.37 Favored Glycine 0 C--N 1.339 0.733 0 C-N-CA 118.946 -1.597 . . . . 0.0 116.754 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 16' ' ' SER . 96.2 m -62.33 133.53 55.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.623 1.211 . . . . 0.0 112.479 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.9 t -126.89 134.29 50.5 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 14.1 t -75.02 135.07 41.3 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.366 0.603 . . . . 0.0 112.285 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -150.86 132.42 14.79 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 4.3 m 59.48 35.02 22.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' SER . 67.3 mttm 77.95 -16.97 0.61 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.892 0.877 . . . . 0.0 112.852 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -110.85 137.63 42.45 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-O 121.009 0.433 . . . . 0.0 111.717 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.716 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 2.1 m -77.94 136.18 37.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.162 0.506 . . . . 0.0 112.257 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -129.12 148.05 51.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.679 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.543 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 19.5 ttm180 -122.63 110.44 15.53 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 C--N 1.327 -0.406 0 O-C-N 123.407 0.442 . . . . 0.0 110.449 -178.678 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.209 0 N-CA-C 112.682 -0.167 . . . . 0.0 112.682 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.0 mm -120.66 127.12 26.42 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.15 125.47 14.14 Favored 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.39 2.06 . . . . 0.0 112.377 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.2 m -85.65 -0.56 55.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.616 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.06 -45.35 3.43 Favored Glycine 0 N--CA 1.453 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 113.406 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.58 ' OE2' HG12 ' A' ' 14' ' ' ILE . 53.8 mt-10 -62.89 142.27 58.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.824 0.345 . . . . 0.0 111.13 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.06 138.35 49.55 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.258 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.9 m -66.25 -15.55 63.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.54 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.43 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 41.9 t -68.77 -34.76 66.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.937 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.402 ' O ' HG23 ' A' ' 11' ' ' ILE . 27.2 m95 -93.24 -57.13 2.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.217 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 10' ' ' TRP . 5.4 pt -160.55 160.34 25.77 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.177 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -63.12 137.93 64.34 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.658 1.572 . . . . 0.0 110.326 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.3 m -75.71 122.77 24.5 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.346 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.58 HG12 ' OE2' ' A' ' 6' ' ' GLU . 12.4 pt -65.64 -37.4 79.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.5 m -60.32 -11.84 7.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.839 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 59.0 m -61.84 -34.3 75.72 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.01 -24.09 66.83 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.974 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.0 pt -107.33 25.92 2.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 109.19 -19.98 28.94 Favored Glycine 0 C--N 1.338 0.674 0 N-CA-C 116.361 1.304 . . . . 0.0 116.361 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.657 ' O ' ' HA ' ' A' ' 16' ' ' SER . 84.1 m -68.54 137.44 54.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.746 1.273 . . . . 0.0 112.004 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.6 p -137.38 138.13 39.57 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 2.1 m -64.95 121.07 13.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.655 0.74 . . . . 0.0 111.934 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -123.67 121.02 34.45 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.6 m 57.44 38.3 28.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 24' ' ' SER . 97.2 mttt 81.17 -18.34 0.5 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.988 -1.006 . . . . 0.0 113.3 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.11 133.51 52.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 117.955 0.343 . . . . 0.0 110.826 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 4.1 m -68.23 129.68 40.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.446 0.641 . . . . 0.0 112.434 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -132.82 154.54 50.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.24 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.452 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 51.7 ttp180 -146.49 122.76 10.9 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 121.448 0.642 . . . . 0.0 110.023 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 pt -129.18 140.05 37.49 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.947 0.374 . . . . 0.0 110.184 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.91 128.42 24.22 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.383 2.056 . . . . 0.0 112.596 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 63.1 m -82.06 -48.37 11.48 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.618 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 159.25 -55.82 0.35 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.564 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.84 158.68 35.63 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.614 0.721 . . . . 0.0 111.248 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m -128.6 137.61 51.78 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.07 3.86 2.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.098 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.1 t -85.81 -33.57 7.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -104.12 -52.45 2.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.254 -0.885 . . . . 0.0 112.012 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.42 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -146.17 157.64 49.35 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-O 120.776 0.322 . . . . 0.0 111.645 -178.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.49 146.91 86.21 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.811 2.341 . . . . 0.0 111.149 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.497 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 23.8 m -64.36 103.75 0.68 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.6 mt -69.57 -36.67 72.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.591 ' HA ' HG12 ' A' ' 18' ' ' ILE . 68.8 m -63.51 0.25 0.77 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.841 -1.527 . . . . 0.0 111.923 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.61 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 65.2 m -60.36 -33.58 72.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.01 -22.18 65.91 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.425 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.591 HG12 ' HA ' ' A' ' 15' ' ' SER . 1.4 mm -94.13 9.85 4.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.612 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.38 17.09 43.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.731 . . . . 0.0 113.487 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 16' ' ' SER . 93.8 m -94.13 154.91 17.35 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 t -144.23 149.96 37.19 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.98 126.57 30.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.206 0.526 . . . . 0.0 110.858 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -144.34 121.66 11.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 m 58.08 37.8 26.52 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.139 0.495 . . . . 0.0 110.973 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt 68.49 13.73 9.01 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.839 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -133.91 143.15 39.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.9 m -78.55 121.14 24.22 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -126.47 148.95 49.59 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.358 0.599 . . . . 0.0 110.707 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.629 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 28.2 ttm180 -112.04 108.72 18.12 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 . . . . . 0 N--CA 1.471 0.607 0 O-C-N 124.014 0.821 . . . . 0.0 110.79 -177.867 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.444 0 CA-C-O 120.069 -0.295 . . . . 0.0 113.775 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.94 126.58 52.95 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 117.303 0.551 . . . . 0.0 110.592 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.79 120.41 8.29 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.445 2.096 . . . . 0.0 112.582 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 61.4 m -76.23 -25.3 54.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.441 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.18 -31.01 8.27 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.7 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.545 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 32.9 mt-10 -61.53 130.72 47.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.61 0.243 . . . . 0.0 110.411 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.18 125.9 51.55 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 m -65.14 -18.19 65.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.527 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.8 t -71.23 -35.53 58.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.309 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.3 m95 -89.92 -52.88 4.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.505 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -155.58 153.85 27.11 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.285 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.16 147.91 88.63 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.581 2.187 . . . . 0.0 111.231 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.6 m -58.27 103.94 0.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.574 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.77 -39.85 80.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 54.5 m -64.3 2.65 0.56 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 113.61 -1.632 . . . . 0.0 111.695 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.671 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 62.5 p -62.47 -32.65 73.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.67 -20.64 57.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.728 -1.124 . . . . 0.0 111.203 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.7 pt -119.62 26.53 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.13 -22.15 16.39 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 16' ' ' SER . 85.6 m -68.13 137.67 55.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.992 1.396 . . . . 0.0 111.957 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 p -133.77 138.4 45.71 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.085 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.4 t -72.23 130.69 41.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.872 0.368 . . . . 0.0 111.492 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.505 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 17.7 ttpt -153.84 127.47 8.72 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 16.5 m 59.14 36.01 23.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.822 0.344 . . . . 0.0 111.031 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 24' ' ' SER . 1.1 mptm? 71.54 10.54 6.5 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.532 0.733 . . . . 0.0 112.643 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.783 HG13 ' HE1' ' A' ' 28' ' ' TYR . 2.1 p -140.01 139.93 36.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.147 0.499 . . . . 0.0 110.318 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 34.0 m -78.93 136.13 37.17 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.783 ' HE1' HG13 ' A' ' 26' ' ' VAL . 27.7 m-85 -128.45 146.04 50.92 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.339 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.609 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 26.5 ttm180 -118.83 107.18 13.3 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.358 0 CA-C-O 121.427 0.632 . . . . 0.0 109.829 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 29' ' ' ARG . 37.4 pt -122.95 137.13 27.65 Favored Pre-proline 0 C--N 1.333 -0.123 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.3 129.29 23.66 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.548 2.165 . . . . 0.0 113.512 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.3 m -93.87 9.6 36.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.088 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.88 -41.96 2.44 Favored Glycine 0 C--N 1.333 0.376 0 CA-C-N 116.144 -0.48 . . . . 0.0 113.459 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -63.75 141.17 58.87 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 122.639 0.376 . . . . 0.0 110.588 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.38 132.6 53.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.5 t -70.49 -28.31 64.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.397 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.8 t -71.45 -40.36 72.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.677 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -71.44 -52.63 17.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.552 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -149.66 156.22 38.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -62.13 138.93 75.57 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.08 1.187 . . . . 0.0 109.15 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 16' ' ' SER . 66.1 m -59.47 99.56 0.06 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.4 mt -68.94 -32.98 56.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 62.5 p -64.12 -12.62 41.31 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.231 -1.349 . . . . 0.0 110.776 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.764 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 6.6 t -62.87 -34.79 78.12 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.89 -20.95 64.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.32 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.4 pt -113.19 21.53 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 120.0 -31.2 5.4 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 119.522 -1.323 . . . . 0.0 115.743 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.764 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.3 m -71.28 171.14 11.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 118.12 0.96 . . . . 0.0 111.232 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.3 p -166.47 145.24 5.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.203 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 72.3 m -53.34 129.13 30.85 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 110.467 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.619 ' HB2' ' HZ3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -153.07 115.92 4.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.5 m 55.82 41.94 29.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.544 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 24' ' ' SER . 1.0 OUTLIER 76.1 -14.52 0.79 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.582 0.753 . . . . 0.0 112.856 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.411 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 24.1 t -112.55 146.81 16.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.911 0.386 . . . . 0.0 110.757 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.0 m -73.5 119.51 17.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.411 ' HE1' ' HB ' ' A' ' 26' ' ' VAL . 3.2 m-85 -123.72 144.92 49.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.498 0.666 . . . . 0.0 111.521 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.426 ' O ' HG12 ' A' ' 2' ' ' ILE . 51.5 ttm-85 -102.58 101.87 12.06 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.535 -1.211 . . . . 0.0 107.884 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.8 m120 . . . . . 0 N--CA 1.473 0.718 0 O-C-N 123.864 0.728 . . . . 0.0 110.951 -178.266 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 N-CA-C 113.831 0.292 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.441 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.5 mp -96.75 125.75 45.57 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 117.329 0.565 . . . . 0.0 110.231 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -56.62 123.59 14.22 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.133 1.888 . . . . 0.0 112.287 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.4 m -76.52 -37.98 55.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.305 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.09 -40.7 2.07 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.323 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.65 133.01 44.44 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-O 121.245 0.545 . . . . 0.0 111.278 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -106.5 127.7 53.51 Favored 'General case' 0 C--O 1.244 0.763 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.206 178.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.98 37.12 0.18 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.701 0.762 . . . . 0.0 110.972 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.754 HG22 ' HE3' ' A' ' 25' ' ' LYS . 21.4 t -124.37 -40.87 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.445 ' O ' HG13 ' A' ' 11' ' ' ILE . 17.1 m0 -92.8 -49.23 6.17 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.119 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 10' ' ' TRP . 56.9 mt -157.27 135.22 7.26 Favored Pre-proline 0 N--CA 1.468 0.463 0 O-C-N 123.006 0.191 . . . . 0.0 110.723 -178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.21 139.74 80.94 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.478 2.119 . . . . 0.0 111.763 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.442 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.7 m -73.83 117.83 16.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.279 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.13 -34.47 66.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.404 ' HA ' HG12 ' A' ' 18' ' ' ILE . 77.9 p -60.6 -12.65 10.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.222 -1.353 . . . . 0.0 112.0 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 19.1 m -59.63 -36.09 75.66 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.29 67.28 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.875 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 15' ' ' SER . 41.0 pt -104.91 17.22 5.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.71 -21.13 8.07 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 119.038 -1.553 . . . . 0.0 115.524 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 16' ' ' SER . 55.6 m -64.77 138.21 58.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 118.272 1.036 . . . . 0.0 111.76 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.3 t -123.6 134.32 53.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.651 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.5 t -75.73 116.77 16.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.022 0.439 . . . . 0.0 110.576 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -130.91 126.41 36.04 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.7 m 58.58 36.94 25.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.198 0.523 . . . . 0.0 110.666 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.754 ' HE3' HG22 ' A' ' 9' ' ' VAL . 31.5 mmmt 70.7 11.27 7.2 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.962 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 p -136.78 134.73 48.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.174 0.511 . . . . 0.0 109.68 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 27.0 m -79.17 134.37 36.7 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -129.79 146.13 51.55 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.635 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 2' ' ' ILE . 9.6 ptp180 -114.04 99.44 7.65 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.568 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.6 t30 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.696 -178.634 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.196 0 N-CA-C 112.737 -0.145 . . . . 0.0 112.737 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 70.3 mt -123.81 130.48 24.42 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 27.9 Cg_exo -62.21 126.07 17.79 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.615 2.21 . . . . 0.0 111.983 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.4 m -78.36 -22.63 47.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.612 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.86 -38.54 3.06 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.608 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -69.85 137.57 51.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.982 0.42 . . . . 0.0 110.72 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 t -111.1 144.95 39.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 122.024 0.916 . . . . 0.0 110.426 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -73.8 -16.97 61.14 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 113.701 -1.591 . . . . 0.0 110.859 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 25' ' ' LYS . 46.0 t -78.28 -38.95 23.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.99 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.2 m95 -77.54 -52.2 9.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.553 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.569 HD12 ' HD2' ' A' ' 12' ' ' PRO . 8.1 tp -177.72 141.82 0.46 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.569 ' HD2' HD12 ' A' ' 11' ' ' ILE . 1.2 Cg_endo -46.21 133.44 15.31 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.394 2.063 . . . . 0.0 112.075 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.2 m -71.86 122.58 21.0 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.405 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.8 mp -65.8 -35.58 75.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.423 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 61.4 p -61.19 -15.59 35.76 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.829 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 74.5 m -61.32 -35.41 77.3 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.89 -23.1 66.1 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.432 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 pt -108.71 23.37 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.29 -23.57 7.59 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 119.119 -1.515 . . . . 0.0 115.986 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.628 ' SG ' ' HD2' ' A' ' 29' ' ' ARG . 96.5 m -65.07 134.56 54.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.533 1.167 . . . . 0.0 112.213 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.3 t -117.86 133.32 56.04 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.939 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 40.4 t -76.77 117.12 18.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.943 0.402 . . . . 0.0 110.616 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -140.78 129.17 22.49 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.5 m 60.6 31.97 20.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.121 0.486 . . . . 0.0 110.105 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.495 ' HB3' HG23 ' A' ' 9' ' ' VAL . 64.8 mttp 69.7 14.07 8.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.13 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.405 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 30.5 t -131.88 140.75 47.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.4 m -87.67 132.81 33.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.304 0.573 . . . . 0.0 112.474 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.405 ' CE1' ' HB ' ' A' ' 26' ' ' VAL . 72.5 m-85 -134.54 144.87 48.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.679 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.628 ' HD2' ' SG ' ' A' ' 20' ' ' CYS . 6.1 ptm180 -139.29 130.17 26.26 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.1 m120 . . . . . 0 N--CA 1.469 0.503 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.976 -179.109 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.371 0 N-CA-C 112.882 -0.087 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.4 mt -127.31 130.48 23.72 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -62.83 123.43 12.27 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 122.351 2.034 . . . . 0.0 112.217 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 54.5 m -73.96 -32.08 63.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.358 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.54 -46.15 1.1 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.744 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.516 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 50.3 mt-10 -66.48 146.56 54.4 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.016 0.436 . . . . 0.0 111.256 -179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.91 133.13 56.4 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -66.79 -13.91 62.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.306 0.574 . . . . 0.0 111.579 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.3 -35.57 27.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.311 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.9 m95 -89.5 -44.41 10.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.629 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.481 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.6 tt -165.34 141.8 4.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.167 -178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.481 ' HD2' HG13 ' A' ' 11' ' ' ILE . 43.2 Cg_exo -53.72 146.91 42.54 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.183 1.922 . . . . 0.0 111.705 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 56.5 m -59.33 103.12 0.16 Allowed 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.4 mm -70.75 -32.2 48.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.504 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 15.8 p -61.97 -9.21 6.48 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.348 -1.751 . . . . 0.0 111.364 178.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 22.1 m -60.04 -27.09 66.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.42 -31.34 71.27 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.947 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.9 pt -99.9 14.93 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.754 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.27 -2.49 46.99 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.266 -0.969 . . . . 0.0 115.457 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 16' ' ' SER . 64.2 m -72.45 140.2 48.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 118.613 1.206 . . . . 0.0 110.319 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -127.5 142.0 51.51 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 23' ' ' LYS . 50.3 t -70.32 114.38 8.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.02 0.438 . . . . 0.0 110.787 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' A' ' 22' ' ' CYS . 29.0 mmmt -129.08 122.77 30.65 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.0 m 56.85 39.36 29.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.964 0.411 . . . . 0.0 111.409 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp 71.19 11.13 6.84 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -135.69 138.56 47.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.03 0.443 . . . . 0.0 110.406 178.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 18.3 m -71.41 125.33 26.72 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.587 -178.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -128.22 154.22 46.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.388 0.613 . . . . 0.0 111.23 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -144.2 120.35 10.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.67 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.0 t30 . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 121.356 0.598 . . . . 0.0 110.539 -179.101 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.244 0 N-CA-C 112.65 -0.18 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.8 mm -129.09 130.43 23.41 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.63 131.08 40.33 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.715 2.277 . . . . 0.0 112.494 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.617 ' SG ' ' HG2' ' A' ' 29' ' ' ARG . 61.4 m -76.87 -40.93 45.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.164 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.65 -46.19 1.05 Allowed Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.346 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.736 ' HG3' ' SG ' ' A' ' 27' ' ' CYS . 14.3 pt-20 -83.02 159.43 22.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.199 0.523 . . . . 0.0 110.709 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 9' ' ' VAL . 1.6 m -134.18 142.29 47.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.489 0.661 . . . . 0.0 110.672 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -74.53 13.89 0.55 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.458 179.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.688 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 44.2 t -78.7 -35.14 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -120.36 -38.25 2.93 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.587 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 26.6 pt -139.26 151.14 66.69 Favored Pre-proline 0 N--CA 1.463 0.215 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -72.23 142.35 37.48 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.602 2.201 . . . . 0.0 110.329 178.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.499 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 24.7 m -58.84 99.43 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 14' ' ' ILE . 8.6 tp -67.55 -35.37 72.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.498 ' C ' ' HB2' ' A' ' 20' ' ' CYS . 49.7 m -61.6 -3.31 1.0 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.408 -1.724 . . . . 0.0 111.937 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 54.5 m -59.0 -29.86 67.56 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 177.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.11 -29.25 68.48 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.491 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.0 pt -103.46 22.71 2.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.73 -3.87 56.18 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.149 -1.024 . . . . 0.0 115.224 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 16' ' ' SER . 45.9 m -71.47 146.17 48.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 118.297 1.049 . . . . 0.0 110.683 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.0 t -134.81 132.59 38.85 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.113 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 45.4 t -78.36 138.08 38.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.722 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.447 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 2.5 ptpt -165.97 134.79 3.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.3 m 59.08 29.43 18.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.399 0.619 . . . . 0.0 109.815 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.688 ' HE3' ' HA ' ' A' ' 9' ' ' VAL . 30.6 mtpp 63.13 26.06 15.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.175 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.8 p -137.31 143.28 34.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.736 ' SG ' ' HG3' ' A' ' 6' ' ' GLU . 35.2 m -88.16 124.03 33.4 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -131.73 152.67 50.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.269 0.557 . . . . 0.0 110.881 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.617 ' HG2' ' SG ' ' A' ' 4' ' ' CYS . 9.5 ptt85 -142.07 123.36 14.76 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.135 -0.938 . . . . 0.0 109.027 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 . . . . . 0 N--CA 1.467 0.378 0 O-C-N 123.353 0.408 . . . . 0.0 110.786 -179.313 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.614 0 N-CA-C 112.294 -0.322 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.6 mm -112.21 115.49 50.0 Favored Pre-proline 0 N--CA 1.461 0.106 0 CA-C-N 117.03 0.415 . . . . 0.0 110.193 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.51 126.61 14.38 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.496 2.131 . . . . 0.0 113.286 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 m -80.06 -35.57 36.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.139 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.99 -40.19 1.71 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.376 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.556 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 16.2 mt-10 -62.43 152.54 34.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.681 0.277 . . . . 0.0 110.664 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -130.6 129.89 43.31 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.321 0.581 . . . . 0.0 110.862 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.1 m -75.69 36.99 0.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.998 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.454 ' H ' ' C ' ' A' ' 7' ' ' SER . 17.0 t -112.64 -27.14 2.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.1 m-90 -130.88 -35.5 1.42 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.18 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 24.0 pt -140.11 145.25 41.13 Favored Pre-proline 0 N--CA 1.463 0.224 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.21 154.08 70.45 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.438 2.092 . . . . 0.0 111.525 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.408 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 30.3 m -71.88 101.23 2.6 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.292 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.5 mm -65.99 -36.37 77.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.3 m -62.5 -0.36 0.59 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.237 -1.347 . . . . 0.0 112.135 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.689 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 32.4 m -62.96 -30.69 71.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.45 -25.45 66.01 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.976 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.0 pt -109.3 3.5 9.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.16 -26.01 5.36 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.4 -1.381 . . . . 0.0 116.244 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.689 ' O ' ' HA ' ' A' ' 16' ' ' SER . 1.5 m -67.61 139.85 56.86 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.868 1.334 . . . . 0.0 112.503 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.4 p -142.46 158.6 43.52 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.048 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m -58.8 117.15 4.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.219 0.533 . . . . 0.0 112.061 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.468 ' HG3' ' HB2' ' A' ' 28' ' ' TYR . 74.9 mmtt -134.62 111.33 9.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.8 m 57.17 40.5 28.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.125 0.488 . . . . 0.0 109.992 -178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 24' ' ' SER . 30.9 mmtp 76.22 -12.36 1.03 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.132 -0.94 . . . . 0.0 113.028 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HB ' ' HE1' ' A' ' 28' ' ' TYR . 19.6 t -109.36 143.46 19.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 117.893 0.315 . . . . 0.0 110.156 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 62.6 m -74.29 115.38 13.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.914 0.387 . . . . 0.0 111.806 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.468 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . 3.9 m-85 -125.41 142.47 51.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.478 0.656 . . . . 0.0 110.583 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.604 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 69.2 ttt-85 -98.6 86.97 3.69 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 . . . . . 0 N--CA 1.468 0.47 0 O-C-N 124.084 0.865 . . . . 0.0 109.687 -177.202 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.0 mt -128.9 128.27 23.43 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.62 122.61 11.94 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.483 2.122 . . . . 0.0 112.725 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.503 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.1 m -78.26 -32.41 49.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.975 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.7 -36.51 3.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.026 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.525 ' OE1' ' HA ' ' A' ' 13' ' ' CYS . 34.0 mt-10 -69.06 124.68 24.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.948 0.404 . . . . 0.0 110.682 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.58 136.19 33.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.71 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 m -69.02 -27.37 65.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.524 0.678 . . . . 0.0 111.301 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.46 -31.57 38.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.106 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.454 ' O ' HG23 ' A' ' 11' ' ' ILE . 13.0 m0 -79.12 -59.95 2.57 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.718 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 10' ' ' TRP . 4.2 pt -162.75 163.96 17.1 Favored Pre-proline 0 N--CA 1.469 0.501 0 O-C-N 123.243 0.339 . . . . 0.0 110.505 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -64.35 136.5 51.36 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 121.803 1.669 . . . . 0.0 109.985 178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.525 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 3.4 m -77.29 116.72 18.14 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.706 -177.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 14' ' ' ILE . 3.6 mp -64.41 -36.87 78.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 m -60.37 -6.07 1.4 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.236 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 38.4 p -59.35 -34.99 73.04 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.74 -27.1 68.48 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.115 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 pt -99.35 12.7 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.34 -11.97 19.26 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 119.663 -1.256 . . . . 0.0 114.967 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 16' ' ' SER . 80.7 m -69.28 136.28 51.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 118.225 1.012 . . . . 0.0 110.921 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -130.54 136.77 49.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 27' ' ' CYS . 42.5 t -60.6 129.49 41.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.289 0.566 . . . . 0.0 112.048 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 25' ' ' LYS . 70.0 mmtt -121.83 -155.95 0.66 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -45.5 79.25 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 23' ' ' LYS . 11.8 mptt 61.84 6.89 1.78 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.222 1.009 . . . . 0.0 111.913 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.0 t -146.59 139.03 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 O-C-N 122.289 -0.257 . . . . 0.0 111.561 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.6 m -75.63 135.69 40.48 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -129.17 142.15 50.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.488 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.503 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 57.7 ttt180 -98.78 106.39 18.64 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.0 t30 . . . . . 0 N--CA 1.473 0.703 0 O-C-N 123.996 0.81 . . . . 0.0 110.878 -178.206 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.512 0 N-CA-C 113.712 0.245 . . . . 0.0 113.712 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.7 mt -95.99 127.0 42.48 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 117.042 0.421 . . . . 0.0 110.717 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.51 124.63 15.49 Favored 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 122.308 2.005 . . . . 0.0 112.316 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 35.4 m -83.65 10.08 10.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.961 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.48 -39.25 1.91 Allowed Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.212 -0.518 . . . . 0.0 112.525 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.43 ' CD ' ' HA ' ' A' ' 13' ' ' CYS . 42.7 tt0 -63.37 139.98 58.83 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.88 136.47 54.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.038 0.447 . . . . 0.0 110.676 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.2 m -69.02 -17.96 63.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.821 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.411 ' CG2' ' HB3' ' A' ' 25' ' ' LYS . 40.4 t -66.24 -39.14 83.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.99 179.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -87.72 -55.67 3.68 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.76 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.2 mt -151.24 136.41 10.42 Favored Pre-proline 0 N--CA 1.462 0.15 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.712 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -49.8 141.36 28.27 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.314 2.01 . . . . 0.0 111.312 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.43 ' HA ' ' CD ' ' A' ' 6' ' ' GLU . 35.6 m -52.95 98.06 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 65.3 mt -69.85 -32.45 51.94 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.5 ' HA ' HG12 ' A' ' 18' ' ' ILE . 11.5 m -61.71 -2.93 0.92 Allowed 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 113.31 -1.768 . . . . 0.0 111.537 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.74 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 68.7 m -57.99 -35.5 71.3 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.45 -27.42 69.27 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.321 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.5 HG12 ' HA ' ' A' ' 15' ' ' SER . 7.7 mm -81.33 -19.13 11.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.476 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.95 1.62 12.95 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.185 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.74 ' O ' ' HA ' ' A' ' 16' ' ' SER . 75.5 m -79.75 138.52 37.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.855 0.359 . . . . 0.0 110.077 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 p -121.61 143.22 49.43 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.215 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.4 t -76.66 120.54 21.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.133 0.492 . . . . 0.0 111.222 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.558 ' HE2' ' CE1' ' A' ' 28' ' ' TYR . 16.3 ttpt -134.83 125.58 27.13 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 p 51.64 39.94 26.2 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.082 0.468 . . . . 0.0 111.318 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 69.21 16.52 8.48 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.681 179.474 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.429 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 44.2 t -131.71 140.34 48.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 38.8 m -82.1 128.51 34.2 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.558 ' CE1' ' HE2' ' A' ' 23' ' ' LYS . 56.5 m-85 -131.88 144.38 50.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.096 0.474 . . . . 0.0 110.89 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.548 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 59.6 ttt-85 -126.16 113.83 17.55 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 177.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.5 t30 . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 121.581 0.705 . . . . 0.0 109.49 -178.092 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.206 0 N-CA-C 112.82 -0.112 . . . . 0.0 112.82 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.0 mt -125.63 129.26 24.43 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -63.14 124.94 14.79 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.386 2.058 . . . . 0.0 111.786 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.9 m -77.15 -32.62 56.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.847 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.6 -44.51 1.22 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.601 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.468 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 53.8 mt-10 -66.93 146.89 53.91 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.949 0.404 . . . . 0.0 110.875 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.87 137.49 52.75 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.6 m -64.1 -25.63 68.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.426 0.632 . . . . 0.0 111.243 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.4 t -70.38 -33.15 52.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.275 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -81.67 -59.74 2.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.938 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.3 pt -156.85 161.71 29.01 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.897 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -62.76 144.42 93.76 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 121.965 1.777 . . . . 0.0 110.533 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 22' ' ' CYS . 44.4 m -61.58 101.29 0.18 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 67.2 mt -69.82 -32.89 53.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.606 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 23.4 p -61.97 -8.38 5.12 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.34 -1.755 . . . . 0.0 111.456 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.675 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 16.8 m -60.43 -28.32 68.18 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.66 -28.34 68.51 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.07 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.9 pt -105.28 21.72 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.98 -4.62 56.04 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.235 -0.984 . . . . 0.0 115.413 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.675 ' O ' ' HA ' ' A' ' 16' ' ' SER . 92.7 m -74.45 143.6 44.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.427 1.114 . . . . 0.0 110.351 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -132.01 138.9 48.42 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.176 -0.327 . . . . 0.0 110.985 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.402 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 19.1 t -74.51 128.14 34.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.872 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -166.29 138.26 3.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.414 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.4 m 60.98 30.36 19.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.085 0.469 . . . . 0.0 110.229 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 62.2 mttp 71.13 7.57 6.19 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.668 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.621 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 25.4 t -133.88 150.8 31.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 110.444 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 33.3 m -84.42 121.04 27.0 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.621 ' CE1' ' HB ' ' A' ' 26' ' ' VAL . 87.3 m-85 -123.36 148.47 46.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.939 0.399 . . . . 0.0 111.082 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.52 ' HB2' ' HA ' ' A' ' 20' ' ' CYS . 54.9 ttp85 -140.87 121.68 14.42 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.147 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 . . . . . 0 N--CA 1.469 0.506 0 O-C-N 123.547 0.529 . . . . 0.0 110.746 -178.77 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.3 mt -126.32 128.47 24.4 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -60.16 131.98 41.86 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.461 2.107 . . . . 0.0 112.823 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 85.2 m -96.62 17.51 16.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.535 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.33 37.89 93.79 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.885 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' OE1' ' HA ' ' A' ' 13' ' ' CYS . 42.5 tt0 -149.01 153.46 37.93 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -139.06 139.15 37.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.367 0.603 . . . . 0.0 111.152 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -10.22 59.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.597 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.838 HG22 ' HE3' ' A' ' 25' ' ' LYS . 25.2 t -71.77 -38.23 65.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.446 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -89.93 -43.82 10.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.996 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.591 HG13 ' HD2' ' A' ' 12' ' ' PRO . 12.5 tt -166.53 141.95 3.72 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.263 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.591 ' HD2' HG13 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -47.09 138.9 15.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.609 2.206 . . . . 0.0 111.709 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.41 ' HA ' ' OE1' ' A' ' 6' ' ' GLU . 59.7 m -56.73 98.47 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -177.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.9 mm -69.01 -30.7 47.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.475 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 71.3 p -59.85 -12.45 7.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.801 178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.703 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 30.0 m -57.49 -33.98 68.59 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.33 -28.16 66.56 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.732 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.1 pt -104.76 27.56 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.66 1.58 63.72 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.703 ' O ' ' HA ' ' A' ' 16' ' ' SER . 77.1 m -86.53 162.58 17.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 118.197 0.998 . . . . 0.0 110.405 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 t -150.02 148.37 28.96 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.6 t -70.62 114.39 8.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.111 0.481 . . . . 0.0 110.731 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -125.84 115.41 19.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.4 m 58.56 38.67 25.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.131 0.491 . . . . 0.0 110.671 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.838 ' HE3' HG22 ' A' ' 9' ' ' VAL . 30.5 mtpp 71.12 7.21 6.1 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.222 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.8 t -123.7 138.32 53.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.7 m -75.74 118.67 18.81 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -132.61 145.14 50.85 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.417 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -104.12 105.59 15.81 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.473 0.683 0 O-C-N 123.776 0.673 . . . . 0.0 110.441 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 111.704 -0.559 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 48.5 mm -120.67 126.37 26.74 Favored Pre-proline 0 C--N 1.331 -0.196 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 2' ' ' ILE . 33.0 Cg_exo -59.24 122.64 11.89 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.528 2.152 . . . . 0.0 112.795 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 29' ' ' ARG . 56.0 m -88.11 -32.51 18.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.448 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.56 -37.96 2.88 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.779 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.461 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 27.5 mt-10 -59.65 144.83 46.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.9 0.381 . . . . 0.0 110.635 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.42 126.22 43.47 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.1 -7.63 24.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.437 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.3 t -77.59 -31.72 17.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.971 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -104.09 -53.57 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.896 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.6 mm -147.85 136.37 11.34 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.227 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -56.8 146.67 76.92 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.488 2.125 . . . . 0.0 111.745 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.595 ' HB2' ' OG ' ' A' ' 16' ' ' SER . 1.6 m -61.35 102.12 0.21 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.211 -178.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.8 mm -68.7 -38.13 78.5 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.493 ' HA ' HG12 ' A' ' 18' ' ' ILE . 18.0 m -63.84 4.42 0.29 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.846 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.767 ' HA ' ' O ' ' A' ' 20' ' ' CYS . 73.2 m -61.12 -35.44 77.06 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.43 -21.24 66.59 Favored 'General case' 0 CA--C 1.526 0.036 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.455 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.493 HG12 ' HA ' ' A' ' 15' ' ' SER . 8.7 mm -89.2 -17.59 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.013 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.78 -13.88 5.54 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.653 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.767 ' O ' ' HA ' ' A' ' 16' ' ' SER . 82.5 m -68.72 151.57 46.49 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.7 m -150.73 141.56 22.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 36.4 t -65.26 124.08 21.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.279 0.562 . . . . 0.0 111.152 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.704 ' HD3' ' HB2' ' A' ' 28' ' ' TYR . 27.9 mtpp -141.18 116.2 9.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 25' ' ' LYS . 19.0 m 57.79 40.06 26.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.931 0.396 . . . . 0.0 111.038 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 24' ' ' SER . 33.0 mmtp 72.58 0.56 3.67 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.928 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.58 ' HB ' ' CE1' ' A' ' 28' ' ' TYR . 23.8 t -119.47 140.33 43.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 6' ' ' GLU . 39.2 m -85.73 122.79 30.33 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.086 0.469 . . . . 0.0 112.055 -178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.704 ' HB2' ' HD3' ' A' ' 23' ' ' LYS . 64.8 m-85 -128.0 135.65 50.19 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.088 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.694 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 5.9 tmm_? -84.6 96.72 9.27 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 N--CA 1.47 0.566 0 O-C-N 124.041 0.838 . . . . 0.0 110.039 -177.917 . . . . . . . . 0 0 . 1 stop_ save_